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CHAPTER 1
“EPIGENETIC CONSEQUENCES OF PRE-CONCEPTIONAL EXPOSURES IN HUMAN”
This chapter was adapted in part from the following publication:
Estill MS, Krawetz SA. (2016) “The Epigenetic Consequences of Paternal Exposure to
Environmental Contaminants and Reproductive Toxicants.” Current Environmental Health
Reports 3(3):202-13. doi: 10.1007/s40572-016-0101-4.

i. Summary
The Developmental Origins of Health and Disease (DOHaD) hypothesis proposes that
periconceptional environment influences offspring phenotype, partially through epigenetic
mechanisms [1-3]. Both maternal and paternal peri-conceptional environments are now
believed to contribute to offspring phenotype. Assisted reproductive technologies, such as in
vitro fertilization, alter the pre- and post-fertilization environment of the human embryo.
Manipulation of the early embryo for treating human infertility is suspected of contributing to
offspring abnormalities through epigenetic mechanisms. While the causal paternal
components of DOHaD are insufficiently understood, particularly in human, the preconceptional environment of the father may influence several components of the male
germline. In addition to the haploid paternal DNA, spermatozoa carry RNA, proteins and
chromatin marks to the embryo. Murine and limited human studies suggest that epigenetic
marks in the mature spermatozoa may be modified by the paternal environment, including
common endocrine disruptor exposures. Frequent human exposures to endocrine disruptors,
exogenous chemicals that can mimic or alter hormonal responses, make it imperative to fully
define the affected epigenetic marks in human sperm.
ii. Background
The Developmental Origins of Health and Disease (DOHaD) theory proposes that
preconceptional, prenatal and childhood exposures affect health outcomes later in life.
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Maternal health is a critical component of DOHaD, as maternal stressors, diet, and chemical
exposures can directly affect both the oocyte and the growing fetus across gestation. Maternal
psychological stress during gestation, often measured by self-reporting, is often correlated
with autism symptom severity [4] and toddler cognition and temperament [5, 6]. Maternal diet
is well documented to be associated with offspring health [7, 8]. Certain chemical exposures
during human gestation are well known to be detrimental to fetal development. For example,
gestational thalidomide use, prescribed as an antiemetic to counter morning sickness, leads
to limb and organ deformation [9]. However, more subtle effects, in the absence of a gross
fetal morphological phenotype, may occur with gestational exposure to exogenous chemicals.
For example, diethylstilbestrol (DES), a synthetic estrogen, was once prescribed under the
assumption that DES would prevent adverse pregnancy outcomes, such as pre-term birth and
miscarriages. However, gestational exposure to DES has since been associated with
reproductive system cancers and reproductive tract problems in the exposed offspring [10].
With the majority of DOHaD studies focus on the maternal contribution to fetal health,
the paternal aspect of DOHaD remains largely unexplored. However, there is evidence for the
non-genetic transfer of paternal environmental information to the embryo and subsequent
fetus (Figure 1.1). Murine experiments on paternal exposure to chemicals, extreme diets,
exercise or adverse psychological events suggest that the paternal experience is passed
along to the offspring, presenting an offspring phenotype. For example, male mice fed a
Western-like diet produce offspring with metabolic dysfunction, an effect which is suggested
to be mediated by spermatozoal RNAs [11]. The intergenerational effects of paternal diet also
extend to simpler organisms, with a drosophila model showing that acute paternal dietary
sugar reprograms offspring metabolism [12]. Stressful events in both neonatal and adult male
mouse are capable of modifying phenotype, such as fear and anxiety responses, in
subsequent offspring [13-15].
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Figure 1.1. DOHaD maternal and paternal contributions. Maternal and paternal germlines
may be influenced by their environments and stimuli, such as chemical exposures and food
availability. On the maternal side, the uterine condition can also be affected by the maternal
environment. Environmental insults to parental reproductive tissues and the developing fetus
can influence the phenotype (e.g. health) of the offspring during childhood and into adulthood.
Accordingly, environmental perturbations in the human may also affect offspring.
While the long-term observations are required to demonstrate the isolated/specific paternal
contribution in humans to the offspring and subsequent generations, historical records of
isolated communities do suggest that parental nutrition influences the disease risk of
subsequent generations [16]. Observations of a Swedish parish, Överkalix, suggest that
dramatic shifts in pre-pubertal food availability of paternal grandmothers increases the risk for
cardiovascular mortality in female grandchildren, via the F1 sons, suggesting a spermmediated mechanism. Subsequent work on the Uppsala Birth Cohort Multigeneration Study
further suggested that abundant access to food during the slow-growth period (pre-pubertal
period) of paternal grandfathers is associated with elevated mortality in grandsons, also
supporting a sperm-mediated mechanism [17]. The well-documented 1944-45 Dutch famine,
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caused by a German blockade of the Western Netherlands during World War II, yielded a
cohort of individuals who experienced gestational undernutrition. Maternal undernutrition
during gestation of male offspring (F1 generation) resulted in the grandchildren (F2
generation) being prone to obesity [18].
To understand the impact of human paternal environment, it is critical to thoroughly
characterize the components of the male gamete, as well as the mechanisms by which
common environmental exposures may alter spermatozoal contents. Human populations are
exposed to a wide spectrum of environmental contaminants, some of which are considered
reproductive toxins [19]. Certain exposures are intentional, such as the case of
chemotherapeutic treatments, intended to kill fast-growing cells, including the target cancer
cells. However, chemotherapy often has negative repercussions on the reproductive system,
up to and including infertility. Other such reproductive toxins include certain heavy metals,
such as lead, and endocrine disruptors, such as bis-phenol A (BPA), which can disrupt
gametogenesis and reproductive functions [20]. Epidemiological studies have examined the
effect of such toxins on the human male reproductive system. However, the basic tenant of
epidemiological studies in the male human is to infer how one or more substances alter the
hormonal profile, seminal characteristics, or both. Unfortunately, except in extreme cases of
sperm parameter abnormalities, such as azoospermia or globozoospermia, the clinical utility
of traditional seminal characteristics at predicting fertility is limited [21, 22]. The contribution
of subtle epigenetic alterations, such as DNA methylation and histone marks, to reproductive
phenotypes and fertility potential has, until recently, received little attention.
The mechanisms underlying phenotypic changes in DOHaD are largely proposed to
be epigenetic. Although genotype and consequent gene-environment interactions certainly
account for a portion of a response, controlled murine experiments indicate a long-lasting
effect that perpetuates a phenotype across an individual’s lifetime, and possibly to the
individuals offspring [11, 23-25]. This long-lasting mechanism occurs despite the mutability of
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epigenetic marks across an individuals’ lifetime [26-28]. Epigenetics is broadly defined as the
non-permanent alteration of DNA structure. Common epigenetic alterations are DNA
methylation, histone modifications, and chromatin states (euchromatin/heterochromatin).
DNA methylation, the addition of methyl groups to individual bases, occurs primarily in the
context of methylated cytosines. In mammals, 5-methylcytosine (5-mC) is thought to be the
primary type of methylated cytosine [29]. Other epigenetic alterations, while being more
transitory in nature, also can alter DNA structure, such as regulatory RNA and TF binding.
The involvement of the epigenome in Assisted Reproductive Technologies and the male
germline is explored below.
iii. Epigenetics in embryonic development
Human infertility is a common condition, with approximately 12% of couples of
childbearing age in the United States experiencing a prolonged time to conception or the
inability to conceive [30]. Assisted reproductive technology (ART) therapies to address
infertility range from non-invasive to invasive. Non-invasive therapies include Timed
Intercourse (TIC) (having intercourse during the predicted window of ovulation), and IntraUterine Insemination (IUI) (manual placement of sperm inside a woman's uterus to facilitate
fertilization). Invasive therapies include Gamete Intrafallopian Tube Transfer (GIFT) (external
mixing of sperm and oocyte, followed by immediate transfer to the fallopian tube), In Vitro
Fertilization (IVF) (in vitro oocyte fertilization, followed by transfer to recipient uterus), and
Intra-Cytoplasmic Sperm Injection (ICSI) (IVF, with manual fertilization via direct microinjection of sperm into the egg. Controlled ovarian hyperstimulation, commonly known as
superovulation, is the administration of exogenous gonadotropins to promote the release of
multiple oocytes in a single cycle. Superovulation is often used in conjunction with IVF and
ICSI, in order to obtain viable embryos and increase chances of pregnancy.
With regards to offspring health, IVF is considered a safe procedure and is now
commonplace. Approximately 5 million children have been born through the use of ART [31]
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since the first IVF child was born approximately 36 years ago. Despite the positive impact of
ART, this technology presents an atypical nutritional, biochemical, and hormonal environment
to the developing embryo. Whether this has an effect on the long-term health of the conceptus
and the magnitude of effect remains to be resolved in humans.
The “natural” ovulation cycle involves sequential hormone peaks, that result in follicle
recruitment, maturation, and release at ovulation. Concurrently, the uterine endometrium
undergoes proliferation and vascularization, to yield a thick endometrial layer capable of
supporting embryo implantation and growth [32]. Intercourse (or IUI) around the time of
ovulation, when successful, fertilizes the oocyte within the fallopian tubes. The resulting
embryo then continues its journey to the uterus, where implantation takes place.
While each part of the “natural” fertilization process is designed for optimal oocyte
selection, fertilization, and embryonic development, the focus of IVF is the production of
sufficient numbers of high-quality oocytes for subsequent fertilization. Over the years, IVF
procedures have been refined to optimize production of high-quality embryos [33]. However,
the superovulation procedures, in addition to the psychological and physical stresses of the
female patient [34], neglect the endometrial health and implantation capacity. In the context
of DoHAD, the periconceptional environment of a child born through IVF is comprised of the
oocyte milieu (superovulation, oocyte retrieval, and gamete storage), fertilization, and the
environment surrounding early embryonic development (in vitro growth and uterine
environment). Modification of this pre-implantation environment by assisted reproductive
technologies may have unintended consequences on embryo growth and resulting health of
the child. Additionally, the growing use of oocyte/embryo cryopreservation may further modify
the embryonic environment. Overall, the use of ART procedures, particularly IVF and ICSI,
may unduly alter the epigenome of the fetus. This concept is explored in Chapter 2.
iv. sperm RNA
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The male gamete, spermatozoa, serves to deliver the paternal DNA and other cargo
to the oocyte [35]. Sperm are produced in the seminiferous tubules of the testis through a
series of pre-meiotic, meiotic and post-meiotic processes known as spermatogenesis
(reviewed in [36]). Within the seminiferous tubule, post-meiotic processes require the
transformation of a round spermatid (with typical cellular structure) into the unusual
spermatozoal structure, containing a flagellum, highly condensed nucleus, mitochondrial
midpiece, and very little cytoplasm. After sperm differentiation within the testis, the sperm
enter the epididymis and undergo additional maturation during the approximately two weeks
of epididymal transit [37]. This epididymal maturation potentiates the sperm’s fertilizing ability
and motility [38].
In the past, spermatozoa were perceived to merely be a vessel for the paternal DNA.
However, sperm were subsequently shown to not only contain DNA, but transmit RNA,
proteins and chromatin marks to the embryo [35]. Mature spermatozoa are known to be
transcriptionally and translationally inert. However, labeled probes, microarrays and
eventually, RNA-sequencing, have identified a wide range of RNAs present in sperm, both in
mammals and other organisms [35]. The majority (~85%-96%) of sperm DNA is packaged in
the specialized proteins called protamines, which provide a compact chromatin structure ~10
fold more compact than the nucleosome structure generated by histones [39-41]. However,
sperm still contain some histones, which are known to preferentially localize at promoters of
developmental transcription and signaling factors [39, 42]. In addition to proteins directly
involved in chromatin structure, other proteins with diverse roles are also delivered to the
embryo [43]. This additional cargo, which is delivered to the oocyte, may then influence
fertilization and subsequent fetal health. Recent work on the mammalian epididymis has
shown that epididymal exosomes (epididysomes), which contain proteins, RNAs and other
molecules, are integrated into sperm during epididymal transit [44, 45]. The RNA profiles
observed in the ejaculated spermatozoa thus reflect the final outcome of spermatogenesis,
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which includes both RNAs generated in preparation and those acquired during epididymal
maturation for transmission to the future embryo.
Recent work in humans currently indicate that sperm epigenetic marks and RNAs can
be modified by paternal environment [46]. Comparison of obese males to lean controls
suggested differential profiles of non-coding RNAs and DNA methylation. Additionally, in a
cohort of obese men undergoing bariatric surgery, longitudinal observations of sperm DNA
methylation show shifts in methylation at several genomic loci, including loci involved in
appetite regulation [Donkin cell metabolism 2016]. In a human trial of endurance training, 6
weeks of endurance training was sufficient to remodel both sperm RNA levels and DNA
methylation [47]. While DoHAD studies in human have primarily focused on the maternal
contributions, the preconceptional environment of the male gamete may also play a role in
intergenerational offspring health in human [16, 17].
v. Endocrine disruptors on male reproduction
Like the female reproductive system, the male reproductive system is under the control
of the endocrine system. In humans, the hypothalamic–pituitary–gonadal axis (HPG axis) is a
primary modulator of reproductive function. As shown in Figure 1.2, the hypothalamus
produces Gonadotropin-releasing hormone (GnRH), which influences the adjacent pituitary
gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH) into the
bloodstream. LH subsequently enters the Leydig cells and promotes testosterone production.
Concurrently, FSH promotes the release of androgen-binding protein (ABP), allowing the
binding of testosterone by the Sertoli cells [48]. Androgens, particularly testosterone, are
critical to maintaining spermatocytes and completion of meiosis. Although FSH is not required
for spermatogenesis, the targeted uptake of androgens by Sertoli cells optimizes
spermatogenesis. While testosterone serves as a negative regulator of the hypothalamus and
pituitary gland, thus producing a negative feedback loop in the HPG axis, the contrasting
functions of activins and inhibins (Figure 1.2) also likely play a role regulatory role in
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maintaining spermatogenesis [49]. Among the many functions, activin is a growth factor that
can stimulate the pituitary gland to secrete FSH. In contrast, inhibin, which is produced in
reproductive tissues (as well as other tissues), can suppress pituitary FSH production [50, 51].
Disruption of the HPG axis in males, by environmental factors, age, or genetic mutations, can
result in altered spermatogenesis or hypogonadism [52-54].

Figure 1.2. Hypothalamic–pituitary–gonadal axis in the adult human male. The
hypothalamus within the brain, whose location is approximated by a black dot, secretes
Gonadotropin-releasing hormone (GnRH). GnRH stimulates the adjacent pituitary gland to
secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH) into the bloodstream.
FSH and LH then enter the testis, promoting the production of androgens, particularly
testosterone, and inhibin. Testosterone acts in a paracrine manner to create a negative
feedback loop, suppressing GnRH secretion by the hypothalamus, and also suppressing FSH
and LH production at the level of the pituitary gland. Concurrently, inhibin produced the Sertoli
cells acts in an endocrine manner to suppress FSH production by the pituitary gland.
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Endocrine disruptors, exogenous chemicals that can mimic or alter hormonal
responses, are a prevalent feature in urban environments [19]. A heterogeneous collection of
natural and synthetic chemicals have been identified as likely EDs, including several wellpublicized

pesticides,

such

as

dichlorodiphenyltrichloroethane

(DDT),

and

plastic

components, such as bisphenol A (BPA) and phthalate esters [55]. Phthalates, suspected
endocrine disruptors, are commonly used as solvents and plasticizers in consumer products,
such as polyvinyl chloride. They have also been incorporated into coatings used in
medications [56, 57]. Phthalates have been noted to act on peroxisome proliferator‐activated
receptors (PPAR) [58, 59]. Additionally, different phthalate species, including phthalate
metabolites, have different capacities for modifying an endocrine response [58-60]. Although
considerable literature suggests that gestational and neo-natal phthalate exposure is
detrimental to reproductive function [61], the health effects of phthalates at environmentally
relevant doses in adult humans is still uncertain, particularly in the adult male, although
existing human studies are described below. Interestingly, chronic in vivo exposure of rats to
the tolerable daily intake (TDI) of BPA altered protein expression and histone acetylation [62,
63]. While rats and mice cannot replace pertinent observations in humans, such model
organisms do suggest that humans may also be subject to subtle reproductive changes when
challenged with endocrine disruptors.
Epidemiological studies on adult phthalate exposures and semen parameters have
associated elevated phthalate levels with abnormal sperm morphology [64], sperm
concentration [65, 66], oxidative stress [67], and DNA damage [68]. Among IVF couples,
phthalate levels in the male partner are inversely correlated with high-quality blastocysts [67].
While a controlled study of adult human males exposed to a low, chronic dose of phthalates
[69, 70] indicates hypothalamo-pituitary-testis axis dysregulation and declining sperm motility,
the mechanisms directly underlying the spermatozoal modifications in such individuals are yet
undetermined. The intergenerational and transgenerational impact of such phthalate
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exposures in the adult human male remains unknown. However, animal models, and limited
data in human, suggests that paternal experiences, such as diet or stress, can have
phenotypic consequences in the offspring. Such intergenerational effects are expected to be
mediated through epigenetic mechanisms, such as chromatin structure or RNAs delivered by
the spermatozoon at fertilization [17, 71-73].
vi. Overview
The contribution of the male gamete and pre-implantation environment to offspring
health, while important, is relatively understudied. ART procedures, such as IVF and ICSI,
can alter the pre-implantation environment of the oocyte, growing embryo, and uterus. Despite
the manipulations involved in ART, offspring derived from ART procedures are generally
healthy [74]. However, such offspring may exhibit subtle epigenetic effects, exemplified by the
small, but elevated, risk of congenital defects due to imprinting disorders, such as BeckwithWiedemann and Prader-Willi syndromes [75]. In Chapter 2, I explore the role of IVF/ICSI
protocols in the DNA methylation of infants. The study presents DNA methylation changes in
infants conceived through the use of Fresh Embryo Transfer (ET), Frozen Embryo Transfer
(FET), or Intrauterine Insemination (IUI). The relative similarity between FET and IUI indicates
that the fetus’s DNA methylation is either unchanged by, or altered in an inconsistent manner,
by FET. This is likely due to improved uterine receptivity in FET and IUI conceptions compared
to ET. Overall, this study supports the use of FET in IVF/ICSI procedures [76].
During fertilization, the male gamete contributes DNA, RNA, and epigenetic marks.
Spermatozoal RNA can also provide an epigenetic mechanism. Chapter 3 explores the RNAs
present in the male germline and early embryo. This analysis indicates that, in addition to
annotated transcripts, numerous intergenic and intronic RNAs are present in human
spermatozoa. These novel RNAs were identified using a pipeline for discovering intergenic
RNAs from standard read alignments. Implementation of the RNA Element Discovery
Algorithm (REDa) on somatic, embryonic, and germline tissues revealed presence of both
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novel RNAs and exonic RNAs in each tissue [77]. Spermatozoa contain many more novel
RNAs than somatic (e.g. liver) tissue, suggesting that transcription of intergenic and intronic
RNAs may be important for spermatogenesis. Notably, genomic repeats exhibit a shifting
transcriptional enrichment pattern across spermatogenesis and early embryogenesis.
Using the spermatozoal RNAs identified by the REDa approach, Chapter 4 examines
the impact of phthalate exposure on male reproduction. The Mesalamine and Reproductive
Health Study (MARS) (NCT01331551) was initiated (https://clinicaltrials.gov/) to directly
address the physiological effect of in vivo di-butyl phthalate (DBP) exposure on male
reproduction. Within the MARS study, subjects with Inflammatory Bowel Disease (IBD) were
exposed to longitudinally alternating DBP exposures. Using a cross-over design and
longitudinal data structure, each subject acts as their own control, thus mitigating genetic
variation and environmental variation (e.g. lifestyle and exposome) that often complicates
causal assessment in epidemiology. The results of longitudinal modeling suggest that
exposure to, or removal of, high DBP produces transcriptomic effects that require longer than
one spermatogenic cycle to resolve, if at all. While the two study arms exhibit enrichment of
different biological pathways, the H1BH2 arm, which initiates the study on high DBP, displayed
activation of oxidative stress and DNA damage response pathways. Network analysis of small
RNAs and genomic repeats also suggest that transcription of small RNAs and genomic
repeats contribute to spermatid development. Together, this work provided insight into both
the influence of phthalate on the male germline and the RNA dynamics of human
spermiogenesis.
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CHAPTER 2
“THE IMPACT OF ASSISTED REPRODUCTIVE TECHNOLOGY ON THE EPIGENETIC
PROFILE OF NEWBORNS”
This chapter was adapted from the following publication:
Molly S. Estill, Jay M. Bolnick, Robert A. Waterland, Alan D. Bolnick, Michael P. Diamond,
and Stephen A. Krawetz. (2016) “Assisted reproductive technology alters deoxyribonucleic
acid methylation profiles in bloodspots of newborn infants.” Fertility and Sterility, Volume 106,
Issue 3. Pages 629-639.e10, https://doi.org/10.1016/j.fertnstert.2016.05.006.
i. Summary
Little is known of the genome-wide effect of assisted reproductive technologies (ART),
on the genome and epigenome of the conceptus. To address this shortfall, I have examined
the DNA methylation profile of newborns conceived naturally, or through the use of intrauterine
insemination (IUI), or in vitro fertilization (IVF) using Fresh or Cryopreserved (Frozen) embryo
transfer. Newborn methylation levels of these four different conception types, stratified by
gender, were compared using the HumanMethylation 450k platform. Perturbation of probe
clusters within genes and enhancers suggests that the newborns born from ART possess a
dramatically different methylation profile compared to those naturally conceived. Intriguingly,
there was a striking similarity of the methylation profile of IUI and IVF-Frozen embryo transfer
infants, but not IVF-Fresh. This suggests a possible reduction of epigenetic aberrations in the
IVF conceptions using cryopreservation and implicates that a resetting mechanism is acting
upon cryopreserved embryos. These results are in accord with the observed reduction in birth
defects using those protocols that employ cryopreserved embryos. Periconceptual nutrition is
known to alter epigenomes of offspring at specific loci termed metastable epialleles (MEs).
IVF culture conditions can mimic various nutritional conditions experienced by the early
embryo. With this consideration, analysis of the ART methylation changes in MEs was
undertaken to test the hypothesis that ME loci were sensitive to early nutritional exposure. IVF
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culture conditions and parental infertility showed consistently altered methylation at certain
MEs. This is the first study to reveal an impact of ART or fertility status on MEs and suggests
a lasting epigenetic effect of IVF nutrition on the developing embryo.
ii. Introduction
The DoHAD hypothesis [78] suggests that environment during the periconceptional
period, as well as later stages of embryonic, fetal, and postnatal growth, can persistently
impact health. Epigenetic modifications, including histone modifications and DNA methylation,
are suspected to be one of the mechanisms by which prenatal environment influences
offspring health. Accordingly, nutritional status at the time of conception in rural Gambian
women altered the DNA methylation profile at metastable epiallele (ME) loci in the children.
This effect was modulated, at least in part, by methyl donor availability in the food sources
available at the time of conception [79, 80].
Assisted reproductive technology (ART) provides infertile couples several treatment
options, including ovulation induction followed by intrauterine insemination (IUI), in vitro
fertilization (IVF), and intracytoplasmic sperm injection (ICSI). Despite the positive impact of
ART on fertility outcomes, these procedures present an atypical nutritional, biochemical, and
hormonal environment to the developing embryo. Murine studies suggest that the transient
stresses that IVF places on the growing embryo can result in a considerable change in gene
expression, metabolism, and growth trajectory [81-83], which can persist into adulthood [8487]. Although there are likely several underlying mechanisms for these effects of IVF, one
such mechanism that has been proposed is the increased incidence of random epigenetic
errors, including changes in imprinted genes [83, 88].
ART procedures are generally accepted as safe for the mother and conceptus in
humans. However, there is an elevated risk of birth defects, neurologic disorders, and
imprinting disorders in conceptions generated through IVF and ICSI [89, 90]. In addition to the
increased rate of imprinting disorders in the ART population [75, 91], several recent studies
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comparing the metabolic and cardiovascular health of children conceived by ART with those
conceived naturally indicate a trend toward impaired glucose metabolism and cardiovascular
function [92-94]. Such health risks observed in ART-conceived children may result from
underlying epigenetic aberrations presented by parental infertility or ART itself. However, it is
important to note that evidence for concerted epigenetic changes in the ART population [95100] is countered by a number of studies asserting that the epigenome of ART-conceived
offspring is essentially unchanged [101-104].
Studies investigating the effect of ART on the human epigenome often observe a
limited number of genomic loci, which are usually regions of known interest associated with
imprinting syndromes. However, two studies recently expanded the number of genomic
regions examined in ART studies. One described DNA methylation in the promoter regions of
736 select genes, which were primarily associated with imprinting and growth regulation, from
10 IVF and 13 in vivo–conceived children [95]. The second used an Illumina Infinium Human
Methylation27 Beadchip array, identifying 733 CpG sites of differential methylation when
comparing the cord blood of 8 IVF and 10 naturally conceived children [98]. However, these
two studies did not address the impact of infertility, which is the primary reason why ART is
prescribed, nor did they provide a genome-wide assessment. By employing the Illumina
Infinium HumanMethylation450k BeadChip on newborn blood samples, we began to fill in
these gaps, revealing that a larger span of genomic sites may be impacted by parental
infertility and ART than previously appreciated. A targeted investigation of children born after
transfer of cryopreserved or fresh ICSI embryos further delineated the epigenetic impact of
these two different ART protocols, while suggesting that embryo cryopreservation may
indirectly improve epigenetic outcome.
iii. Materials and Methods
Acquisition of Newborn Bloodspots
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Newborn residual bloodspots, which were collected from Michigan newborns between
24 and 36 hours after birth for metabolic screening, were obtained from the Michigan Neonatal
Biobank (www.mnbb.org/). After Michigan Department of Community Health (approval
#037913MP4X), Wayne State University, and Biotrust institutional review board approval, 120
women (40 per group) were selected who conceived after one of three types of infertility
treatments (IUI, ICSI with fresh embryo transfer [FH], or ICSI with frozen embryo transfer
groups [FZ]). Sample requests were then given to the Michigan Biotrust for Health, and
bloodspots were subsequently requested from the newborn of each of the women in the
different categories through the Michigan Neonatal Biobank using storage codes only (all data
were deidentified). For the three procedure categories, a total of 18 IUI, 38 FH, and 38 FZ
bloodspots were obtained for calculation of DNA methylation, as detailed in Figure 2.1A.
While the clinical parameters of the newborn and mother for the samples analyzed in this
study were not known, the majority of bloodspot samples represent individuals born in the
Detroit and metro Detroit regions. As a naturally conceived control, 16 male and 27 female
bloodspots were also examined. Intensity Data (IDAT) files from the 450k assay of naturally
conceived (NAT) newborn bloodspots were graciously provided by Dr. Douglas Ruden,
Wayne State University [105]. The NAT samples were also previously obtained from the
Michigan Neonatal Biobank. In total, 137 individuals were utilized in methylation comparisons.
All methylation analyses were performed at the Wayne State University Applied Genomics
Technology Center.
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Figure 2.1. Samples and conception group comparisons subject to differential
methylation analysis. (A) Number of individuals analyzed in this study, according to
conception type and gender. (B) Directional arrows indicate that the conception group at the
source of the arrow is the methylation dataset (control) against which that at the termination
of the arrow (case) is being compared. (C) Pipeline provided by ChAMP was used to filter,
normalize, and apply batch correction, to obtain corrected methylation values. Aclust was then
implemented to calculate methylation changes in probe clusters, followed by downstream
analyses. Concurrently, the same corrected methylation values were analyzed using a linear
model to calculate differential methylation of individual probes and verify the results obtained
from Aclust.

Study Design and Data Processing
To assess the effects of infertility treatments (specifically ICSI and cryopreservation)
on genome-wide DNA methylation profiles of newborns, a case–control design was
implemented (Figure 2.1B). Neonatal bloodspots from newborns conceived through
unassisted (NAT) and IUI conceptions provided controls from fertile and infertile backgrounds,
respectively. In this case–control design, a given conception group considered as a “case,”
such as ICSI fresh embryo transfer, was matched to a “control,” such as IUI. The unassisted
conception control, NAT, served as a control for the IUI, FH, and FZ conception groups. The
DNA extracted from bloodspots was assessed for DNA quality (Appendix A) and assayed
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using the Illumina Infinium HumanMethylation450 BeadChip array. The Chip Analysis
Methylation Pipeline (ChAMP) pipeline was utilized for processing the datasets into
methylation profile (as measured by β-values) (Figure 2.1C).
Each conception comparison, outlined in Figure 2.1B, addressed a specific query.
Comparison of either FH or FZ with IUI was undertaken to identify ICSI-associated changes
within the group of parents requiring artificial insemination to conceive. Within the ICSI (FH
and FZ) group, differences between FH and FZ were assessed to discern the effects of fresh
embryo transfer and cryopreserved embryo transfer. Subsequent comparison of IUI, FH, or
FZ with NAT identified differences between children born to parents undergoing infertility
treatment and those born to fertile parents. Methylation changes between males and females
within the same conception group were undertaken to examine how the epigenome might
differ between genders [106-108].
The ChAMP pipeline was used to analyze the 450k signals, normalize the methylation
values to produce β-values (the proportion of methylated CpG sites) and identify the
differentially methylated probes [109]. Blood cell distributions of each sample were estimated
using the estimatecellcount function in minfi. The single value decomposition function of
ChAMP provided the relative influence of plate, assay characteristics, and blood cell
proportions on sample methylation. In an effort to minimize technical variation, all multiplymapped probes, as well as probes containing single-nucleotide polymorphisms in either the
target CpG or the 10 bases of probe closest to the target CpG site [110, 111], were removed
from differential methylation analysis. This excluded 91,058 probes from analysis, leaving
394,454 probes prior to calculating differential methylation. All sample comparisons were
subjected to batch correction using ComBat, in order to eliminate the effects of array batch.
To eliminate the risk of identifying false positives due to gender imbalances, I implemented a
strategy of comparing results from male and female groups separately. This approach
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increased the confidence in assigning genes and other genomic loci as differentially
methylated, while removing gender as a confounding variable.
Batch-corrected β-values from the ChAMP pipeline were used in the A-clustering
algorithm [112]. The algorithm generates clusters of correlated autosomal probes, followed by
general estimating equation (geepack) estimation of the differentially methylated autosomal
clusters. Differentially methylated clusters were as having a minimum absolute average effect
size (methylation) change of 2.5% and Benjamini-Hochberg adjusted P value of <.05.
Calculating Differential Methylation Using Limma
The β-mixture quantile dilation (BMIQ)-normalized, batch-corrected β-values of all
reliable probes produced by the ChAMP pipeline were applied to limma, which calculated
differential methylation of individual probes [113]. Differentially methylated probes were
defined as having a minimum absolute methylation change of 2.5% and Benjamini-Hochberg
adjusted P value of <.05. Limma yielded similar proportions of hypermethylated and
hypomethylated probes, when contrasted to clusters of probes, and generally supported the
trends in counts of differentially methylated regions between the conception types.
Calculating Differential Methylation of Promoters and Gene Bodies
The locations of all RefSeq genes were obtained from Ensembl, build hg19/GRCh37.
Promoters of genes were defined as 1 kb upstream of the unified gene start site. The
identification of clusters and probes within gene bodies or genomic loci was performed using
a series of bedtools utilities and custom R scripts. For a given comparison, all differentially
methylated clusters (filtered for a methylation change of 2.5% and Benjamini-Hochberg
corrected P value of <.05) with at least 75% of the cluster intersecting a gene body or promoter
were assigned to that particular gene. Because of the potential for numerous non-differential
clusters to reduce average gene body methylation below the threshold of 2.5% methylation
change, only differentially methylated clusters were considered in the calculations for gene
body methylation. Therefore, for a given gene, the methylation change was calculated from
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the average of all effect size (methylation) changes of all differentially methylated clusters
assigned to that gene. Gene bodies were then further filtered for a minimum absolute average
effect size (methylation) change of 2.5%. Differentially methylated genes, as calculated using
Aclust clusters, are referred to as hypermethylated or hypomethylated according to an effect
size (methylation) change of greater than 0.025 or less than −0.025, respectively.
Regulatory/enhancer Regions
Human regulatory regions and putative human enhancers (indicated here as
“regulators”), were obtained from Andersson et al. [114]. Clusters were intersected with the
set of 43,011 permissive regulators to identify the clusters overlapping the regulators. The
change in regulator methylation was calculated as the average of all differentially methylated
clusters located in the given regulator. To avoid spurious associations of methylation changes,
all differentially methylated regulators were required to have a minimum absolute average
methylation change of 2.5%.
Genome Annotation and Relative Enrichment
Annotation of significant clusters with respect to promoters, introns, exons, and
intergenic regions was calculated with the “Annotation & Statistics” function of Genomatix
(July 2014 build), using the December 2013 Eldorado annotation of the hg19 genome.

iv. Results
Study Sample Characteristics
As the cohort was composed entirely of newborns, the postnatal environment was
expected to have minimal effect on DNA methylation. While cellular composition of blood
samples can affect methylation profiles, the estimated cellular composition of each sample
did not significantly impact the methylation status in the cohort. The general differences
among the samples were small, as determined by pairwise comparison of all autosomal probe
β-values (minimal correlation of at least 0.90). This is concordant with previous studies, which
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suggest that the global pattern of methylation of prepubertal children is not affected by ART
[101, 103]. Supporting the previous observation, I found that principle component analysis
(unsupervised clustering) did not effectively cluster the NAT, IUI, and ICSI groups. This
recapitulated previous observations that methylation profiles of ART and control individuals
do not segregate in clustering analysis [95].
Differential Methylation of Probe Clusters
As outlined in Figure 2.1B, the conception groups were compared to identify
differentially methylated probes and clusters. Aclust was used to identify each cluster of two
or more correlated probes and calculate differential methylation at each cluster [112]. While
numerous previous studies have listed differential methylation at individual CpG sites, the
biological impact of a single CpG is questionable. Therefore, the Aclust approach was used
to identify methylation changes across multiple adjacent CpG sites, given that methylation
differences that extend over multiple CpG sites can be viewed as confirmatory and are likely
to have a biological impact. To avoid spurious associations of methylation change, regions of
interest were required to contain multiple differentially methylated probes, as well as exhibit a
minimum absolute average methylation change of 2.5% [112]. As summarized in Figure
2.2A,B and Figure 2.3A, several interesting differential methylation patterns emerged. The
naturally conceived group exhibited considerable differential methylation when compared to
all three assisted conception groups. Hypomethylated clusters were observed more frequently
within the ART groups (Figure 2.2B), concordant with a similar result in a non-ICSI sample
group [98]. Within each conception group, differentially methylated clusters in females
(compared with the male control) were more frequently hypermethylated than hypomethylated
(Figure 2.3A). Comparisons between three assisted conception groups revealed
considerable differences between FH and IUI or FH and FZ, while, in contrast, there were
comparatively fewer differences between IUI and FZ. It should be noted that the A-clustering
algorithm used for calculating differential methylation is a comparatively recent technique
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[112]. Therefore, the possibility that the A-clustering algorithm was responsible for the
unexpected patterns in methylation changes between assisted conception types was
considered. In order to verify the A-clustering results with a different method, a commonly
used linear modeling algorithm, limma, was also used to identify differentially methylated
probes [113]. Based on the trends observed with A-clust and limma approaches, the similarity
between the IUI and FZ was considered reliable. This similarity was independent of BMIQ
normalization and was not due to the batch correction or the A-clustering algorithm or
inadvertent sampling bias, as shown by random subsampling.

Figure 2.2. Intracytoplasmic sperm injection and IUI compared with NAT show
differential methylation of clusters and gene bodies. (A) Total counts of differentially
methylated clusters between conception groups for males and females, shown in blue and
pink, respectively. Red bracket indicates comparisons of FH and FZ with IUI, presenting the
greater degree of differential methylation in the FH vs. IUI comparison than that of FZ vs. IUI.
(B) Distribution of the change in the β-value for statistically significant clusters, as a function
of conception comparison. Changes in the female and male comparisons are shown in light
red and blue, respectively. (C) Pie chart labeled “Genome Annotation” indicates the proportion
of the human genome that lies within exons, introns, promoters, and intergenic regions. The
pie chart labeled as “Cluster Annotation” provides the proportion of all statistically significant
clusters (regardless of methylation change) that overlap exons, introns, promoters, and
intergenic regions. Clusters that overlay one or more features are denoted as “partial.”
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Figure 2.3. Trends in differentially methylated clusters between males and females of
identical conception groups. Hypermethylation in the female group (compared with a male
control) is shown in red, whereas hypomethylation is presented in blue. (A) Counts of clusters
differentially methylated between females and males of the same conception group. (B)
Counts of gene bodies differentially methylated between females and males of the same
conception group.

Differentially methylated clusters tended to be associated with promoters and exons
of protein-encoding loci (Figure 2.2C) with β-value changes averaging approximately 5%
(Figure 2.2B). Several clusters exhibited changes larger than 10%, including a
hypomethylation of the Speriolin-like protein (SPATC1L) promoter in IUI and ICSI (FH and
FZ) when compared to NAT (with the hypomethylation frequently exceeding 10%).
Characteristics of Differential Methylation
Methylation changes between the individual conception methods were first examined
with respect to the promoters and gene bodies of all unified RefSeq genes. Differential
methylation in gene bodies was observed more frequently than differential promoter
methylation. Figure 2.4 summarizes the counts of differentially methylated gene bodies,
which reflected the overall number and direction of methylation changes of differentially
methylated clusters for each given comparison. Collectively, these gene-specific methylation
differences may reflect phenotypic alterations [115] that may occur in the various conception
groups.
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Figure 2.4. Intracytoplasmic sperm injection and IUI show considerable differential
methylation in gene bodies compared with NAT. Bars indicate the counts of differentially
methylated gene bodies between conception groups. Counts of differentially methylated gene
bodies generated for (A) male- and (B) female-specific comparisons. Hypermethylated and
hypomethylated gene bodies are represented in red and blue, respectively.
In addition to providing coverage of RefSeq genes, the Infinium HumanMethylation450
BeadChip contains probes designed for various intergenic regions. These regions can
encompass regulatory loci (e.g., enhancers and silencers/regulators) residing outside of
promoters and gene bodies. Such regulatory loci can act independently or in concert with
proximal regulatory regions, and consequently alter chromatin organization and tissue
expression [116, 117]. Using putative regulators identified from the FANTOM5 cap analysis
of gene expression atlas, changes in the methylation status of regulators [114, 118] between
conception types was examined.
Numerous regulators were differentially methylated when the three assisted and NAT
conception groups were compared (Appendix B). Fewer regulators were differentially
methylated when FZ was compared with IUI, as opposed to when FH was compared with IUI
or FZ, reflecting the relative similarity of the FZ and IUI groups (Appendix B). As shown in
Table 2.1, certain regulators were also altered between males and females of the same
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conception group, suggesting that certain enhancers may exhibit gender-specific methylation
patterns. A total of 21 regulators exhibited altered patterns of methylation between the
genders in two or more conception groups (Appendix C). This common group of 21 regulators
may play therefore a role in sexual dimorphism of the human fetus [86, 119].
Table 2.1. Counts of enhancers altered between males and females of identical
conception groups.

Hypermethylated
Hypomethylated
Total

Female
vs
Male,
NAT
28
15
43

Female
vs
Male,
IUI
44
4
48

Female
vs
Male,
FH
5
5
10

Female
vs
Male,
FZ
12
10
22

Comparing ICSI (FH and FZ) and IUI with a NAT control showed that regulators were
most frequently hypomethylated (Figure 2.5 and Appendix D), which reflected the general
trends towards hypomethylation in the complete cluster set for the given comparisons.
Interestingly, three hypomethylated regulators were consistently differentially methylated
among all three assisted conception groups and NAT control. In addition, 15 regulators were
consistently altered between the ICSI (FH and FZ) and NAT control, as well as the subset of
5 regulators (Appendix D) altered between all three assisted conception groups and NAT
control.

Figure 2.5. Enhancers consistently altered in ICSI
groups compared with NAT. Populations of
hypermethylated and hypomethylated enhancers altered
in the IUI, FH, or FZ vs. NAT comparison were identified
and enumerated. Quantities of hyper- or hypomethylated
enhancers are denoted as “Hyper” and “Hypo,”
respectively. The quantity of enhancers found in common
between two or more comparisons and exhibiting identical
methylation trends (e.g., increased or decreased
methylation in both comparisons) are indicated in the
intersections of the Venn diagram.

26
Imprinted Genes are Differentially Methylated in IUI and ICSI Newborns
Imprinted genes play a critical role in fetal growth and are epigenetically repressed in
a parent-of-origin-specific manner [120]. Due to this epigenetic repression by cis-acting
differentially methylated regions, an imprinted gene will exhibit preferential expression from
either the paternal or maternal allele [121]. In humans, the combination of the 450k platform
and bisulphite sequencing has allowed for the identification of cis-acting differentially
methylated regions, which may act as imprinting control regions [121].
Previous mouse and human studies have investigated changes in the methylation
status at imprinted loci, including loci associated with metabolism and fetal growth (e.g., H19
and IGF2) after ART [75, 83, 88, 90]. Recent work has also shown that high-quality human
embryos generated from ART exhibit a high degree of DNA methylation errors in imprinted
loci [122]. Within the collections of differentially methylated genes, an enrichment of imprinted
genes was found when comparing ICSI (FH and FZ) with the IUI control (Table 2.2), with
hypomethylated genes contributing strongly to this enrichment. This enrichment trend was
also observed in the comparison of ICSI (FH and FZ) with NAT. Taken together, imprinted
genes were differentially methylated more often than expected by chance when comparing
any assisted conception group with NAT (P value: 1.47 × 10−3 to 2.04 × 10−11). The
biological implications of the observed methylation changes in the imprinted genes remains
to be determined.
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Table 2.2. Imprinted genes are differentially methylated between different conception
types. Enrichment of differentially methylated imprinted genes between conception groups,
segregated according to gender. Comparisons yielding P-values less than 0.05 and 0.01 are
highlighted in red and blue, respectively.

Female Female
FH vs
Female vs Female vs
vs Male, vs Male,
IUI,
Male, FH Male, FZ
NAT
IUI
Male
Differentially
methylated
genes
Imprinted
genes
Maternally
imprinted
genes
Paternally
imprinted
genes
Significance
of imprinted
genes
Significance
of maternally
imprinted
genes
Significance
of paternally
imprinted
genes

FH vs
IUI,
Female

FZ vs
IUI,
Male

FZ vs
FZ vs FH, FZ vs FH,
IUI,
Male
Female
Female

IUI vs
NAT,
Male

IUI vs
NAT,
Female

FH vs FH vs FZ vs
NAT, NAT, NAT,
Male Female Male

FZ vs
NAT,
Female

687

565

103

197

813

1069

93

85

1417

1187

982

968

695

887

766

922

18

18

4

4

23

23

5

10

27

27

32

25

18

25

27

33

7

9

1

2

8

15

3

1

14

16

16

13

8

13

13

14

11

9

3

2

8
3.66E
-05

6.17E05

3.41E06

9.05E
-07

10
2.50
E05

12
1.96
E07

14
7.32
E10

19

5.92E02

16
1.51
E10

12

9.48E03

9
2.85
E09

11

1.71E
-06

2
1.03
E03

13

2.17E05

15
5.39
E07

2.18E02

7.91E
-04

2.89E01

1.58E01

1.82
E02

7.83E
-05

7.37
E03

2.58
E01

2.89E03

7.31E05

8.48
E06

3.24E
-04

8.66
E03

1.47
E04

3.68
E05

6.00E05

1.03E04

4.25E
-04

7.56E03

1.41E01

1.30
E06

3.83E
-02

4.74
E02

7.89
E11

3.38E03

5.89E03

2.79
E06

4.76E
-04

4.54
E04

2.29
E04

3.18
E06

1.06E08

7.34E12

The effect of IVF/ICSI conception on long-term health and metabolism is still actively
debated. Therefore, our collection of imprinted genes were assessed for known associations
with human metabolism. Differentially methylated clusters in the promoter and gene body of
the maternally expressed long noncoding RNA H19 were observed when IUI and ICSI (FH
and FZ) were compared with NAT, but not when ICSI (FH and FZ) was compared with IUI
(Figure 2.6) [123]. These observed cluster changes occurred in the paternally methylated
H19 Differentially Methylated Region (DMR) [121]. IGF2, a paternally expressed growthpromoting hormone, was also hypomethylated in both promoter and gene body clusters when
female IUI and ICSI (FH and FZ) were compared with NAT (Figure 2.6). The paternally
methylated IGF2 DMR2 region [121], located in the last two exons of the IGF2 gene, was
relatively hypomethylated in female IUI and ICSI (FH and FZ) compared with NAT.
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Figure 2.6. Certain imprinted genes associated with metabolism and cancer exhibit
differential methylation. UCSC genome browser images of promoter and gene bodies of
imprinted genes (A) H19, (B) IGF2. Hypermethylated clusters and hypomethylated clusters
are colored in blue and orange, respectively. Cluster heights represent the magnitude of
methylation change, in scale with the y axis.
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MEs are Altered in Both the Infertile Control and ICSI Newborns
The nutritional environment encountered by the early embryo is among the factors that
likely differ between unassisted conception and IUI or ICSI (FH and FZ). Correspondingly, a
modulation of metabolism-associated genes suggests that a nutritional component, such as
the culture conditions of IVF/ICSI protocols, may affect the epigenome. Therefore, genomic
loci known to be impacted by periconceptional nutrition (i.e., metastable epialleles), were
assessed.
Metastable epialleles (MEs) were first characterized in mouse models [124] and have
recently been identified in humans [79]. DNA methylation at these loci is stochastically
established within the blastocyst and is also driven by periconceptional nutritional status [79,
125, 126]. In order to assess effects of the early embryonic nutritional environment associated
with ART, the clusters identified as differentially methylated in the comparison of NAT with the
three assisted conception groups were overlapped with MEs. Of 109 high-confidence MEs
identified in a recent genome-wide screen [127], 22 were informative in the 450k-based
analysis. Remarkably, 19 (86%) of these, plus two MEs that were not directly assayed but
existed within a cluster, were differentially methylated in at least one of all possible conception
group comparisons (Table 2.3). Hypomethlation predominated the MEs in all three assisted
vs. NAT comparisons. Taken together, these clusters suggest that certain epialleles (e.g.,
those associated with DUSP22 and SPATC1L) are indeed susceptible to methylation changes
in both genders upon IUI or ICSI (FH and FZ) as compared with NAT conception (Figure 2.7,
Table 2.3). Interestingly, DUSP22, a dual specificity phosphatase, has been implicated as a
negative regulator of estrogen receptor-α–mediated signaling and STAT3-mediated signaling,
and hypermethylation of the DUSP22 promoter is correlated with Alzheimer's disease risk
[128-130]. The function of the protein encoded by SPATC1L is unknown, but it has been
shown to be expressed in testis as well as certain cell lines. The paralog of SPATC1L,
SPATC1, encodes a novel sperm centrosome protein (speriolin) that binds CDC20 [131], and
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perhaps SPATC1L plays a yet undetermined broader role in reproduction. The long-term
health implications of altering methylation at these sites has yet to be determined.

Figure 2.7. Metastable epialleles at DUSP22 and SPATC1L show considerable and
concerted differential methylation. University of California Santa Cruz (UCSC) genome
browser representation of female comparisons between conception groups for MEs located
at (A) DUSP22 and (B) SPATC1L. Hypermethylated clusters and hypomethylated clusters are
colored in blue and orange, respectively. Cluster heights represent the magnitude of
methylation change, in scale with the y axis.
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Table 2.3. Metastable epialleles are differentially methylated between conception
types. Differentially methylated metastable epialleles were segregated into hypermethylated
and hypomethylated loci. Genes associated with the respective epialleles are then indicated.
The magnitude of the methylation change, in units of β-values, are shown in italics for each
epiallele. FH = fresh embryo transfer; FZ = frozen embryo transfer groups; IUI = intrauterine
insemination; ME = metastable epiallele; NAT = naturally conceived.
Conception
comparisons

Hypermethylated
MEs

Associated
genes

Hypomethylated MEs

Associated genes

FH vs IUI,
male

chr21:4760420147604400 (0.16);
chr21:4760480147605000 (0.16);
chr21:4760500147605200 (0.16);
chr7:43050014305200 (0.04);

SPATC1L;
SDK1

chr2:113992801-113993000 (−0.15); chr2:113993001113993200 (−0.15);

PAX8; PAX8-AS1

FH vs IUI,
female

chr21:4760420147604400 (0.11);
chr21:4760480147605000 (0.11);
chr21:4760500147605200 (0.11);

SPATC1L

chr14:54816001-54816200 (−0.09); chr19:2921800129218200 (−0.19); chr2:113992801-113993000 (−0.08);
chr2:113993001-113993200 (−0.08); chr5:135415601135415800 (−0.14); chr5:135415801-135416000 (−0.14);
chr5:135416201-135416400 (−0.14); chr6:291801-292000
(−0.29); chr6:292001-292200 (−0.29); chr6:292201-292400
(−0.29); chr6:292401-292600 (−0.29); chr7:43050014305200 (−0.05);

LOC100420587;
PAX8; PAX8-AS1;
VTRNA2-1;
DUSP22; SDK1

FZ vs IUI,
male

chr21:4760420147604400 (0.14);
chr21:4760480147605000 (0.14);
chr21:4760500147605200 (0.14);

SPATC1L

chr18:7451400174514200 (0.07);
chr2:113992801113993000 (0.18);
chr2:113993001113993200 (0.18);

LOC100131655;
PAX8; PAX8AS1

chr1:19110801-19111000 (−0.18); chr2:128453201128453400 (−0.27); chr2:128453401-128453600 (−0.27);
chr6:291801-292000 (−0.40); chr6:292001-292200 (−0.40);
chr6:292201-292400 (−0.40); chr6:292401-292600 (−0.40);
chr7:4305001-4305200 (−0.04);

SFT2D3; WDR33;
DUSP22; SDK1

FZ vs FH,
female

chr2:128453201-128453400 (−0.25); chr2:128453401128453600 (−0.25); chr21:47604201-47604400 (−0.10);
chr21:47604801-47605000 (−0.10); chr21:4760500147605200 (−0.10); chr4:1523001-1523200 (−0.10);
chr5:135415601-135415800 (−0.12); chr5:135415801135416000 (−0.12); chr5:135416201-135416400 (−0.12);

SPATC1L;
SFT2D3; WDR33;
VTRNA2-1

IUI vs NAT,
male

chr21:47604201-47604400 (−0.23); chr21:4760480147605000 (−0.23); chr21:47605001-47605200 (−0.23);
chr7:4305001-4305200 (−0.08); chr2:128453201128453400 (−0.21); chr2:128453401-128453600 (−0.21)

SPATC1L; SDK1;
SFT2D3; WDR33

FZ vs IUI,
female
FZ vs FH,
male

IUI vs NAT,
female

chr4:15230011523200 (0.10)

chr21:47604201-47604400 (−0.27); chr21:4760480147605000 (−0.27); chr21:47605001-47605200 (−0.27);

SPATC1L

FH vs NAT,
male

chr4:15230011523200 (0.11)

chr2:128453201-128453400 (−0.16); chr2:128453401128453600 (−0.16); chr6:291801-292000 (−0.11);
chr6:292001-292200 (−0.11); chr6:292201-292400 (−0.11);
chr6:292401-292600 (−0.11);

SFT2D3; WDR33;
DUSP22

FH vs NAT,
female

chr4:15230011523200 (0.06)

chr21:47604201-47604400 (−0.16); chr21:4760480147605000 (−0.16); chr21:47605001-47605200 (−0.16);
chr6:291801-292000 (−0.14); chr6:292001-292200 (−0.14);
chr6:292201-292400 (−0.14); chr6:292401-292600 (−0.14);

SPATC1L;
DUSP22

FZ vs NAT,
male

chr4:15230011523200 (0.10)

chr10:135341601-135341800 (−0.12); chr1:1911080119111000 (−0.13); chr2:128453201-128453400 (−0.22);
chr2:128453401-128453600 (−0.22); chr6:291801-292000
(−0.13); chr6:292001-292200 (−0.13); chr6:292201-292400
(−0.13); chr6:292401-292600 (−0.13); chr7:43050014305200 (−0.04)

CYP2E1; SPRN;
SFT2D3; WDR33;
DUSP22; SDK1
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Conception
comparisons

Hypermethylated
MEs

Associated
genes

FZ vs NAT,
female

Female vs
male, NAT

chr19:2921800129218200 (0.10);
chr2:113992801113993000 (0.08);
chr2:113993001113993200 (0.08);

Hypomethylated MEs

Associated genes

chr10:135341601-135341800 (−0.10); chr21:4760420147604400 (−0.22); chr21:47604801-47605000 (−0.22);
chr21:47605001-47605200 (−0.22); chr6:291801-292000
(−0.11); chr6:292001-292200 (−0.11); chr6:292201-292400
(−0.11); chr6:292401-292600 (−0.11);

CYP2E1; SPRN;
SPATC1L;
DUSP22

LOC100420587;
PAX8; PAX8AS1;

chr4:1523001-1523200 (−0.08)

Female vs
male, FZ

Several adjacent MEs on chromosome 2 were observed to be hypomethylated solely
in the male comparisons of ICSI (FH and FZ) groups to NAT. Within the same comparisons,
these MEs were not consistently altered in the female cohort. These MEs are located in a
potential regulatory region adjacent to SFT2D3, WDR33, and LIMS2. Additionally, these loci
were hypomethylated in both FZ as compared with FH males and females. Taken together,
this suggests that the type of IVF/ICSI treatment (i.e., cryopreserved or fresh embryo transfer)
impacts methylation status to varying degrees, with FZ embryo transfer increasing the level
of hypomethylation at this locus in the male cohort. A significant methylation change at this
ME in males alone (FH vs. NAT, FZ vs. NAT) suggested a gender-specific effect on
establishing the epigenome of this locus. Although Silver et al. [127] identify the top 10 MEs
altered by season of conception in Gambian individuals, the DUSP22-, SPATC1L-, and
SFT2D3-associated MEs found to be hypomethylated in ART individuals compared with NAT
are not among them. Therefore, the differences in nutritional and periconceptional milieu
between the rainy and dry season are likely different from those of unassisted and assisted
conceptions.
v. Discussion
ART has been successfully applied to produce many phenotypically healthy human
children. However, in both humans and model organisms, the impact of ART on the
epigenome and long-term health of offspring is disputed. This confusion is compounded by a
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lack of understanding of the epigenetic contribution to the health of ART conceptuses. To
begin to disentangle the possible epigenetic impact of ART techniques, such as ICSI and
cryopreservation, from that of underlying infertility, the present cohort included both NAT- and
IUI-conceived newborns as comparative groups. This work verified previous literature
indicating that ART does not induce extensive global changes in DNA methylation [103].
In contrast, numerous differentially methylated loci were identified when conception
types were compared. The three assisted conception groups also exhibited differences from
the natural conception group, thus supporting the view that subtle epigenetic changes
occurred in children from parents who sought fertility treatment, relative to those conceived
naturally. Consistent with this tenet, 4 of the 18 candidate CpG sites altered in placental tissue
from children born to fertile parents compared with infertile parents [99] are located in or near
significant clusters of two imprinted genes, growth factor receptor-bound protein 10 (GRB10)
and necdin (NDN). While A-clustering recapitulated the hypomethylation of placental GRB10
CpG sites in bloodspots of ART children compared with fertile controls [99], it was not
congruent with NDN. This discordance is likely reflective of tissue-specific DNA methylation
in peripheral blood and placenta. Methylation differences between ICSI and naturally
conceived controls were generally discordant with previous studies’ conclusions on imprinted
genes [95, 98]. This discordance is likely reflective of study differences in sample size and
composition. Overall, a screen of imprinted DMRs does not identify altered DNA methylation
profiles in placenta and cord blood samples in ART newborns compared with those
spontaneously conceived [132]. This screen agreed with the conclusions drawn from the
current cohort, in which the majority of imprinted genes in human do not show consistent or
significant methylation changes.
The results of this work suggested that alterations in DNA methylation may explain at
least a portion of the increased risk of birth defects in fresh embryo transfer, as well as the
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increased birth defect risk in individuals with a history of infertility [89]. As we have shown, the
IUI and FZ groups exhibit noted epigenetic similarity.
This is consistent with the recent suggestion that cryopreservation, in conjunction with
ICSI, can reduce the risk of birth defects associated with ICSI births to that of the general
population

[89].

Interestingly,

a Drosophila

model of

intergenerational

metabolic

reprogramming recently demonstrated a resetting of the fly sperm epigenome after heat shock
[12]. It is tempting to suggest that cryopreservation in ART may yield a similar outcome (i.e.,
the epigenetic resetting of the human embryo). However, the true nature of the mechanism
underlying the reduction in aberrant DNA methylation in the FZ newborns remains unknown.
In all human studies to date, the combined effects of cryopreservation, embryo quality, uterine
receptivity, and parental health have yet to be segregated. Moreover, the endometrial
receptivity of women undergoing ovarian stimulation, which is often utilized in fresh embryo
transfer, is likely shifted in comparison with that of naturally cycling women undergoing frozen
embryo transfer [31]. This suggests that the relative endometrial receptivity may play a role in
establishing the implantation environment and ultimately, the epigenome, of the conceptus.
Previous studies considering the impact of ART on the human conceptus have largely
been limited in the number and type of genomic loci examined. Uniquely, the present work
identified both regulatory regions (i.e., enhancers) and MEs as being affected by infertility and
ART. The 450k array locus-specific β-values for various MEs, including PAX8, SPATC1L, and
VTRNA2-1 of Table 2.1, through comparison to quantitative bisulfite pyrosequencing of MEs,
are known to provide a reliable proxy for methylation status [127]. Altered methylation at
enhancers, and more broadly, regulatory regions has the potential to impact gene expression
and long-term health status. Modulation of MEs was consistent with previous nutritional
studies [79, 127], thus indicating that the periconceptional environment of the early human
embryo, which includes IVF culture conditions for the IVF and ICSI conceptus, leaves a lasting
impression on the epigenome.
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Compared with unassisted pregnancies in the general population, ART pregnancies
are susceptible to multifetal gestation and adverse pregnancy complications. One must
therefore consider the clinical characteristics that may impact DNA methylation and blood cell
populations in neonatal studies. These include gestational age, multifetal pregnancies,
pregnancy

complications,

fetal–maternal

characteristics,

racial

characteristics,

and

sociodemographic status, sample characteristics to which this study was blinded.
Nevertheless, although gestational age ranged from 30 to 40 weeks, approximately 80%
reached full term; 89.5% were singletons. Accordingly, the majority of each conception group
was comprised of full-term, singleton pregnancies.
With current available approaches, the veracity of bloodspot composition estimates
from newborn bloodspots is unproven [133]. However, methylation at MEs is known to be
established in the early embryo and remain consistent across diverse tissues ranging from
blood to hair follicles [79, 127]. Additionally, previous DNA methylation studies suggest that
although leukocytes are composed of approximately 54% neutrophils, the remaining
approximately 19 different cell types do not affect the majority of loci examined [134]. In the
present cohort, leukocyte composition was estimated using the method of Jaffe and Irizarry
[135], and the resulting blood cell proportion estimates do not significantly influence the 450k
methylation profiles. Hence, any differences in leukocyte composition do not seem to underlie
the group differences in ME methylation.
This work serves as a resource for future studies on IVF populations. It provided the
first large-scale 450k dataset on cytosine methylation in newborns conceived through three
different assisted conception procedures: IUI, ICSI–fresh embryo transfer, and ICSI–
cryopreserved embryo transfer, and provided comparison to a naturally conceived cohort. The
association of methylation changes in these loci with ART-conceived child's clinical
phenotypes and long-term health can now be investigated. Identification of differentially
methylated genes between comparisons of conception types suggests that epigenetic
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mechanisms may at least partly underlie the observed risks of neurologic and birth defects
seen in the ART population and assisted births [89, 90]. The reduction in birth defects from
after cryopreserved embryo transfer [89] is suggested here to have an epigenetic basis, given
that FZ groups exhibited reduced epigenetic changes. This tenant biologically supports the
use of frozen embryo transfers rather than fresh embryo transfers in association with IVF and
ICSI.
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Chapter 3
“DEFINING THE SPERM TRANSCRIPTOME: RNA ELEMENT DISCOVERY FROM GERM
CELL TO BLASTOCYST”
This chapter was adapted from the following publication:
Molly S Estill, Russ Hauser, Stephen A Krawetz. “RNA element discovery from germ cell to
blastocyst”. Nucleic Acids Research. 2018 Dec 21. Cover feature. doi: 10.1093/nar/gky1223.
i. Summary
Recent studies have shown that tissue-specific transcriptomes contain multiple types
of RNAs that are transcribed from intronic and intergenic sequences. The current study
presents a tool for the discovery of transcribed, unannotated sequence elements from RNAseq libraries. This RNA Element (RE) discovery algorithm (REDa) was applied to a spectrum
of tissues and cells representing germline, embryonic, and somatic tissues and examined as
a function of differentiation through the first set of cell divisions of human development. This
highlighted extensive transcription throughout the genome, yielding previously unidentified
human spermatogenic RNAs. Both exonic and novel X-chromosome REs were subject to
robust meiotic sex chromosome inactivation, although an extensive de-repression occurred
in the post-meiotic stages of spermatogenesis. Surprisingly, 2.4% of the 10,395 X
chromosome exonic REs were present in mature sperm. Transcribed genomic repetitive
sequences, including simple centromeric repeats, HERVE, and HSAT1, were also shown to
be associated with RE expression during spermatogenesis. These results suggest that
pervasive intergenic repetitive sequence expression during human spermatogenesis may play
a role in regulating chromatin dynamics. Repetitive REs switching repeat classes during
differentiation upon fertilization and embryonic genome activation was evident.
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ii. Introduction
Expression profiles of known RNAs have been catalogued for a range of cell types,
with the use of expression arrays and, more recently though RNA deep-sequencing studies.
This

has

yielded

a

series

(https://www.gtexportal.org/home/),

of

useful
EMBL-EBI’s

databases

including

Expression

GTEx
Atlas

(https://www.ebi.ac.uk/gxa/home/), The Human Protein Atlas (https://www.proteinatlas.org/),
and ENCODE (www.encodeproject.org) [135-140]. These databases and RNA-seq studies
generally focus on annotated genes and transcript variants that are derived from transcript
modeling programs such as Cufflinks [141] and are provided as part of the Refseq and
Gencode annotation [142, 143].
Both coding and non-coding RNAs play major roles in all cellular processes. In addition
to protein-coding RNAs, at present, there are 48 different non-coding and pseudogene
classes of RNA documented in the version 27 annotation of the Human Gencode.
Approximately 40% of the annotated genes in Gencode correspond to long and short noncoding RNA genes [144]. Non-coding intergenic regions are known to contain regulatory
RNAs. These include long intergenic non-protein coding RNA (lincRNA), enhancer RNA
(eRNA), piwi-interacting RNA (piRNA) and circular RNAs, with others just beginning to be
described [145-148]. The human transcriptome is likely to be more complex than even these
annotations indicate, as an estimated three quarters of the human genome is transcribed
[149]. This would include novel tissue-specific RNAs, whose roles remain to be established
[150].
The palette of RNAs appear enriched in certain specific tissues, with each providing a
specialized function, e.g., brain - cognitive and functional system level control, and germline
– stem cell – defining development [151-153]. Their corresponding complexity is exemplified
in the testis by the collection of unique structural and functional spermatozoal-specific
transcript variants [154] that are observed during maturation, as sperm assume their unique
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shape. This culminates with the compaction of the sperm nucleus to a transcriptionally and
translationally inert structure. The latter is ensured by fragmenting rRNAs [155], as well as
others and completes with the expulsion of the majority of the cytoplasm. In addition to the
paternal genome and sperm encapsulated RNAs [156], RNA/proteins and other molecules
from distant tissues acquired during epidydimal transit [71, 157] are delivered at fertilization.
This provides a pathway for soma-to-germline transmission [156, 158, 159] that perhaps
conveys signals echoing how other tissues have responded to the environment (reviewed in
[160]).
Previous literature has shown that unannotated transcripts corresponding to intronic
and intergenic regions of the spermatogenic genome are comparatively abundant in human
sperm [154, 161-163]. They vary amongst species and in response to and can provide
markers of disease [163-165]. These observations drove the development of an algorithm to
systematically identify the genomic locations of RNAs, defined as RNA elements (RE)., i.e.,
regions transcribed throughout the genome. This unbiased analysis tool is not limited to those
RNAs currently defined in the databases as it does not seek to generate gene structures from
REs. It is compatible with a range of Next Generation Sequencing (NGS) platforms, RNAs
from varied sources, abundance, quality, and levels of fragmentation, i.e., FFPE-like RNAs.
The RNA Element Discovery algorithm (REDa) approach only requires the BAM file of
genomic alignments to detect transcribed regions of novel loci in conjunction with well-known
annotated loci.
RE discovery was applied from the perspective of the human male germ cell to
blastocyst paradigm. A series of spermatogenesis and embryogenesis pattern specific
intergenic human REs were identified, indicating that the transcriptome extends well-beyond
the annotated genes, including those delivered at fertilization. Tissue-specific REs comprised
of intronic and intergenic REs were uncovered and, in some cases, exon boundaries
extended. Transcribed genomic repetitive sequences, such as simple repeats, HERVE, and
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HSAT1, were shown to be associated with RE expression during spermatogenesis, and may
play a developmental stage specific role. Similarly, in the human embryo, MER73 was
associated with RE transcription at the minor wave of zygotic genome activation and MLT2A1
and SVA-D expressed through the major wave during the transition to the embryonic genome.
This provided a deeper understanding of the dynamic transcriptome of human sperm, as well
as uncovering the possible role of specific repetitive sequences in the spermatogenesis.
iii. Materials And Methods
RE discovery
The current study used Gencode release 26 (for GRCh38) and the GRCh38 genome
for RE discovery, which is detailed in Appendix E. RNA-seq samples used in RE discovery
are described in Appendix F. Sample reads were pre-processed prior to RE discovery with
Trimmomatic version 0.36, trimming Illumina adaptors and poly(A+) sequences, where
appropriate, with parameters “LEADING:3 TRAILING:3 SLIDINGWINDOW:4:15”. Reads
were aligned to the GRCh38 genome using HISAT2 (version 2.0.6), using the parameters “p10 -max-seeds 30 -k 2”. Read coverage was provided to the RE discovery tool in bigwig
format, generated by converting BAM files to bedgraph format, using the bedtools tool
genomeCoverageBed, with the parameters “-split –bg”, and subsequently bigwig format,
using the bedGraphToBigWig program (available from the UCSC Genome Browser utilities).
The threshold parameter µ for RE discovery was set to 2.5 reads per million, to minimize their
contribution of background noise. Novel REs from each study were combined using custom
R commands, which merged overlapping novel REs, re-annotated the merged REs, and
added the merged REs to the exonic REs, to produce a collective set of REs. The collective
set of REs for the different samples was subsequently used in all analyses. For comparison
of RE discovery to established transcript-building software, Cufflinks (v2.2.1) and Stringtie
(v1.3.4) were used on the same pre-processed reads previously used for RE discovery [141,
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166]. Default parameters for both Cufflinks and Stringtie were employed, using Gencode
release 26 (for GRCh38) as the reference annotation.
Differential expression (LMEM, fold change, LM)
A linear mixed-effects model (LMEM) was used to calculate differential expression
between poly(A+) and total RNA libraries from oocyte through early embryonic development
[167-169]. The LMEM was used with a random slope and intercept for each cell type, to
consider heterogeneity across cell types [formula= RPKM ~ RNA.type + (1 + RNA.type |
Tissue)]. Residuals of randomly selected REs were analyzed for homoscedasticity, ensuring
that the assumptions of the LMEM were satisfied. Multiple testing correction was applied to
P-values for resultant slopes, using Benjamini-Hochberg correction [170].
Differential expression of poly(A+) and total RNA libraries in sperm and testis tissue
𝑚𝑒𝑎𝑛(𝑇𝑜𝑡𝑎𝑙 𝑅𝑁𝐴)

was determined using a fold-change (Fold change= 𝑙𝑜𝑔2 ( 𝑚𝑒𝑎𝑛(𝑝𝑜𝑙𝑦(𝐴+ )) )). The use of an
expression ratio, rather than linear modeling, was necessary due to the technical differences
between the total RNA sperm samples [163] and the three poly(A+) sperm libraries [171], as
well as the absence of multiple independent total RNA testis samples [154].
RE enrichment for repetitive sequences
In cases when median RE RPKM in spermatozoa exceeded 1 RPKM (thus removing
REs with low coverage in most samples), peak RE RPKM was 25 RPKM and subsequently
used as an expression threshold. REs were first assigned as “Expressed” if the median RPKM
for the cell/tissue type was greater than 25 RPKM. The enrichment or depletion of repetitive
sequences in the expressed REs was calculated using UCSC’s Repeatmasker track (for
GRCh38), a hypergeometric test and custom R code. The proportion of each genomic repeat
in all available REs was used as input probability, with the number of expressed REs for the
given cell type used as the sample size. The probability of drawing the actual number of
expressed REs overlapping the given repeat type was adjusted using a Bonferroni correction

42
[172]. To identify repeats of interest, significantly enriched or depleted repeats were
additionally filtered to remove repeats with minimal over- or under-enrichment. Thus, only
repeats whose difference between the expected and observed RE count was greater than 10
REs were retained.
Expression clustering
Expression patterns across spermatogenic cell types were identified using the R
package Mfuzz [163, 173-175]. Mfuzz is designed for soft clustering of gene expression timeseries data. Soft clustering is a form of clustering where a data point (e.g. transcript) can
belong to more than one pattern. The samples used in clustering were the Jan et al.
spermatogenesis libraries [175], as well as a set of 7 ejaculated sperm samples from fertile
males [163]. It should be noted that these 7 samples are a subset of the 52 “Control” sperm
samples used for expression comparisons in Chapter 4. The median expression value for the
7 mature sperm samples was used to represent the mature sperm samples as a single value.
The RE dataset was then composed of a single library for Adark SSCs, Apale SSCs,
Leptotyne/Zygotene, Early Pachytene, Late Pachytene, and Round spermatids, while the
library for ejaculated sperm was the median expression value for 7 fertile males. In a step
intended to remove universally lowly expressed REs, REs were processed to remove those
which did not exceed 25 RPKM in at least one sample. Mfuzz clustering was performed,
generating 20 cluster patterns, with a minimal membership of 0.7 required for inclusion of an
RE in a pattern.
Paternal/maternal transmission
REs were assigned as maternally transmitted to the zygote with median zygotic level
˃ 10 RPKM, sperm < 2 RPKM, and oocyte > 25 RPKM. REs were assigned as paternally
transmitted with moderate confidence with median zygotic level > 10 RPKM, sperm > 25
RPKM, and oocyte < 5 RPKM. REs were assigned as paternally transmitted with greatest
confidence with median zygotic level > 10 RPKM, sperm > 25 RPKM, and oocyte < 2 RPKM.
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FDR calculation for GTEx and PPV calculation for sperm
The accuracy of the RE discovery algorithm to identify expressed loci was calculated
using the Jodar et al. dataset, which consisted of 7 fertile human sperm samples, prepared
using total RNA [163]. RE discovery was performed on the 7 samples, at a range of µ from 1
to 10 RPM, at increments of 0.5 RPM. The RPKM of the resulting novel REs for each sample
was calculated, along with the median RPKM across the 7 samples. Experimental thresholds
for calling a RE as “expressed” ranged from 1 to 200 RPKM, at increments of 1 RPKM. At
each expression threshold, the number of REs with a median RPKM at or exceeding the
threshold were recorded. The Positive Predictive Value (PPV) at each expression threshold
and µ was calculated as
𝑃𝑃𝑉 =

𝑁𝑜𝑣𝑒𝑙 𝑅𝐸𝑠 > 𝐸𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑡ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑
𝑁𝑜𝑣𝑒𝑙 𝑅𝐸𝑠 > 𝐸𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑡ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑 + 𝑁𝑜𝑣𝑒𝑙 𝑅𝐸𝑠 ≤ 𝐸𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑇ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑

The ability of the RE approach to recapitulate tissue expression in the established
databases was determined using the testis expression in the GTEx database [138]. The
median TPM for all GTEx testis samples was downloaded and was processed to replace
duplicated common gene names with the mean TPM for all instances of the gene name. Only
gene names found in both GTEx and exonic REs were used in subsequent intersect analysis.
The unique gene names with expression exceeding 5 TPM were compared to those of the
exonic REs exceeding 25 RPKM.
Gene ontology
Ontological

analysis

was

performed

with

the

Genomatix

software

suite

(https://www.genomatix.de/), version 3.10. The GeneRanker function (using Genomatix
Eldorado version 12-2017) generated the ontological enrichment of signaling pathways.
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iv. Results and Discussion
RE identification and classification
The RE discovery algorithm was designed to detect expressed regions of the genome
using RNA-seq, regardless of the sequencing platform or read structure. A detailed
description of RE discovery is presented in Appendix E, and the corresponding code is
provided online (https://github.com/mestill7/RE_discovery). Briefly, the known gene
annotation (e.g., RefSeq, Ensembl, Gencode) for the genome of interest is parsed into
individual exon locations. In the current study, Gencode release 26 (GRCh38) was used, with
non-coding entries considered as annotated “exons” [144]. As summarized in Figure 3.1A,
RE discovery first requires the sequenced reads to be processed, e.g., adaptors trimmed and
low-quality bases removed, prior to alignment to the genome of interest. For the unannotated
regions of the genome, the mean read coverage was calculated for each 10 bp genomic
segment and the 10 bp segments with sufficient read coverage, determined by a threshold µ,
retained. For the purposes of this study, µ = 2.5 reads per million provided well-balanced
signal to noise ratio (Figure 3.2) that was suited for RNA libraries generated from low-input,
potentially fragmented RNAs, as is often found in clinical Formalin-Fixed Paraffin-Embedded
(FFPE) samples and spermatozoa [154, 176]. The overlapping 10 bp regions were
subsequently merged to yield the final novel REs for each collection of samples studied. The
merging steps allow for a maximum of 150 bp between element bins, intended to allow for
gaps in coverage caused by sequencing bias and/or biological fragmentation.
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Figure 3.1. Pre-processing for RE
discovery. (A) RNA-seq reads, in fastq
format are processed to remove lowquality bases and adaptor sequences.
The trimmed reads are then aligned to
the genome, and the duplicate
alignments removed. Read coverage is
then used to identify 10 bp segments with
read coverage surpassing μ. The
expressed 10 bp segments (shown in
blue) are merged and annotated
according to their adjacency to exons
(shown in red). (B) RE discovery
workflow for four theoretical RNA-seq
samples. Each sample has a different
library size, and correspondingly,
different read coverage thresholds at a μ
of 2.5 Reads per million (RPM). Nonexonic regions of read coverage
surpassing the assigned threshold are deemed “Novel REs”. Merging novel REs from the four
different samples, yields two novel REs, one from Sample 1 (S1) and one from Sample 3 (S3)
that are separated by up to 150 bp. Novel REs of the different samples S1 and S3 are merged
into a final RNA element, represented in purple. Exonic REs are excluded from this merging
step. The final novel RE set for the four samples is then annotated as intronic, near-exon,
purple, (<10kb from exon), and orphan REs (>10kb from exon).

Figure 3.2. Background noise for read coverage thresholds. X-axis represents the
experimental threshold for calling a RE as “true positive (TP)”. The corresponding Positive
Predictive Value (PPV) is calculated as (TP/(TP+FP)). The PPV curve is provided for levels
of μ from 1 RPM to 10 RPM. The X-axis represents the expression threshold required for
assigning a RE as expressed, and ranges from 1 to 200 RPKM. A PPV of 0.95 (corresponding
to a False Discovery Rate (FDR) of 5%), is shown as a black line.
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Novel REs were then annotated according to their genomic position, relative to known
exons (Figure 3.1B). “intronic” REs were located within introns, while any non-intronic REs
located within 10 kb of an annotated exon were designated “near-exon” REs; “orphan” REs
were at a distance greater than 10 kb from any known exon. An exonic RE was extended into
a near-exon RE if they were within 50 bp and the difference in read coverage was < 50%. As
summarized in Figure 3.3, previously published RNA-seq studies representative of human
spermatogenesis, mature sperm, oocyte, embryonic stages, and liver samples, detailed in
Appendix F, were subject to RE discovery. This set of RNA-seq libraries encompassed both
poly(A+) selected and total RNA preparations. A database of REs across the different tissue
and types was created by merging the novel REs from each study with the exonic and noncoding transcript REs and used in all subsequent analyses.
A specific set of RE discovery parameters (µ = 2.5 reads per million and minimum
required distances between genomic bins), were used to provide an acceptable signal to noise
ratio in the sperm RNA libraries. Due to the exploratory nature of this study, maximizing the
number of REs, while still excluding spurious signals, was of particular interest. Modification
of the parameters used in the REDa method will allow increased detection stringency (thus
reducing the number of REs detected) or more permissive RE detection (thus increasing the
number of REs detected). Increased stringency during RE detection can easily be achieved
by increasing the required µ (thus increasing the threshold required to mark genomic bins as
“expressed”) or by increasing the minimum proportion of samples with the required minimum
read coverage to retain a genomic bin for RE designation.
The accuracy of the RE approach, which separates exons into individual units, rather
than linking exons into a whole transcript, was tested by comparing expressed REs in testis
libraries to the testis expression levels given by GTEx. At least 91% of gene names associated
with testis-expressed exonic REs overlap with gene names expressed in GTEx testis tissue,
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suggesting that the RE approach can recapitulate the patterns designated in established
expression databases.

Figure 3.3. Tissue types used for RE discovery. The male germline within the testis tissue
is divided into and represented by seven stages of spermatogenesis. The female germline is
represented by a single-cell oocyte with embryonic stages that range from zygote to
blastocyst. Somatic tissue is represented by the liver sample. Total RNA or poly(A+) enriched
RNA-seq libraries are indicated in split squares, with blue representing poly(A+) selected
samples, red indicating total RNA samples, and a split blue/red square as both library
preparations.
The above RE identification method was developed to ensure accuracy in face of
extensive RNA fragmentation, naturally occurring in human sperm. Certain tissue
preparations, such as FFPE, also yield compromised RNA preparations. Given that several
established transcript-building algorithms are readily available, I compared both Stringtie
(v1.3.4) and Cufflinks (v2.2.1) to the RE approach for two random sperm samples and two
male human cell lines. RNA-seq datasets from human cell lines, i.e., SRR020288 (h1 hESC)
and SRR3192556 (OCI-LY7, derived from a B cell lymphoma), provided independent datasets
when testing the RE method. Using minimal thresholds of expression (>10 RPKM in REs, >1
FPKM in Cufflinks and Stringtie), the majority of expressed REs overlap locations of
transcripts generated using transcript-building software. Across the 4 samples, 67%-92% of
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“expressed” REs overlap Stringtie results, and 81%-90% overlap Cufflinks results at the above
thresholds of expression. Notably, regardless of the transcript-building method and required
expression thresholds, a majority of REs (complete range 21%-93%) lacking overlaps with
Cufflinks and Stringtie results are exonic REs, suggesting that the established transcriptbuilding methods are less than ideal for fragmented or unevenly covered transcripts.
Additionally, the presence of spliced reads, a critical component to transcript-building, is
reduced in spermatozoal RNAs (36% - 40%) compared to RNAs from cell lines (41%-64%).
Other investigators have also employed a targeted Cufflinks [168] discovery approach to
identify novel linear embryo transcripts. Reflective of the low level of expression and rigor
required for identification, the majority of these linear transcripts were not discovered using
the RE strategy (data not shown).
With the function of the novel REs being unknown, I hypothesized that the novel REs
may have regulatory roles. To assess this, REs were overlapped with a series of epigenetic
marks and regulatory genomic sequences (Figure 3.4). For regulatory chromatin marks
(proximity to DNase hypersensitive regions, proximity to CTCF binding sites, proximity to
Topologically Associating Domains (TADs), and proximity to ENCODE Transcription Factor
Binding Sites (TFBS)) [177-182], the novel RE classes largely showed a similar overlap
proportion as exonic REs. All RE classes showed very little overlap with piRNA clusters [183,
184]. TADs mark the physical interaction of genomic regions and the minimal overlap of all
RE classes with TAD boundaries suggests that novel REs are not primarily involved in
establishing TADs. However, it is important to note that the compilation of REs are detected
in at least one of a variety of tissues (across spermatogenesis, embryogenesis, and somatic
tissue). Therefore, the overlaps summarized in Figure 3.4 do not preclude a tissue-specific
relationship of REs with a given epigenetic mark, such as TADs. Notably, all classes of novel
REs had a high overlap (>50%) with repetitive sequences (UCSC’s Repeatmasker track (for
GRCh38) [185], compared to the approximately 22% overlap in exonic REs.

49

Figure 3.4. Overlap of REs with epigenetic marks and regulatory genomic sequences.
The proportion of each RE class classified as overlapping a given epigenetic mark or genomic
sequence is indicated on the Y-axis, with the type of epigenetic mark or genomic sequence
indicated on the X-axis. The type of RE class is indicated with exonic REs in black, near-exon
REs in light blue, intronic REs in green, and orphan REs in yellow. “DNase” indicates overlaps
within DNase I Hypersensitivity Peak Clusters from ENCODE (95 cell types) or 5 kb of a
cluster. “CTCF” indicates overlaps within CTCF binding sites in the GM12878 cell line
(determined from ChIP-seq) or 5 kb of a binding site. “TAD” indicates overlaps within 5 kb of
a topologically associating domain (TAD) ending site. “ENCODE TFBS” indicates overlaps
with Transcription Factor Binding Sites (TFBS) from Encode (ENCODE Mar 2012 Freeze).
“piRNA Cluster” indicates overlaps with piRNAs in the human genome. “Repetitive
sequences” indicates overlaps with UCSC’s Repeatmasker track (last updated 2014-01-10).
RNA-seq complexity of RNA elements
The RE discovery algorithm was developed to identify transcribed intergenic loci from
RNA-seq data. Many novel loci (e.g., near-exon and orphan REs) were hypothesized to be
derived from non-polyadenylated RNAs, since this class appears underrepresented in the
genome and the GENCODE annotations. A series of poly(A+) selected and Total RNAs from
a range of cell types that capture fertilization to early embryonic development from oocyte,
zygote, 2-cell embryo, 4-cell embryo, 8-cell embryo, and morula (Figure 3.3) and the male
germline, through ejaculated sperm and testis, were examined [167-169]. Applying a linear
mixed-effects model (LMEM) to Total and poly(A+)-selected RNAs from the human oocyte and
various stages of early embryonic development, revealed a comparatively lower number of
REs detected within the poly(A+) selected fraction (Figure 3.5). In general, the number of
novel REs that were either increased or depleted by poly(A+)-enrichment do not markedly
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differ (Figure 3.5B). Interestingly, the number of orphan REs approximately doubled upon
poly(A+)-enrichment as compared to the Total RNA fractionation. This suggests that a
population of orphan REs belong to a larger, yet unknown set of polyadenylated transcripts.
To determine if poly(A+) enrichment of orphan REs reflected a genomic repeat, the distribution
of repeats within the 150 poly(A+) enriched orphan REs was assessed and is shown in Figure
3.5C. Within the 129 orphan REs that contain a repetitive element, the majority were LTRs
and SINEs. It is worth noting that 40 of the 55 LTR-containing REs were ERVL-MaLRs. This
is a non-autonomous LTR-retrotransposon element derived from ERV [186, 187] that may
function in regulating gene expression during the oocyte-to-embryo transition [188].

Figure 3.5. Orphan REs are enriched in poly(A+) samples. (A) Volcano plot of slope
changes in REs from LMEM in oocyte and embryo, with the X-axis representing slope change
in log10-transformed RPKM, and the Y-axis representing the Benjamini-Hochberg-adjusted
P-value as a negative log10-transformed P-value. Positive slope and negative slope indicate
increased abundance in total RNA and poly(A+) preparations, respectively. Each point
represents a single RE, with blue points indicating statistically significant REs (adjusted Pvalue <0.05) with absolute slope changes exceeding 25 RPKM. (B) Distribution of REs
enriched in either total RNA or poly(A+) libraries, according to the annotation class. (C) The
distribution of orphan REs enriched in either total RNA or poly(A+) libraries, according to
repeat class.
The effect of poly(A+) enrichment was also assessed individually for human sperm and
testis samples, providing the other half of the equation to early post-fertilization development.
Poly(A+) enrichment has contrasting effects on exonic REs in spermatozoa and testis, with
poly(A+) enrichment depleting and enriching exonic REs in sperm and testis, respectively.
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However, unlike embryos, novel REs were markedly enriched in sperm and testis total RNA
libraries, reflective of the relatively uncharacterized state of this cell type (Figure 3.6).
Although poly(A+) enrichment does effectively reduce RNA library complexity, it does not
appear to select for RNAs of any given biological function or pathway, with many GO terms
shared in both the poly(A+)-enriched and Total RNA-enriched gene sets of the human embryo.
This reiterates previous studies that indicate a reduction of transcript diversity and exon
expression upon poly(A+) enrichment [189].
The number of human zygotic LTR and SINE-associated REs that may be derived
from poly(A+) intergenic transcripts is of note. In accord with the data of others [190-193], this
could afford transcript stabilization and nuclear export [194] perhaps increasing their retention
in a given cell of the dividing embryo. Notably, at least in mouse, the transcription of
retrotransposon-derived RNAs is thought to impact chromatin accessibility, and thus
embryonic development [195].

Figure 3.6. Total RNA libraries are
enriched for Novel REs in sperm
and testes. (A) Histogram of fold
changes (log2 transformed) are shown
for (A) mature sperm and (B) testes
samples. The X-axis indicates the
Log2 of the Total RNA/polyA+ ratio,
with positive change and negative
change representing enrichment in
total RNA and poly(A+) libraries,
respectively. Note the novel REs all
exhibit a shift to the right, indicating
increased expression in total RNA
samples.
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RNA element expression across spermatogenesis
RE expression throughout spermatogenesis was examined as a comparison to
previously published patterns of whole transcript expression during the spermatogenic
cycle[175]. The spermatogenic stages encompassed 6 cell types (Spermatogenic Stem Cells
(SSCs) through Round Spermatids), isolated using laser capture microdissection [175].
Clustering of the various REs expression patterns across spermatogenesis was initially
performed using Mfuzz, [173, 174] with the published 6 cell types [175]. RE expression across
spermatogenesis recapitulated those patterns previously observed using whole transcripts.
To extend the analysis to the final stage of spermiogenesis, RNA-seq from ejaculated sperm
datasets from fertile males [163] were included (Figure 3.3). The addition of mature sperm
enabled the discovery of several patterns specific to early round spermatids and maturing
round spermatids, as observed through mature spermatozoa (Figure 3.7A-D). The final
stages of spermatogenesis involve a burst of transcription, as well as the formation (and
eventual loss) of the residual body as the majority of the cytoplasm is expunged from the cell.
The burst of transcription in round spermatids was observed as a general increase in
transcription of exonic REs that include 34,226 REs found in round spermatids but not in the
late pachytene stage spermatocytes. Interestingly, a large portion of spermatid and/or mature
sperm-specific clusters were generated from novel REs, suggesting that intergenic and
intronic REs play a substantial role in the final stages of spermatogenesis that forms each
spermatozoon as summarized in Table 3.1. To verify these observations, expressed (median
expression >25 RPKM) REs for each spermatogenic stage were partitioned according to RE
class (Figure 3.7E). The vast majority of REs expressed in pre-meiotic and meiotic stages
were exonic (85%±7%). This was followed by a notable increase in the number of novel REs
in Round Spermatids and Spermatozoa. The contribution of novel REs to the total
transcriptome rose to 47% in mature sperm.
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Figure 3.7. Mfuzz clusters highlighting the round spermatid to spermatozoon transition.
(A-D) Clusters with increased expression in round spermatids and/or mature spermatozoa.
(E) RNA element abundance as a function of annotation class and cell type with median
RPKM >25.
Table 3.1. RE class distribution of Mfuzz clusters. The “Pattern” column indicates the
expression pattern across spermatogenesis. The count of exonic REs, near-exon REs,
intronic REs, and orphan REs belonging to the given pattern are indicated in columns “EXON”,
“NOVEL_10KB_EXON”, “NOVEL_INTRONIC”, and “NOVEL_ORPHAN”, respectively.
PATTERN

High Round spermatids
and Spermatozoa
High Round spermatids
High Spermatozoa
High
Leptotene/Zygotene
and Round spermatids
High
Leptotene/Zygotene
High Adark and Apale
High Adark
High Adark, Apale and
Late Pachytene
High Apale
High
Leptotene/Zygotene,
Low Round spermatids
& Spermatozoa

EXON

NOVEL_10KB_EXON

NOVEL_INTRONIC

NOVEL_ORPHAN

1992

513

1333

286

5502
5012

1325
4157

5019
11874

1453
4458

1607

59

167

27

3403

345

1727

333

618
1198

3
23

11
105

2
18

513

29

32

11

996

16

64

10

519

28

33

12

Ontological analysis of the exonic and novel REs (with the exception of orphan REs)
showed that the most abundant REs in round spermatids were enriched for genes involved in
organelle biogenesis and maintenance. This is in accord with the physiological changes
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occurring during spermiogenesis. REs that are abundant in both round spermatids and
spermatozoa were enriched for TNF-alpha signaling, associated with maintaining a
homeostatic state [196, 197]. The TNF-alpha signaling-associated REs enriched throughout
the post-meiotic phase of spermatogenesis may be another part of a surveillance mechanism
to ensure an optimal contribution [165]. REs that were primarily abundant in spermatozoa
were associated with a range of signaling pathways, such as Glutamate Receptor signaling,
WNT signaling, NGF signaling, EGFR1, and Signaling by Rho GTPases. WNT signaling has
several roles in spermatogenesis, from maintenance to maturation, and thus motility [198200]. The role of NGF signaling in spermatogenesis in humans is unclear but has been
implicated in mammalian Sertoli-germ cell signaling, sperm motility, and the acrosome
reaction [201, 202]. Sperm EGFR activation is a major driver of sperm capacitation [203, 204],
while Rho GTPases are likely to aid as mediators of the acrosome reaction [205]. Odorant
receptors may be required for sperm chemotaxis in mammals [171], while glutamate receptors
may also be involved in capacitation and/or sperm chemotaxis [206, 207] although such
functions have yet to be demonstrated in mammalian systems.
Sex-chromosome expression during spermatogenesis
Meiotic sex chromosome inactivation (MSCI), the process by which genes located on
the X-chromosome are repressed during meiosis, is essential for successful meiosis during
human spermatogenesis [208]. However, abundant evidence suggests that numerous Xlinked genes escape post-meiotic X chromosome silencing (PMCI), a process that may be
less effective in humans than other species [209, 210]. In comparison, most classes of Ylinked REs undergo silencing during MSCI, with the exception of Y-linked orphan REs that
are present throughout spermatogenesis.
As shown in Figure 3.8, repression of exonic X-linked REs during spermatogenic
MSCI is evident. This is followed by de-repression of X-linked exonic and novel REs, that
return to pre-meiotic levels in mature sperm (Figure 3.8A). Notably, several X-linked REs
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were intensely expressed (at a threshold of 25 RPKM) in solely one spermatogenic stage,
including the post-meiotic stages, i.e., round spermatids and to a greater extent, mature sperm
(Figure 3.8B). Overall, the patterns of X-linked REs across spermatogenesis imply a larger
upregulation of genes and novel REs in the post-meiotic stages than previously thought, with
the number of expressed X-linked REs largely following the patterns laid by autosomes. Of
the 289 paternally transmitted REs, two were located on the X-chromosome, and both were
exonic REs. The two REs are located (in hg38 coordinates) at chrX_2717605_2717652 and
chrX_149929645_149930127, corresponding to CD99 and XX-FW81066F1.2, respectively.
The spermatogenic roles of CD99, a cell surface glycoprotein involved in T-cell adhesion
processes, and XX-FW81066F1.2, a poorly described transcript with a putative protein
structure or antisense lncRNA function [135], are unknown. Although few paternally derived
zygotic RNAs are X-linked, the expression patterns of REs located on the X chromosome
were largely congruent with the current paradigm of Meiotic sex chromosome inactivation
(MSCI) and reactivation during spermatogenesis [210]. However, the data also suggest that
the process of post-meiotic X chromosome silencing (PMCI) during human spermatogenesis
is selective, as many genes and novel REs escape silencing.
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Figure 3.8. X-chromosome expression during spermatogenesis. (A) The number of
expressed REs across each spermatogenic stage, for two representative autosomes (upper
panels chr1 and chr2) and the sex chromosomes (lower panels chrX and chrY). The
connected points are colored according to the RE class, with exonic REs in orange, intronic
REs in green, near-exon REs in light blue, and orphan REs in purple. The X-axis of each
graph presents the spermatogenic stage, with the pre-meiotic stages represented by Adark and
Apale, the meiotic stages represented by Leptotene/Zygotene, and early/late Pachytene, and
the post-meiotic stages represented by round and mature sperm. (B) An expression heatmap
of X-chromosome REs that are primarily expressed (>25 RPKM) at one spermatogenic stage.
RE class, shown adjacent to the RE expression column, shows exonic REs in black, intronic
REs in green, near-exon REs in light blue, and orphan REs in yellow.
Paternal transmission of REs to the human embryo
It has been proposed and shown in vitro that human sperm deliver a cadre of RNAs
upon fertilization [154, 160, 211, 212]. In the current study, the series of human RNA-seq
profiles from sperm, oocyte, and embryo allowed for the identification of REs that are
transmitted to the human oocyte solely by sperm. These are in addition to those 26,740
zygotic REs (5% FDR), associated with a total of 6,118 individual named genes, which are
essentially provided by the oocyte, but not present in sperm (Figure 3.9). Up to 289 sperm
REs were identified as a majority contributed by paternal transmittance, with an FDR of ~3.4%,
and 75 REs essentially provided by the sperm, at an FDR of ~2.7% (Figure 3.10A,B).
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Interestingly, the 289 REs were enriched for “cycling of RAN in nucleocytoplasmic transport”
(p=8.36 x 10-8) and the Unc 51 Like Kinase (p=1.47 x 10-3). RAN cycling is required for
effective translocation of RNA and proteins across the nuclear pore. The human sperm REs
contain RANGAP1, XPO7, XPO6, NUP210, and NUP214, as members of the nucleoporin
complex. Interestingly others have shown that at least in embryonic stem cells, the
nucleoporin complex may regulate parentally imprinted genes [213]. In comparison, the Unc
51 Like kinase is associated with autophagy a process that is essential for the oocyte-toembryo transition [214]. These observations are consistent with the view that the paternal
RNAs may contribute to re-establishing nuclear transport in the zygote and clearance of
extraneous cellular complexes post-fertilization, when cell lineages begin to be established.
Compared to the oocyte’s maternal contribution, relatively few paternal full-length RNAs are
likely to be exclusively contributed to the embryo [156]. Of note, the genes associated with
the paternally transmitted REs did not overlap those long RNAs suggested to be paternally
derived in mouse [215]. This is likely due to the differences in genome activation, which occurs
in the late 1- cell zygote in mouse [216], compared to the later 4-8 cell stage of human
embryos, or other sperm derived RNAs providing a substitutive function [154, 217].

58

Figure 3.9. Expression heatmap of
maternally derived REs. The overall
expression level is represented in “RE
expression”, with red indicating a median
expression exceeding 25 RPKM. RE class,
shown adjacent to the RE expression
column, shows exonic REs in black, intronic
REs in green, near-exon REs in light blue,
and orphan REs in yellow. The REs
presented are supplied by the oocyte to the
zygote (Sperm < 2 RPKM; Oocyte > 25
RPKM; Zygote > 10 RPKM)

Figure 3.10. Expression heatmap of paternally derived REs. The overall expression level
is represented in “RE expression”, with red indicating a median expression exceeding 25
RPKM. RE class, shown adjacent to the RE expression column, shows exonic REs in black,
intronic REs in green, near-exon REs in light blue, and orphan REs in yellow. The REs
presented are supplied by the sperm to the zygote, with strong sperm preference (A) Sperm
> 25 RPKM; Oocyte < 2 RPKM; Zygote > 10 RPKM and moderate sperm preference (B)
Sperm > 25 RPKM; Oocyte < 5 RPKM ; Zygote > 10 RPKM
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Differential gene expression during embryogenesis
Transcriptomic changes across mammalian embryogenesis have been well-studied,
using both microarrays and RNA-seq [218-222]. However, these experiments have not
addressed the contribution of intergenic RNAs to embryogenesis and, importantly, during
human embryogenesis. Towards filling this gap, examination of expression changes of novel
REs from oocyte to blastocyst, while considering the contribution of the spermatozoon, tested
the hypothesis that both exonic and novel REs would exhibit distinct patterns.
To identify differentially expressed REs, a linear model was applied to the single-cell
oocyte and embryonic RNA-seq datasets [168, 223]. Differential expression with REs
reiterated previous analysis of RefSeq-annotated genes suggested that the oocyte, zygote,
and 2-cell embryo contain a similar distribution of transcripts [168]. Few differences (59 REs)
were identified between oocyte and zygote, and no differential REs were identified between
zygote and 2-cell embryo (Figure 3.11). As expected, exonic REs exhibited characteristics of
maternal genes, which are supplied by the oocyte and diluted as the embryo develops in
anticipation of the 4 & 8-cell stage extensive Embryonic Genome Activation (Figure 3.12)
[224]. This included a set of novel maternal REs specific to the early zygote (maternal genes)
and EGA (the 4 & 8-cell stage). The majority of these novel maternal REs were intronic,
suggesting e.g., (1) incomplete processing, (2) expression within an intron, (3) retention of
circular RNA, or some other form. They were supplemented by a series of maternal intergenic
orphan REs. Interestingly, novel REs also followed similar patterns, defining clusters of REs
that are present during the minor first wave of human ZGA, as well as clusters that are active
during EGA (Figure 3.13). While the novel REs with a maternal gene pattern are enriched for
neuronal genes (Neuronal system, p=2.12e-05), those expressed during EGA are associated
with protein metabolism (p=4.90e-06), consistent with the energy requirements of the early
embryo.
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Figure 3.11. Differential RE expression across early embryonic development. The count
of differential up- and down-regulated REs as embryogenesis proceeds is shown below the
diagrams of cell types. The annotation classes of the total differential REs are summarized in
the bottom table.

Figure 3.12. Expression heatmap of differentially expressed exonic REs across early
embryogenesis. The overall expression level is represented in “RE expression”, with red
indicating a median expression exceeding 25 RPKM. RE class, shown adjacent to the RE
expression column, shows exonic REs in black. The REs presented are differentially
expressed across at least one stage.
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Figure 3.13. Differential novel REs across embryogenesis. The overall expression level is
represented as left panel “RE expression”, with red indicating a median expression exceeding
25 RPKM. RE class, shown adjacent to the RE expression column, shows intronic REs in
green, near-exon REs in light blue, and orphan REs in yellow. The REs presented from oocyte
to blastocyst are differentially expressed across at least one developmental stage.
Expression of genomic repeats across spermatogenesis and embryogenesis
Genomic repetitive elements and small non-coding RNAs are thought to play a role in
confrontation-consolidation of the maternal and paternal genomes after fertilization [162, 225].
As novel REs tend to overlap genomic repetitive sequences, I examined RE expression to
determine what genomic repeats may influence RNA expression throughout spermatogenesis
and early human embryo development (Figure 3.14). The relative enrichment or depletion of
repetitive sequences in the expressed REs was calculated for each available cell type. Briefly,
the number of instances of genomic repeats overlapping expressed REs in each cell type
were compared to an expected random distribution, with the random distribution drawn from
the repeat occurrence in all available REs. Using a hypergeometric test, both relative
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enrichment and depletion of repeat families were calculated across cell types. Despite the
many instances of repeat depletion, there were relatively few instances of enrichment.

Figure 3.14. Expression of repetitive sequences across spermatogenesis and
embryogenesis. Moderate enrichment (mean RE expression > mean expression across all
cell types) is shown in pink, and strong enrichment (mean RE expression is an upper outlier)
is shown in red. The name of the genomic repeat is given on the left of the diagram, and the
cell type is shown at the top of the diagram.
Although several studies have examined the influence of environment on epigenetic
marks, such as DNA methylation, at genomic repeats in spermatozoa, much less is known
about genomic repeat expression during spermatogenesis and if genomic repeats are in part
driving spermatogenesis, perhaps through transcriptional regulation or chromosomal
reorganization [226, 227]. Four repeat families, LTR71B, HERVE-int, HSAT1, and MER1A
were primarily expressed in both round spermatids and mature spermatozoa, while the
centromeric repeat AATGG(n) showed greatest expression in the leptotyne/zygotene and late
pachytene stages through the post-meiotic phase [228]. The simple repeat AAGA(n) was
enriched solely in mature spermatozoa. The genomic repeats identified here as expressed
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spermatogenesis. For example, the centromeric repeat AATGG(n) likely plays a role in
establishing stage specific chromosomal structure and position throughout spermatogenesis
[229, 230]. The simple repeat AAGA(n) and HSAT1, primate-specific Satellite repetitive
element, may also play a role in organizing sperm nuclear structure through Matrix-Associated
Regions (MARs) of sperm, which are enriched in TTCT(n) and TCTT(n) repeats [230]. The
remaining spermatogenesis-associated repeats LTR71B, HERVE, MER1A are all members
of the HERV family of retroviruses or DNA transposons. The murine embryo and sperm are
known to express a LINE-1-encoded Reverse Transcriptase (RT) that may serve to reverse
transcribe the sperm-supplied retroviral and transposon RNAs for integration into the genome
[44, 231, 232]. Insertion by retrotransposition might then act to provide regulatory networks,
or genetically/epigenetically modify the developing embryo [44, 231] during syngamy.
However, the presence of LINE-1-encoded RT in mature murine spermatozoon does not
appear to extend to an enrichment of LINE1 RNAs in human sperm or zygote. This likely
reflects a species differences, although one cannot exclude the influence of differing
methodologies. However, MLT2A1 and SVA-D were both present during EGA, while MER73
was strongly enriched in oocyte and the early embryo (Figure 3.14). Both MLT2A1 (primatespecific) and MER73 are LTRs for ERVL endogenous retrovirus, while SVA-D is a hominidspecific composite retroelement (SINE-R + VNTR + Alu) [187]. Although SVA-D is a marker
of naive human ESCs, consistent with the enrichment from 4 cell to morula stage, it is not
enriched in blastocyst stage, from which human ESC cell lines are derived [233]. The ERVL
retrotransposon has been previously implicated in mammalian embryonic development [188].
Notably, the presence of an RT in the early embryo would provide the opportunity for LTR71B,
HERVE-int, and MER1A, components of HERVs and DNA transposons, to undergo
transposition [234].

64
Overall, the above data suggest that the mechanism(s) driving spermatogenesis may
involve the use of repetitive sequences as regulators of transcription and/or chromatin states
[195, 235, 236]. Its nuclear architecture reflects the complex and orchestrated compaction
and restructuring of its chromatin via protamination. This is linked through the nuclear
matrix/lamina in a non-random manner [237], consistent with the current 3D models [238].
The enrichment of centromeric AATGG(n) repeat RNAs appears in the leptotyne/zygotene
and late pachytene stages through the post-meiotic phase [228]. This repeat can form a
double folded hairpin [228], that in mice can promote RNA:DNA hybrids mediating
heterochromatin formation [239]. Perhaps this aids in excluding large repetitive DNA domains
from homology searching enhancing the fidelity of meiosis as observed by the clustering of
pericentromeric chromatin during meiosis [240].
In summary, this work introduced a RE discovery algorithm (REDa) that identifies
tissue and cell type specific expression in both exonic and intergenic REs. Expression patterns
of REs were identified across human spermatogenesis, extending the current knowledge of
the transcriptome in developing human sperm. In addition to observing considerable effects
of poly(A+) enrichment, the sheer abundance of intergenic RNAs suggests that they play a
large role in spermiogenesis. Of note, extensive expression of repetitive elements during
spermatogenesis, suggests that perhaps these are driving spermatogenesis, while spermdelivered repeat-derived RNAs may play more of a regulatory role in the human embryo.
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CHAPTER 4
“THE EFFECTS OF DI-BUTYL PHTHALATE EXPOSURE FROM MEDICATIONS ON
HUMAN SPERM RNA”
This chapter was adapted from the following publication:
Molly Estill, Russ Hauser, Feiby L. Nassan, Alan Moss, and Stephen A. Krawetz. “The effects
of high exposure to di-butyl phthalate from medications on human sperm RNA among men”,
In review with Scientific Reports.
i. Summary
Endocrine disruptors, chemicals that perturb hormonal function, are suspected of
affecting reproductive function. Low-dose exposures to endocrine disruptors such as
phthalates, widely used as plasticizers, is widespread. Patients with Inflammatory Bowel
Disease (IBD) are often prescribed mesalamine, that in some forms is encapsulated within a
di-butyl phthalate (DBP)-containing coating. The Mesalamine and Reproductive Health Study
(MARS) was designed to address the physiological effect of in vivo phthalate exposure on
male reproduction. As part of this effort, sperm RNA profiles among men with IBD and their
relationship to DBP was longitudinally assessed across binary (high or background) DBP
crossover exposures. As the level of DBP was altered as +/- DBP (H, high vs B, background),
numerous changes in the composition of sperm RNA elements were detected. This was
observed when the acute and recovery phases were compared, suggesting that, exposure to,
or removal from high DBP, produces effects that require longer than one spermatogenic cycle
to resolve, if at all. While the two study arms exhibit enrichment of different biological
pathways, the arm which initiates the study on high-DBP mesalamine displayed activation of
oxidative stress and DNA damage response pathways. However, DBP exposure has a
minimal effect on small RNAs. Small RNAs were negatively correlated with specific genomic
repeats, suggesting that they may contribute to repeat regulation. This provided insight into
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both the influence of phthalate on the male germline, as a dynamic function of RNA during
human spermiogenesis.
ii. Introduction
Endocrine disruptors, exogenous chemicals that can mimic or alter hormonal
responses, are a prevalent feature in urban environments. A heterogeneous collection of
natural and synthetic chemicals have been identified as likely EDs, including several wellpublicized

pesticides,

such

as

dichlorodiphenyltrichloroethane

(DDT),

and

plastic

components, such as bisphenol A (BPA) and phthalate esters [55]. Phthalates, suspected
endocrine disruptors, are commonly used as solvents and plasticizers in consumer products,
such as polyvinyl chloride. They are also incorporated into coatings used in medications [56,
57]. Phthalates have been noted to act on peroxisome proliferator‐activated receptors (PPAR)
[58, 59]. Additionally, different phthalate species, including phthalate metabolites, have
different capacities for modifying an endocrine response [58-60]. Although considerable
literature suggests that gestational and neo-natal phthalate exposure is detrimental to
reproductive function [61], the health effects of phthalates at environmentally relevant doses
in adult humans is uncertain, particularly in the adult male.
To directly address the effect of physiological, in vivo phthalate exposure on male
reproduction, the Mesalamine and Reproductive Health Study (MARS) (NCT01331551),
designed as a clinical trial (https://clinicaltrials.gov/ct2/show/NCT01331551), was initiated.
The MARS study, implemented from 2010-2018, was designed to assess semen quality and
hormone levels in human males with longitudinally alternating DBP exposures, administered
via mesalamine-containing medication for the treatment of Inflammatory Bowel Disease and
Ulcerative Colitis. Patients with Inflammatory Bowel Disease (IBD) are often prescribed
mesalamine, a medication which, in some formulations, has di-butyl phthalate (DBP) in the
coating to allow for release of the active ingredient in the distal small intestines and colon [56,
57]. The DBP-coated medication(s), at maximal dosages, range from 300% - 700% of the
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designated EPA Reference Dose (RfD) for a 150-pound individual [241-243]. The use of the
DBP-coated medication produces urinary monobutyl-phthalate (MBP) levels 1000x higher
than the levels found in the general U.S. population [69].
With the MARS study longitudinal data structure, each individual acts as their own
control, thus mitigating the potential exposure fluctuation, genetic variation and minimizes
within environmental variation that often complicates accurate causal assessment of
epidemiological data. As shown in Figure 4.1, the recruited subjects provided semen, urine,
and blood samples across the longitudinal study. The cycle of human spermatogenesis and
subsequent ductal transport takes approximately 90 days [36]. The MARS study required a
minimum medication duration of 90 days, ensuring that an entire spermatogenic cycle
occurred on a single medication. This duration was necessary to ensure that collected semen
samples had developed solely from the current medication period. A total of 73 individuals
were recruited for the MARS study. A subset of the individuals provided longitudinal samples
across alternating DBP exposures, with a total of 60 individuals enrolled in the full protocol
(baseline, crossover, and crossback visits collected) [69].

Figure 4.1. Crossover study design. Men enter the study having taken a mesalamine
medication coated with (+) or without (-) DBP for at least 3 months. Semen, blood and urine
were collected twice (green star) at baseline, after 4 months on an alternate drug (crossover),
and after a final 4 months on the original drug (crossback).
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Ejaculated spermatozoa, and their RNAs provide a snapshot of transcriptomic
processes, capturing the influence of the paternal environment [17, 71, 73, 244] during
spermatogenesis. MARS sperm samples were processed for RNA-seq, generating both a
series of long RNA (>200 nucleotides) and small (<200 bp) RNA libraries to elucidate the
biological processes being modified through phthalate exposure. The transcriptomic effects
of both IBD and DBP exposure were assessed as a function of sperm RNA elements (REs),
to provide a robust quantitative measure of effect [245]. Differential responses to high-DBP
exposures were readily apparent in DBP-naïve men and men chronically exposed to highDBP mesalamine. RNA levels of genomic repeats were examined to determine both which
genomic repeats were well-represented in human sperm and which genomic repeats were
part of the response to high-DBP exposure. While transcription is a dynamic process, the
interactions of the sperm transcriptome until now remained unknown. Correlations between
small RNAs and genomic repeats suggest a dynamic regulatory relationship.
iii. Materials and Methods
Sperm purification and library construction
To perform spermatozoal purifications, MARS samples were brought up to 1 ml
volume with PureSperm Buffer (Nidacon) and laid onto a 50% PureSperm (Nidacon) gradient,
then centrifuged at 300xg for 20 minutes [246]. The pellet was removed and washed in
PureSperm Buffer. Cell counts were performed with a hemacytometer and microscope
including a visual inspection for somatic cells and round spermatids.
Each sample was added to a 2ml tube containing 500ul RLT buffer (Qiagen) with 7.5ul
BME (14.3M), 100 mg 0.2 mm nuclease free SS beads. The sample were homogenized, 500
ul Qiazol (Qiagen) added and homogenized again. 200 ul chloroform (0.124M) was added
and samples shaken by hand then centrifuged at 12,000 x g for 20 minutes at 4⁰C and the
upper aqueous layer removed. RNA was isolated from the aqueous layer using a customized
Qiacube (Qiagen) protocol [246]. RNA samples were treated with 4 U Turbo DNase (Ambion)
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for 20 minutes at room temperature. Samples were tested for DNA contamination by RT-PCR
and intron spanning PRM1 primers [246]. Samples still containing DNA were treated a second
time and tested again by RT-PCR. The RNA samples void of DNA were quantified with a
fluorescent assay as described [247]. An aliquot of RNA (5 ng or 10 ng) of each sample was
used to make cDNA with SuperScript III RT (Invitrogen). The cDNA’s were used as template
for RT-PCR with intron spanning PRM1 primers providing verification of RNA.
Two nanograms of RNA per sample was used with the Seqplex (Sigma-Aldrich)
amplification kit prior to library construction. Fifty nanograms of Seqplex cDNA product was
used with the NEBNext Ultra DNA Library Prep Kit for Illumina (New England Biolabs) to
create sequencing libraries. Complete barcoded libraries were quantified and pooled for
sequencing at a concentration of 2 nM per sample. All samples were subject to paired-end
sequencing using either the NextSeq 500 (Illumina) sequencer, HiSeq 2500 (Illumina)
sequencer or the HiSeq 4000 (Illumina) sequencer.
One nanogram of small RNA per sample was used with the NEXTflex Small RNA-Seq
Kit v2 (Bioo Scientific) to create small RNA sequencing libraries. Complete barcoded libraries
were quantified and pooled for sequencing. Samples were subject to paired-end sequencing
using the MiSeq (Illumina) sequencer.
RNA-seq data processing methods
As a control cohort, RNA-seq datasets from males of idiopathic infertile couples who
fathered a child were downloaded from the Gene Expression Omnibus (GEO), accession
number GSE65683 [163]. A total of 52 RNA-seq datasets were downloaded from the Gene
Expression Omnibus (GEO), accession number GSE65683 [163]. The MARS long RNA
libraries were processed similarly to the GSE65683 samples. Paired-end reads were trimmed
of adaptors and low-quality bases using Trimmomatic (version 0.36) [248], using default
parameters (2:30:10 LEADING:3 TRAILING:3 SLIDINGWINDOW:4:15), and requiring a
minimum

read

length

of

50

bp

(MINLEN:50).

The

TruSeq

Universal

adaptor
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(AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT)
was used as input to Trimmomatic. Paired and unpaired reads were aligned to the consensus
human ribosomal RNA (GenBank: U13369.1) using HISAT2 (version 2.0.6) and the nondefault parameters (-p10 --max-seeds 30 -k 2), then aligned to the human genome (hg38) and
exogenous RNA spike-in sequences, using the same HISAT2 parameters. Reads without
alignments in either U13369.1, the human genome (hg38), or an exogenous RNA were further
assessed for alignments to repeat sequences (RepBase, February 2017 release), using
HISAT2, with the following parameters (-p10 --no-spliced-alignment --max-seeds 10 -k 3).
Reads without alignments in either U13369.1, hg38, an exogenous RNA, or RepBase were
aligned to bacterial and viral genomes using Kraken (version 0.10.5-beta) and Jellyfish
(version 1.1.10), implementing the full Kraken library and filtering alignments with a threshold
of 0.15. Read alignments to the human genome, exogenous RNAs, and U13369.1 were
processed to remove duplicated reads using Picardtools MarkDuplicates (version 1.129).
QC of the MARS study’s long RNA samples was accomplished by examination of
alignment statistics, allowing for the quantitative classification of samples failing QC (Table
4.1) into one of five categories (Category 1: Low genomic alignment, Category 2: High
intergenic reads, Category 3: High bacterial and viral reads, Category 4: High spike-in reads;
Category 5: High unmapped reads).
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Table 4.1. Summary of sample quality. The first two columns (“Study arm” and “RNA type”)
indicate the study arm(s), and RNA type (small RNA or Long RNA library) for the given table
row. “Total Samples” and “Pass QC samples” indicate the number of RNA-seq samples
sequenced and the number of sequenced samples that passed quality control, respectively.
“Subjects with samples” and “Subjects with pass QC samples” indicate the number of patients
for which sequenced samples and sequence samples that passed quality control measures,
respectively, were available. “Average pass QC samples per person” indicates the average
number of sequence samples that passed quality control measures per patient. “Subjects with
a Pair/trio” indicate the number of patients for whom the sequenced samples that passed
quality control measures formed either a continouous pair (baseline & crossover visits or
crossover & crossback visits) or a visit trio (baseline, crossover, and crossback).
Study
arm

RNA type

Targeted
Insert
Size

Total
Samples

Pass QC
samples

Subjects
with
samples

Subjects
with pass
QC
samples

Subjects
with a
Pair/trio

27

Average
pass QC
samples
per
person
3.4

H1BH2
arm
B1HB2
arm
All arms

Long RNAs

150 bp

124

93

27

Long RNAs

150 bp

82

59

21

21

2.8

16

Long RNAs

150 bp

206

152

63

61

2.5

36

H1BH2
arm
B1HB2
arm
All arms

Small
RNAs
Small
RNAs
Small
RNAs

13-50 bp

62

58

21

21

3.0

12

13-50 bp

24

23

12

12

1.9

6

13-50 bp

86

81

33

33

2.6

18

20

RNA element (RE) discovery algorithm (described in [245]) was applied to the MARS
and GSE65683 (control) samples. Expression (in Reads Per Kilobase per Million - RPKM) for
the RE loci was then calculated for all MARS and GSE65683 samples. Due to the use of REs,
rather than whole transcripts, Paired-end read alignments were treated as individual (single)
reads, and the common FPKM value was replace by RPKM. Depending on a read pair’s insert
size and RE length, this approach ran the risk of inflating the read count for a given RE. To
mitigate this risk, read counts were assessed for the forward and reverse reads separately,
with the read count from single (non-paired due to mate loss during quality control) reads were
added to the forward and reverse read counts. The averaged read count between the forward
and reverse reads were then used for generating the RPKM values.
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Small RNA data processing methods
MARS small RNA libraries were trimmed of adaptors and low-quality bases, followed
by removal of reads smaller than 13 bp. sncRNAbench (version 10.14) [249] was used for
assigning reads to small RNA species and repeat classes, followed by a custom code for
generating normalized expression values (RPM- Reads Per Million). Among the 86 samples,
only one had an insufficient number of reads for reliable analysis (a threshold of 1000 aligned
sense reads were required). Common small RNA species of interest, such as miRNAs,
piRNAs, tRNAs, tRNA fragments, and siRNA can be detected with small RNA libraries
(miRNAs ~22 bp) [250], piRNA ~ 24-31 bp [251], and tRNA fragments ~28- to 34-nt [71]).
Differential long RNAs
When comparing IBD samples to normal samples, the control cohort was composed
of couples with idiopathic infertility. Therefore, to reduce the potential effect of infertility on the
overall RNA expression profiles and concurrently maximize the size of the control cohort, only
control sperm samples which presented with live birth (LB) (52 samples) were considered for
use in differential expression [163]. Due to the idiopathic infertility of the couples composing
the control cohort, the male component of the control cohort is not considered phenotypically
normal. However, with respect to inflammatory diseases and in particular, inflammatory bowel
disease or ulcerative colitis, the control samples were assumed to be disease free, and were
thus labeled “Normal” in differential analyses.
To identify REs modified by IBD, a LM was used to compare the Normal sperm to the
B1HB2 arm of the MARS study, with three total comparisons being performed (Normal vs B 1;
Normal vs H; Normal vs B2). The following formula was used for all three comparisons:
“lm(value ~ seqset + lib + age + protamine_ct + sigma_ct + RNA_conc +
cellcount_millions,data=input_data). Multiple-testing correction was applied as BenjaminHochberg. REs modified in a consistent manner (e.g. IBD-enriched or Control-enriched) in
any two of the three visits (B1, H, and B2) were considered for further investigation. In the
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current study, the Control samples were all present in a single sequencing batch, so a batch
effect would be indistinguishable from the designation as a control sample. Several of the
differential REs initially identified as IBD-enriched were differential solely due to near-zero
expression values in all Control samples, suggesting a batch effect. Consequently, such REs
were removed from consideration if the mean Control expression was less than 1 RPKM. This
step removed 6 of the 32 REs enriched in IBD for at least two visits.
To identify REs modified by DBP exposure, a Linear Mixed-Effects Model (LMEM) was
used to detect REs that changed with DBP exposure. Models were applied to each study arm
independently. Two comparisons were done for each study arm, in order to find the changes
occurring from Baseline visit to Crossover visits, and again from Crossover visit to Crossback
visit. The following formula was applied to the H1BH2 arm: “rpkm ~ visit_simp + lib +
period_asacol

+

bmi

+

season_warm

+

smokstat

+

age_bq

+

sigma_ct

+

percent_genomic_duplicated + percent_genomic + (1 | patient)”. The following formula was
applied to the B1HB2 arm of the MARS study: “rpkm ~ visit_simp + lib + bmi + season_warm
+ smokstat + age_bq + sigma_ct + percent_genomic_duplicated + percent_genomic + (1 |
patient)”. Due to the large number of REs tested in each comparison, standard multiple testing
corrections removed all statistical significance. Therefore, a bootstrapped P-value was
generated using random resampling. One thousand iterations were performed by permuting
the RE expression value and running the given model, while maintaining the same sample
order and covariate order. The empirical P-value was thus defined as the proportion of the
1000 random iterations that resulted in a P-value less than the original P-value.
𝐸𝑚𝑝𝑖𝑟𝑖𝑐𝑎𝑙 𝑃. 𝑣𝑎𝑙𝑢𝑒 = 1 −

# 𝑖𝑡𝑒𝑟𝑎𝑡𝑖𝑜𝑛𝑠𝑃.𝑣𝑎𝑙𝑢𝑒>𝑃0
# 𝑖𝑡𝑒𝑟𝑎𝑡𝑖𝑜𝑛𝑠

REs were subsequently classified into eight unique expression patterns, with
significance determined if the absolute value of the slope exceeded 10 RPKM and the
empirical P-value was less than 0.05. REs which changed explicitly with DBP exposure would
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display a pattern of increased expression from Baseline to Crossover visits, then decreased
expression from Crossover to Crossback visits, or vice versa. Patterns of acute change were
defined as those where an RE was significantly up- or down-regulated in the Baseline to
Crossover comparison, but not altered from Crossover to Crossback. Patterns of recovery
were defined as those where an RE was unchanged in the Baseline to Crossover comparison,
but was significantly up- or down-regulated from Crossover to Crossback. Patterns of
additional interest were those that continuously increased across the study arms or
continuously decreased across the study arms.
Differential small RNAs
The human sperm samples investigated for small RNAs (<50 bp) are described above
in Table 4.1. A total of 81 small RNA libraries was subsequently used in modeling, using an
LMEM. Due to the low power in the B1HB2 study arm and insufficient numbers of complete
trios, the predictive variable used was the DBP state (e.g. High DBP and Baseline DBP levels),
whereas the long RNA analysis used the study visit as the predictive variable. The formula
used for both study arms’ small RNAs was “rpm ~ med_simp + bmi + season_warm + age_bq
+ sigma_ct + percent_genomic_duplicated + percent_genomic + (1 | patient)”. In this formula,
the influence of medication (high or low DBP) on small RNA expression was being corrected
for patient BMI, seasonal warmth, patient age, sigma_ct from long RNA libraries, genomic
duplication rate from the long RNA libraries, and proportion of long RNA reads aligning to the
autosomal and sex chromosomes. For concordance of small RNA methods with those of the
long RNAs, multiple testing correction was applied using a bootstrapped P-value, generated
using random resampling. The given model was run 1000 times, permuting the RE expression
value each time, while maintaining the same sample order and covariate order. The empirical
P-value was thus defined as the proportion of the 1000 random iterations that resulted in a Pvalue less than the original P-value. Differential small RNAs were defined as those whose
absolute value of the slope exceeded 5 RPM and empirical P-value was less than 0.05.
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Repeat enrichment
Repeat enrichment was measured using the following formula, where “R” indicates the
REs associated with the repeat of interest, “A” indicates the REs associated with any repeat,
and the required median expression threshold for a study visit is 25 RPKM. Repeat enrichment
is the change in contribution of the given repeat to the repeat population, when a given
expression threshold is applied to both the repeat of interest and the total repeat population.
∆ 𝑟𝑎𝑡𝑖𝑜 =

# 𝑅𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑒𝑑 # 𝑅
−
# 𝐴𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑒𝑑 # 𝐴

The statistical significance of an enrichment or depletion (indicated with a positive or negative
∆ ratio, respectively) was tested using a hypergeometric test, implemented in stats R package.
This method is similar to the one implemented in Estill et al [245]. The repeat enrichment
analysis merely indicates if a repeat type is relatively under- or over-represented in the
expressed REs, relative to the expected proportion when no expression threshold is applied.
Small RNA-only Correlations
Expression levels of genomic repeats and small RNA species were determined using
the small RNA libraries. The total number of small RNA species and genomic repeats totaled
12,779 individual sequences. In order to remove spurious results due to poorly expressed
small RNAs, the compilation was subsetted to those small RNAs with expression exceeding
5 RPM in a portion of each sample set. In the B1HB2 arm, with a total of 24 Samples, using a
threshold of 5 RPM in at least 10 samples, this threshold allowed 602 small RNAs for
correlation. In the H1BH2 arm, with a total of 62 Samples, this threshold allowed 939 small
RNAs for correlation. Spearman correlation was applied to each individual study arm for
correlational analysis of small RNAs.
Correlation of long RNA genomic repeats and small RNAs
To ensure that the conclusions drawn from the small RNA correlations were
consistent, repeat expression estimated from long RNA libraries was generated. The 371,805
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available REs overlapped a total of 4,449 repeat names. The expression of each repeat
instance was averaged across a given sample, producing a resulting expression matrix of
4,449 rows (representing 4,448 repeats and 1 dummy classification of no repeat overlap) and
n sample columns (where n changes according to study arm size). This was merged with a
series of small RNAs (generated previously from sncRNAbench), which were expressed
(greater than 5 RPM) in at least 10 of the 67 small RNA libraries, producing a set of 1,829
small RNAs. The 1,829 small RNAs were correlated with the 4,449 repeats in both the H1BH2
arm (n=50 samples) and B1HB2 arm (n=16 samples), with one small RNA library omitted due
to being a replicate sample. It is important to note that, in order to generate the expression
values for repeats in the long RNAs, the repeats were summarized across all REs overlapping
the given repeat. This approach has the disadvantage of negating locus-specific regulatory
effects (such as cis-regulatory effects), due to the averaging of all individual repeat loci.
Therefore, in the case that repeats do have a regulatory effect, the summarization across all
genomic instances (in context of REs) may introduce inaccuracies.
Ontological enrichment
Gene Ontology (GO) enrichment was generated using the GeneRanker function of
Genomatix

(Eldorado

version

12-2017),

from

the

Genomatix

software

suite

(https://www.genomatix.de/), version 3.10. The gene names associated with differential
exonic, novel near-exon, or novel intronic REs were compiled and used as input to
GeneRanker. Pathway enrichment was assessed using Ingenuity Pathway Analysis (version
1-13, Content build 46901286). The expression changes occurring in differential exonic REs
were compiled and used as input for IPA. The compilation method used was to average the
expression changes of all differential exonic REs belonging to a given gene. This produced a
single slope, p-value, and computed log2ratio for each gene name.
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iv. Results
Expression – RE discovery
RE discovery was performed on MARS samples and external sperm samples [163],
with REDa parameters allowing an RE to be detected if it was present in solely a single
sample. Therefore, downstream analyses used REs that surpass a minimum expression value
(in RPKM) in several samples, thus reducing the computational burden of the downstream
analyses. RE expression was then calculated for all MARS samples and external sperm
datasets described in GSE65683. Novel REs and exonic REs have largely similar length
distributions (Figure 4.2). However, novel REs tend to have much more uneven length
distributions, compared to the exonic REs, which is likely due to the lesser number of novel
REs. Interestingly, each of the novel RE classes exhibited several REs exceeding 1 kb,
suggesting that at least a small number of intergenic and intronic are expressed along a long
stretch of the genome (Appendix G). There were 138 novel REs with a width exceeding 1 kb
(78 near-exon, 50 intronic, and 10 orphan RE classes). Of the 138 novel REs, 103 were
associated with a genomic repeat, with the most common repeat families being Simple
repeats, Endogenous RetroViruses (ERVs), and L1 repeats (30, 16, and 16 REs,
respectively). As expected, approximately 90% of the very long novel REs were within 5 kb of
DNase site [245]. The very long novel REs were not associated with known Topologically
Associating Domains (TADs). Approximately a third of the very long novel REs were within 5
kb of a GM12878 CTCF binding site and/or a known sperm MNase hypersensitive site. The
proportion of sperm MNase-localized very long novel REs was slightly higher than observed
for the complete set of RE classes (ranging from 5% to 25%). However, the very long novel
REs did not appear to be associated with a particular genomic structure, as the overlaps of
very long novel REs with epigenetic marks and regulatory genomic sequences appear to
reflect the expected proportions of the complete set of RE classes [245].
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Figure 4.2. RE length distribution. (A) Histogram of RE lengths, segregated according to
RE type (exonic, intronic, near-exon, and orphan). The X-axis indicates the RE length in log
10 scale, and the Y-axis indicates the number of REs. (B) Smoothed density estimates of the
RE lengths, segregated according to RE type. Exonic REs are noted in red, near-exon (<10
kb from exon) are in green, intronic REs are noted in blue, orphan REs are noted in purple.
Quality control of sequenced sperm RNAs
Quality control of sperm RNA libraries, prior to sequencing, was assessed using the
protocol described previously [252, 253]. Suspected low-quality sperm RNA libraries were
excluded from sequencing. However, despite this precaution, a portion of each set of
sequenced RNA samples often failed post-sequencing quality control. Within the MARs study,
quality control determination of the MARs samples was necessary to remove samples with
poor sequencing performance from subsequent modeling efforts. For QC of the MARS study’s
long RNA samples, a quantitative approach was developed by first qualitatively assessing
which samples appeared either deficient in read coverage or had excessive intergenic reads.
The initial judgement of poor quality samples was based on read profiles and read coverages
at several key loci, such as the human protamine locus (which is expected to have thousands
of reads) and ACSBG2 (which is well-expressed and has few intronic reads). Subsequent
examination of alignment statistics allowed for the quantitative classification of samples failing
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QC into one of five categories (Category 1: Low genomic alignment, Category 2: High
intergenic reads, Category 3: High bacterial and viral reads, Category 4: High spike-in reads;
Category 5: High unmapped reads). The specific classification algorithm used in assigning
the 5 categories is provided in Appendix H. The proportion of samples failing quality control
for the MARS samples are shown in Table 4.1. It is important to note that small RNA libraries
use different criteria for assessing sample quality.
Notably, poorly performing samples tended to have overlapping alignment statistic
ranges. Therefore, the five classifications are not mutually exclusive. In the case of a sample
with potential to belong to multiple classifications, the classifications were assigned in a
sequential order (from Category 1 to Category 5). A sample assigned to one of the five
classifications may still exhibit an acceptable read distribution (e.g. high reads at expected
loci, such as PRM1, and relatively few intergenic reads). This is particularly true for Categories
3 and 5 (Category 3: High bacterial and viral reads; Category 5: High unmapped reads).
However, such visually acceptable samples were still removed from consideration in order to
eliminate the possibility that the samples had altered RNA profiles.
Clinical characteristics were statistically indistinguishable between the study arms,
with the exception of Total_score, a measure of IBD severity symptoms, which was on
average higher in the B1HB2 arm. Both study arms were considered to have very low
Total_scores, with a maximum score of 5 in the current study (observed for a single patient).
By design, all recruited individuals in the MARS study were required to have a mild IBD score
on the simple clinical colitis activity index (five or less for UC) or Harvey-Bradshaw index (four
or less for CD) [69].
Transcriptomic similarity of human sperm to Testis
In addition to the previously described quality control measures, the Krawetz
laboratory developed a method of assessing sample quality through correlational analysis of
RE expression to GTEx expression values [163, 254]. The process first examines each GTEx
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tissue to identify the most highly expressed genes. The top 5,000 most abundant genes were
chosen as an optimal threshold for including both housekeeping genes (which are expected
to be highly expressed) and genes unique to the tissue type. The exonic REs associated with
each gene name were then averaged across a sample to produce a single value. A Spearman
correlation was then implemented across the top 5,000 gene names to determine the relative
similarity of a given sample to each of the 53 tissues. The Spearman rho was subsequently
transformed into a rank, with a rank of 1 given to the tissue with the highest (positive) rho and
53 given to the lowest rho value. A sperm sample would be expected to be most similar to
testis, and therefore have a rank of 1. The resulting tissue similarity distribution for MARS
samples is shown in Figure 4.3. Nearly all quality-controlled sperm samples, such as those
used in the MARS study, were expected to be most similar to Testis. Accordingly, GTEx
correlation of the MARS study samples (Figure 4.3) indicated that the gene expression in the
samples (in the form of averaged exonic REs) was most similar to GTEx testis tissue. The
only two samples without Testis ranking at 1 are ranked as most similar to “Cells - EBVtransformed lymphocytes”, with 2nd and 3rd ratings at Stomach and Prostate tissue. However,
sperm purification protocols make it extremely unlikely that lymphocytes, stomach cells, or
prostate-derived cells would contaminate the purified sperm. Therefore, this Spearman
correlation with non-testis tissue (for the two indicated samples) does not indicate a
contamination of the sperm sample and subsequent failure to sufficiently purify spermatozoa.
The two samples are in the H1BH2 arm, which is the most populous study arm, and are
members of a crossover/crossback set and a trio (baseline, crossover, crossback). The
samples in question are otherwise of acceptable quality, and the diagnostic value of the GTEx
correlations has not been proven. Based on the overall sample quality and large size of the
H1BH2 arm, the inclusion of the two samples in modeling was not expected to adversely
influence or bias the outcome.
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Figure 4.3. GTEx tissue distribution for quality controlled MARS samples. Ranking of
Spearman correlation for the top 5000 genes of each tissue are shown for 152 quality
controlled MARS sperm samples. The X-axis represents the individual GTEx tissues, while
the Y-axis represents the relative ranking of Spearman rho.
In addition to the previous GTEx correlations, the most abundant RNA elements in the
pass-QC samples from the MARS dataset were examined, with the expectation that the RNA
elements should reflect transcripts known to be highly expressed in testis [136]. Table 4.2
presents the top 50 most expressed REs, ordered from highest RPKM to lowest. PRM1,
PRM2, TNP1, SMCP, CRISP2 are expressed primarily in testis, while GIGYF2 is most highly
expressed in testis. This basic analysis indicates that the RNA-seq datasets are indeed
spermatozoal, and therefore, any differentially expressed REs reflect changes in the sperm
transcriptome. As indicated in the methods used for processing the MARS samples,
precautions were taken to ensure that somatic cells were excluded prior to RNA extraction.
The previous GTEx analysis identified two sperm samples were not most similar to testis, but
to EBV-transformed lymphocytes. However, based on purification protocols, this similarity was
not expected to be due to contamination with lymphocyte cell lines. At this time, further
optimization of the correlation approach to GTEx tissues may be needed.
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Table 4.2. Highly expressed exonic REs across the MARS study. The top 50 most
expressed exonic REs, ordered from highest RPKM to lowest, are listed. For REs that
encompass more than one transcript, the gene names are separated by a comma. REs
highlighted in bright yellow indicated a series of genes that are known to be primarily
expressed in testis and sperm.
Element
Identifier

Gene Symbol

chrM_577_3304
chr6_52995620_5
2995950
chr16_11280836_
11281035
chrM_5904_7445
chr14_49586579_
49586878
chr16_11275639_
11275981
chr14_49862550_
49862849
chrM_7518_8269
chr5_7304232_73
04261
chr16_11281127_
11281350
chrM_8366_1414
8
chrM_3307_4331
chrM_4402_5579
chrM_14149_147
42
chr1_152878317_
152878446

MT-TF
RF00100,RN7SK

chr16_11276100_
11276480
chr1_16740516_1
6740679
chr2_216859896_
216860064
chr9_9442060_94
42380
chr2_216859458_
216859695
chrM_14747_159
53
chr12_112267077
_112267394
chr5_7303912_73
03962
chr5_7302224_73
02282
chr3_15738515_1
5738809
chr6_49712501_4
9712604

PRM2

chr2_88788318_8
8788346

ANKRD36BP2

chr15_22771692_
22771750
chr1_16514122_1
6514285

AC011767.1

Median
expression
across MARS
study
352637.5

Note

Tissue expression

Mitochondrial

Low in all tissues
Present in all tissues

Protamine 1, Exon 1

Testis specific

Mitochondrial

Present in all tissues
Present in all tissues

Protamine 2, Exon 1

Testis specific

6053.6
PRM1
MT-CO1
AL139099.4,RN7SL
1
PRM2

5693.2
5124.1

50.03

4284.3
4272.6

21190
Present in all tissues

4121.2
3233.5

Mitochondrial

Low in all tissues
Testis specific

Protamine 1, Exon 2

Testis specific

Mitochondrial

Present in all tissues

Mitochondrial
Mitochondrial
Mitochondrial

Present in all tissues
Brain specific
Present in all tissues

Sperm Mitochondria
Associated Cysteine
Rich Protein, Exon 1
Protamine 2, Exon 2

Testis specific

3147.1
PRM1

2886.1
2672.1
2381.4
1986.0

SMCP
1905.9

58.13
0
144.2

3002.6
MT-ATP8,MTATP6,MT-CO3
MT-ND1
MT-TM
MT-ND6

20530
20780
70.93

RN7SL2
MT-TD
AC091951.1

Median
testis
GTEx
expression
0.71

20530
16720;2798
0;34450
22760
0.71
1774

1606
Testis specific

1887.2

21190

RNU1-4

Unknown
1777.4

TNP1
1764.3

0
Transition Protein 1,
Exon 2

RN7SL5P

Testis specific
8839
Low in all tissues

1737.4
TNP1
1601.2
MT-CYB

0
Transition Protein 1,
Exon 1
Mitochondrial

Testis specific
8839
Present in all tissues

1536.0

15430

RN7SKP71

Low in all tissues
1458.7

0

AC091951.1

Testis specific
1425.8

144.2

AC091951.1

Testis specific
1372.1

144.2

RN7SL4P

Low in all tissues
1368.6

CRISP2
1326.8

1279.4

0.27
Cysteine Rich
Secretory Protein 2,
Exon 2

Testis specific
1194
Present in multiple
tissues, highest in
testis
Unknown

13.94

1270.8
RNU1-1

Low in all tissues
1241.7

0.51
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chr14_66488987_
66489037
chr6_49697860_4
9697957

CCDC196

chr6_34697159_3
4697470
chr14_49853616_
49853914
chr2_216871456_
216871639

AL451165.2

chr22_20341524_
20341548
chr5_7305074_73
05203
chr1_152884403_
152885047

AC007731.1

chr15_28846220_
28846249
chr22_18424977_
18425035
chr2_88788442_8
8788514

GOLGA6L7

chr22_18736559_
18736583
chr5_7301753_73
01894
chr2_232816871_
232817032

LINC01662

chr5_177729023_
177729053
chr16_14997748_
14997826

FAM153A

chr1_144560666_
144560829
chr14_60245752_
60246046
chrM_5761_5891
chrX_103712236_
103712360
chr2_232790698_
232790915

RF00003

Testis specific
1199.3

CRISP2
1193.9

181.4
Cysteine Rich
Secretory Protein 2,
Exon 8

Testis specific
1194
Present in all tissues

1122.3

86.31

RN7SL3

Low in all tissues
1094.1

0.98

LINC01921

Low in all tissues,
possible testis
specificity
Unknown

1085.3
1073.8

0

AC091951.1

Testis specific
1049.6

SMCP
1045.0

144.2
Sperm Mitochondria
Associated Cysteine
Rich Protein, Exon 2

Testis specific
1606
Testis specific

1041.0

42.6

FAM230A

Testis specific
980.6

15.52

ANKRD36BP2

Present in multiple
tissues, highest in
testis
Testis specific

919.6
889.9

13.94
0.36

AC091951.1

Testis specific
867.6

GIGYF2
846.9

144.2
GRB10 Interacting
GYF Protein 2, Exon
21

Present in multiple
tissues, highest in
testis
Present in all tissues

833.9

45.91
18.94

PDXDC1

Present in all
tissues, highest in
testis
Unknown

815.9
807.9

116.9
0

PPM1A
MT-TC,MT-TY
TMEM31

0

Present in all tissues
754.7
748.9

Mitochondrial

Low in all tissues
Testis specific

GRB10 Interacting
GYF Protein 2, Exon
10

Present in multiple
tissues, highest in
testis

746.6
GIGYF2
732.6

30.22
1.79;3.41
147.7

45.91

Influence of sample characteristics on sperm RNA expression
Spermatozoa are considered transcriptionally and translationally inert. RNA profiles of
mature sperm therefore do not reflect active transcriptional activity, but are considered to
reflect transcriptional activity during spermiogenesis and/or transcripts acquired during
epididymal transit. Therefore, the use of the term “expression” refers to the RNA profiles of
the ejaculated spermatozoa. A primary purpose of generating expression values for REs was
for performing differential expression. Therefore, it was essential to determine the sample
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characteristics (patient phenotype and sequencing statistics) that exerted a major influence
on RE expression, and subsequently account for these characteristics when modeling
differential expression. Correct covariate selection is necessary for accurately modeling and
interpreting an outcome (in this case RNA levels). For example, initial differential expression
attempts of the MARS dataset used covariates chosen primarily for their assumed technical
and biological importance. However, partly due to an overall increased variance within the
H1BH2 arm, the outcome of the initial analyses showed a disparity between the two study
arms, with the B1HB2 arm having a far higher amount of differential expression than the H1BH2
arm. An unbiased assessment of the sample characteristics that exhibited the most influence
on RE expression, using Single Value Decomposition, Pearson correlation, and statistical
significance in linear modeling, identified influential covariates. The implementation and
results of each of the steps are provided below. When influential covariates were included in
the expression model, the B1HB2 arm and H1BH2 arm presented a similar number of
differential REs. Therefore, correct covariate selection reduced the disparity in differential
expression between the two study arms.
Covariate selection for the MARS dataset proceeded as described in the following.
The RE dataset was first reduced to the MARS samples that passed QC, and additionally
reduced by removing REs that failed to surpass 25 RPKM in at least a third of the samples of
interest (e.g. Quality-controlled H1BH2 MARS samples). Single Value Decomposition (SVD)
analysis was performed, with the result visualized as shown in Figure 4.4. In the H1BH2 arm
MARS samples, SVD analysis revealed that Principle Component (PC) 1, PC-2, and PC-3
accounted for 93.0%, 5.4%, and 0.49% of the data variance, respectively. In the B1HB2 arm
MARS samples, SVD analysis revealed that Principle Component (PC) 1, PC-2, and PC-3
accounted for 91.1%, 7.6%, and 0.46% of the data variance, respectively. In a dataset
combining both study arms (thus being composed of all quality-controlled MARS samples,
SVD analysis revealed that Principle Component (PC) 1, PC-2, and PC-3 accounted for
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92.2%, 6.3%, and 0.40% of the data variance, respectively. In all quality-controlled MARS
samples, PC-1 was significantly correlated with library duplication rates (in both ribosomal and
genomic reads), percentage of repeat sequence-associated reads, percentage of genomic
(autosomal and sex chromosomes) alignments, percentage of autosomal alignments,
percentage of ERCC spike-in reads, and percentage of ribosomal alignments. Potential colinearity of the sample characteristics, which would be suggested by the presence of highly
positive or negative correlations, was tested using a Pearson correlation, shown in Figure
4.5. The characteristics found to be potentially collinear were the following: library duplication
rates and protamine_ct; percentage of ribosomal alignments and sigma_ct; percentage of
ribosomal alignments and percentage of genomic (autosomal and sex chromosomes)
alignments; percentage of repeat-associated reads and percentage of unmapped reads;
percentage of repeat-associated reads and percentage of adaptor-derived reads.
Figure 4.4. Singular Value
Decomposition Analysis
of
quality-controlled
MARS
samples.
(A)
Association
of
sample
characteristics for H1BH2
arm. (B) Association of
sample characteristics for
B1HB2 arm (C) Association
of sample characteristics for
all quality-controlled MARS
samples, regardless of study
arm. The association of a
sample characteristic with a
Principle Component (PC) is
measured using a standard
linear model (lm) for numeric
characteristics,
while
categorical
or
integer
characteristics
(eg.
Medication, diagnosis, race,
season, smoking status,
R2single_autoXY_dupsremoved) used a Kruskal-Wallis rank sum test (kruskal.test). The Pvalue for the linear model or Kruskal-Wallis test is color-coded for each pairwise test of
Principle Component and sample characteristic, with the color legend provided in the leftbottom corner of each graph.
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Figure 4.5. Pearson correlation of numeric sample characteristics for all qualitycontrolled MARS samples. The Pearson’s rho value is plotted as a color gradient on the
right-hand side of the graph, with deep red representing a negative correlation and dark blue
representing a positive correlation as indicated in the bar.
In order to determine which characteristics would be influential in context of the
research question of interest (expression change with phthalate levels), a basic linear model
was applied to all quality-controlled MARS samples (formula: rpkm ~ visit_cat + lib +
RNA_per_million + period_yr + bmi + season_warm + smokstat + age_bq + sigma_ct +
percent_genomic_duplicated

+

percent_adaptor_badquality

+

percent_ercc

+

percent_genomic + percent_bactviral + percent_repbase). The RNA-seq library parameters
sigma_ct, percent_genomic_duplicated, percent_ercc, and percent_genomic presented a
significant

P-value

(P<0.05)

for

their

concomitant

beta

estimate.

sigma_ct,

percent_genomic_duplicated, and percent_genomic were subsequently used as technical
(RNA-seq library) covariates in linear mixed effects models and basic linear models of the
MARS and pilot datasets. Although ERCC (spike-in) percentage did have a significant P-value
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in the linear model (P=0.027), ERCC RNA spike-ins were previously noted to have extreme
variability in the final sperm RNA-seq libraries. Additionally, ERCC spike-in proportions after
sequencing may correspond to insert quality, as the ERCC mixture may provide a better
template than the sperm RNA. However, ERCC mixtures were added at different
concentrations to the different MARS sequencing batches (in an effort to reduce the amount
of sequencing materials dedicated to the ERCC spike-in). Therefore, ERCC proportion was
omitted from expression modeling. The final components of the formulas for Linear MixedEffects Modeling (LMEM) and Linear Models (LM) accounted for a series of clinical
parameters (Sequencing batch, Time on High-DBP drug, Body Mass Index (BMI), Season,
cigarette smoking, and patient age) and technical parameters (sigma_ct, duplication rate of
genomic (autosomal and sex chromosomes) reads, and percentage of alignments located on
autosomal and sex chromosomes. In the case of datasets missing any of the above
parameters (e.g. external dataset from Jodar et al.), the missing parameters were omitted
from the given model [163].
IBD-induced changes on RNA
Several studies have applied RNA-seq to IBD (previously known as Irritable Bowel
Syndrome (IBS)), with a primary focus on intestinal biopsies. While IBD is an inflammatory
condition that is limited to gastrointestinal tissue, altered brain-gut interactions do occur [255],
and additional direct or indirect effects on peripheral tissues are possible. This is underscored
by work by Gupta et al, who identified 288 dysregulated genes in peripheral blood
mononuclear cells (PBMCs) between IBD and healthy control groups, with 12 of the
dysregulated genes being associated with the immune system (4 anti-inflammatory, 8 proinflammatory). Iborra et al. [256] identified a series of serum miRNAs with altered expression
in IBD. Machine learning approaches have also uncovered a peripheral blood miRNA
signature indicative of IBD [257]. Plasma‐induced signature analyses performed using blood
plasma from IBD patients [258] also suggest that the plasma of CD and UC patients contain
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an immunoregulatory plasma milieu that can induce immune activation in a healthy leucocyte
population, as measured using a high‐density microarray. Given the growing interest in the
male germline as a mediator of intergenerational/transgenerational effects, I hypothesized
that the IBD condition may alter the RNA profiles of the paternal human germline. Using the
MARS B1HB2 study arm as an IBD cohort, the differences between sperm samples from
control males and the B1HB2 study samples were determined. The control males used in the
study were males from idiopathic infertile couples who produced a live birth after infertility
treatment.
Relatively few REs (40 REs) were altered in at least two study visit comparisons to
healthy controls (Figure 4.6). Interestingly, the B2 visit of the B1HB2 study arm exhibits the
highest number of differential REs, with the majority of those REs being unique to the B2 visit
comparison to healthy controls. Within the B1HB2 study arm, the Crossback visit, B2 visit,
represents the return to a low-phthalate condition after an acute exposure to high-DBP
medication. Therefore, the large number of unique differential RES in the B2 visit comparison
is likely due to biological processes initiated after the high-DBP exposure. Overall, the few
differential REs suggest that the IBD condition alone does not substantially alter the
transcriptome of ejaculated spermatozoa. However, small RNA libraries were not available for
the Control cohort. Small RNA species, such as miRNAs, piRNAs, and fragmented tRNAs,
were not compared between IBD and healthy controls. Therefore, I cannot exclude the
possibility that the abundance of small RNAs, which often have regulatory roles, may still be
altered in IBD.
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Figure 4.6. REs that differ between Normal and IBD individuals. (A) Volcano plots of linear
model results for all tested REs. X-axis indicates the log10 expression change (slope) in
RPKM, while the Y-axis indicates the negative log10 Benjamini-Hochberg adjusted P-value.
Red points represent REs that are not statistically significant, while blue points represent REs
that have a Benjamini-Hochberg adjusted P-value less than 0.05 and an absolute slope of at
least 10 RPKM. REs with a positive slope exhibit higher expression in Control individuals,
while those with a negative slope have higher expression in IBD individuals. (B) Venn diagram
of the REs enriched in the IBD individuals, across the three study visits. (C) Venn diagram of
the REs enriched in the Control individuals, across the three study visits.
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Table 4.3. REs consistently altered by IBD. Genes with multiple affected REs are indicated
in bold.
Expression change
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in IBD
Enriched in Control
Enriched in Control
Enriched in Control
Enriched in Control
Enriched in Control
Enriched in Control
Enriched in Control
Enriched in Control
Enriched in Control
Enriched in Control
Enriched in Control
Enriched in Control
Enriched in Control
Enriched in Control

Element Identifier
chr10_49703080_49703099
chr11_22674773_22675014
chr1_245677221_245677520
chr15_33244895_33245438
chr1_90497041_90497080
chr19_37551371_37551665
chr2_178535732_178535828
chr21_8259686_8259815
chr2_200797499_200797575
chr2_202346319_202346358
chr22_41174591_41174824
chr2_30091379_30091408
chr2_97149295_97149361
chr2_97151879_97151939
chr2_97183582_97183654
chr3_113805354_113805525
chr3_47772817_47772936
chr3_52800965_52801146
chr4_141231439_141231485
chr4_15007305_15007595
chr5_176586651_176586842
chr5_176589031_176589182
chr6_147001441_147001543
chr9_34839387_34839416
chrX_126731815_126731844
chrY_12915883_12916027
chr15_29716611_29716838
chr15_29718266_29719138
chr19_10118668_10118727
chr19_11024331_11024438
chr20_38517784_38518000
chr20_410412_410764
chr20_62256057_62256221
chr3_57268398_57268487
chr4_42070526_42070691
chr7_35872666_35872766
chr7_99353909_99354121
chr7_99358340_99358415
chr7_99359534_99359738
chrM_14747_15953

Gene Symbol
C10orf53
GAS2
KIF26B
TMCO5B
NA
ZNF571-AS1,ZNF540
TTN-AS1
RNA5-8S5
AC007163.1
AC064836.2
EP300-AS1
AC016907.2
ANKRD36
ANKRD36
ANKRD36
ATP6V1A
SMARCC1
ITIH3
ZNF330
CPEB2
CDHR2
CDHR2
STXBP5-AS1
FAM205BP
MTCYBP38
DDX3Y
TJP1
TJP1
EIF3G
SMARCA4
RALGAPB
RBCK1
OSBPL2
APPL1
SLC30A9
SEPT7
ARPC1A,AC004922.1
ARPC1A,AC004922.1
ARPC1A,AC004922.1
MT-CYB

RE class
NOVEL_INTRONIC
EXON
NOVEL_INTRONIC
EXON
NOVEL_ORPHAN
EXON
EXON
NOVEL_10KB_EXON
EXON
NOVEL_10KB_EXON
EXON
NOVEL_INTRONIC
EXON
EXON
EXON
EXON
EXON
EXON
EXON
EXON
EXON
EXON
EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
EXON
EXON
EXON
EXON
EXON
EXON
EXON
EXON
EXON
EXON
EXON
EXON
EXON
EXON
EXON

Only 14 REs showed higher levels in Controls and 26 REs were upregulated in IBD,
the majority of which were exonic REs (Table 4.3). However, in the IBD-enriched category,
ANKRD36 and CDHR2 had two or more differential exonic REs. In the Control-enriched
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category, had two or more differential exonic REs. This suggests that select genes or isoforms
are consistently up-regulated or down-regulated in sperm from DBP-naïve individuals.
ANKRD36 is a predicted intracellular protein, with potential nuclear localization, whose
function has not yet been characterized. CDHR2 is a non-classical cadherin, which mediates
formation of intermicrovillar adhesion complexes, necessary for formation of the murine
intestinal brush border [259]. CDHR2, through work on cancer cell lines, has been
hypothesized to act as a molecular switch for contact inhibition of epithelial cells [260]. TJP1
is a tight junction adaptor protein. ARPC1A is a subunit of the human Arp2/3 protein complex.
AC004922.1 is an uncharacterized protein, formed from an ARPC1A and ARPC1B
readthrough. Of the four genes (ANKRD36, CDHR2, ARPC1A, and TJP1), ANKRD36 exhibits
the highest expression. However, all four genes are relatively lowly expressed in
spermatozoa, with a median expression less than 25 RPKM, as ANKRD36, CDHR2,
ARPC1A, and TJP1 have median expression values in sperm of 19.14, 7.32, 0.86, and 2.40
RPKM, respectively.
Of the 36 gene names up- or down-regulated in IBD, 23 of them were expressed in
cultured human Sertoli cells [261], when requiring a threshold of at least 100 baseMean reads
(assigned using DESeq). At this threshold, 14,843 gene names from the Ribeiro et al. dataset
were considered expressed. Three of the 4 noted genes (ANKRD36, TJP1, and ARPC1A) in
Table 4.3 were among the 23 Sertoli-expressed genes. This suggests that the effects of IBD
on spermatozoa may work through Sertoli cells, rather than through absorption during
epididymal transit. Both CDHR2 and TJP1 are associated with cell-cell interactions, further
suggesting that IBD may alter the interactions of Sertoli cell during spermatogenesis and/or
spermiogenesis.
To determine if the 14 Control-enriched and 26 IBD-enriched REs were defined as
differential in previous studies of other laboratories, the differential RE gene names and genes
names identified as altered in previous microarray or RNA-seq studies were compared. The
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exact gene names were compared, so it is important to note that if the published gene names
presented in the literature were updated prior to this analysis, an overlap would not be
identified. The 40 REs’ gene names did not overlap with several previous studies that used
colon biopsies for microarray or RNA-seq, in either human or mouse [262-270]. This is likely
due to the vastly different transcriptomes between intestinal tissue types and male
reproductive tissues (Figure 4.3). The few studies describing changes in peripheral blood
[255, 258] do not provide a comprehensive list of differential genes in the publication, and so
could not be compared to the gene names identified in the current study. Regardless,
spermatozoa are known to have a vastly different transcriptome (compared to somatic cell
types), and so likely would not exhibit overlaps with the peripheral blood studies.
Differential expression analyses of Long REs in MARS study arms
The MARS study design (Figure 4.1) allows for the detection of longitudinal changes
occurring as a result of shifting DBP exposure. A Linear Mixed-Effects Model, when applied
to the repeated longitudinal samples from the MARS dataset, can define the DBP-induced
expression changes, while also taking into account any repeated samples. The LMEM model
formulas were developed for defining the expression changes across study periods (e.g.
Baseline, Crossover or Crossback), while considering biological and technical covariates.
LMEM modeling across the MARS study arms revealed considerable differential expression
(defined as empirical P-value < 0.05 and minimum absolute threshold of 10 RPKM) in each
study arm, as shown in Figure 4.7.
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Figure 4.7. Volcano plots of REs altered across MARS study arms. (A) H1BH2 study arm.
(B) B1HB2 study arm. Blue points represent REs with an empirical P-value < 0.05 and a
minimum absolute threshold of 10 RPKM, while red points represent REs with empirical Pvalue > 0.05 or a minimum absolute threshold less than 10 RPKM.
The majority of all REs were exonic (321,207 REs), with intronic REs being the most
numerous of the novel classes (near-exon: 9,730 REs; intronic: 30,853; orphan: 10,015).
Correspondingly, the majority of REs altered by DBP were either exonic or intronic (Table
4.4B). However, novel REs, highlighted by intronic REs, were major components of all
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observed transcript patterns, indicating that DBP exposure(s) affects far more than known
transcripts. Few REs were differentially expressed in both study arms (H1BH2 arm and B1HB2
arm), suggesting that the alternating DBP exposures affects DBP-naïve males differently from
males chronically exposed to a high-DBP mesalamine. This arm-specific effect was also
observed in the sperm motility and hormonal responses of the MARS individuals [69, 70, 271].
Table 4.4. Expression patterns of REs altered across MARS study arms. (A) Total RE
count for the given expression pattern. Expression patterns are presented to the left of the
table, with blue lines indicating significant slopes and grey lines indicating non-significant
expression changes (slopes).
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Differential REs were then classified into specific response patterns, defining REs
which either changed explicitly with high-DBP exposure, i.e., acute response REs that
changed from baseline to crossover, followed by an opposite recovery response in REs that
changed from crossover to crossback, and REs that increased or decreased across all study
visits. Both study arms had relatively few REs altered concomitantly with DBP exposure
across both transitions (1.7% and 5% in the B1HB2 arm and H1BH2 arm, respectively).
Unexpectedly, the majority of differential REs in either study arm were significantly altered in
a single comparison (i.e., baseline to crossover - acute response or crossover to crossback Recovery). Semen analysis of the MARS subjects described in Nassan et al [69], showed a
continuous decline in sperm motility due to a carry-over effect of high-DBP exposure in the
B1HB2 arm. In accord, as indicated in Table 4.5, several exons of sperm-motility associated
genes (ATP1A4, WDR66, TEKT2, TEKT5, DRC7, CFAP44, DDX4, DNAJA1) were
downregulated in the B1HB2 arm, during the initial high-DBP insult, consistent with the B1HB2
arm’s observed decline in sperm motility [69]. In contrast, in the H1BH2 arm, semen
parameters (including sperm motility) did not change across the study visits and few spermmotility associated genes were linked with differential exonic REs in the H1BH2 arm. Notably,
a small number of B1HB2 arm REs that were not directly associated with motility continuously
increased (6 REs) or decreased (8 REs) across the study visits. The H1BH2 arm REs did not
follow a continuous pattern. All 6 continuously increasing REs were novel, with 5 intronic REs
(AC012531.3, WDR20, AC007993.2, RAE1, GUSBP1) and one near-exon RE (NPIPB10P).
In comparison, nearly all 8 continuously decreasing REs were also novel, with 5 intronic REs
(TMEM104, AC068594.1, AC016590.1, XRN1, FER), one near-exon RE (AC107958.2), one
orphan RE, and a single exonic RE (PRSS21). Interestingly, PRSS21 (Serine Protease 21) is
a cell-surface anchored serine protease present within elongating spermatids that may also
be involved in spermatocyte development [272, 273].
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Table 4.5. DBP-altered exonic REs overlapping genes associated with sperm motility.
All murine genes in MGI database with the associated Gene Ontology term “sperm motility”
(GO:0097722, http://www.informatics.jax.org/go/term/GO:0097722) were downloaded and
transformed into the HGNC (human) gene symbol using custom R code and the BiomaRt
package. The gene symbols associated with the differential exonic REs, partitioned according
to expression change, were then overlapped with the list of HGNC gene symbols. All displayed
gene names represent the gene symbol overlaps.

B1 to H transition;
Increased levels
CATSPERD
TTLL1
DNAH1

H1 to B transition;
Increased levels
CELF3
ATP1A4

B1HB2 arm
B1 to H transition;
H to B2 transition;
Decreased levels
Increased levels
ATP1A4
WDR66
WDR66
GAPDHS
TEKT2
IQCF1
TEKT5
DRC7
CFAP44
DDX4
DNAJA1
H1BH2 arm
H1 to B transition;
B to H2 transition;
Decreased levels
Increased levels
IFT88
IFT88
DNAI1

H to B2 transition;
Decreased levels
CATSPERD
DNAH1

B to H2 transition;
Decreased levels
TEKT5
UBE2B

Biological Response to DBP exposure
The biological impact of DBP on REs was assessed through Gene Ontology (GO)
enrichment. The gene names associated with differential exonic, novel near-exon, or novel
intronic REs in the expression patterns of interest were compiled to resolve GO categories
associated with both novel REs and exonic REs. Table 4.6 summarizes the primary affected
signaling and literature-based pathways. Few of the top GO pathways were shared between
the two study arms, suggesting that shifts in DBP levels differentially affect DBP-naïve males
compared to chronically exposed males. Within the B1HB2 arm, acutely downregulated REs
were associated with “RAN-GAP cycling”, “Focal adhesion kinase signaling”, and “Ras
GTPase binding”. Focal adhesion kinase signaling facilitates integrin-mediated signal
transduction, which has a clear role in maintaining the seminiferous tubule structure [274].
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RAN-GAP cycling, which is a critical component of nucleo-cytoplasmic transport, likely is
involved in epigenetic regulation during spermatogenesis, via movement of regulatory RNAs
[275]. During mammalian spermiogenesis, Ran GTPase may mediate kinesin localization,
which is needed for producing the unusual spermatid form [276, 277]. Interestingly, REs
upregulated and downregulated in recovery of the B1HB2 arm were enriched for NGF signaling
and EGFR signaling. NGF protein is found throughout male reproductive tissues [272, 278280], including mammalian spermatozoa [281], and outside of the suspected regulatory roles
in Sertoli cells [282], likely facilitates sperm motility [202, 283]. A disruption of the NGF
signaling-mediated motility in the B1HB2 arm is thus in agreement with previously noted
decreased motility [69] after administration of a high-DBP mesalamine to high-DBP-naïve
participants. EGFR plays a regulatory role in mammalian spermatogenesis, mediating Sertoligerm cell crosstalk [284], non-classical testosterone signaling [285], and may mediate the
acrosome reaction in mature spermatozoa [203].
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Table 4.6. Gene ontology enrichment summary of differential MARS REs. The gene
names associated with differential exonic, novel near-exon, or novel intronic REs were
compiled and used as input to Genomatix’s GeneRanker function. The signaling pathways
and literature-based pathways were summarized and grouped into common ontological
themes.
Acute change
Recovery
Study
Upregulated REs
arm
Upregulated REs
Amino acid metabolism
NGF signaling
TNF-alpha
EGFR signaling
14-3-3 protein signaling
RAN signaling

B1HB2

Downregulated REs
RAN cycling
Focal adhesion kinase signaling
Ras GTPase binding

Downregulated REs
NGF signaling
EGFR signaling
Protein Kinase D and N

Upregulated REs
Arf6 trafficking
Chromatin organization

Upregulated REs
Lipid metabolism
Calmodulin
Organelle biogenesis and
maintenance

Organelle organization
H1BH2
Downregulated REs
Cell cycle
Coregulation of Androgen receptor
activity
Organelle organization

Downregulated REs
Cyclin D3
Chromatin organization
Coregulation of Androgen receptor
activity

Within the H1BH2 arm, acute response REs were associated with organellar and
chromatin organization, which are requisite for extreme cellular and nuclear remodeling during
spermatogenesis. The corresponding downregulated acute and recovery REs were enriched
for “Coregulation of Androgen receptor activity”, which is coherent with previous mammalian
literature indicating the importance of testosterone in phthalate-induced testicular dysgenesis
syndrome [61, 286]. However, while testicular dysgenesis syndrome reflects pre-natal
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endocrine disruptor exposure, the MARS study suggests that responding to in vivo adult
exposures also elicits androgen disruption, providing another inroad to this pathology. Adult
rat models of high-DBP exposure also indicate a disruption of androgenic activity [287, 288].
Recovery in the H1BH2 arm suggests an involvement of “lipid metabolism” and “calmodulin”.
In the male, Leydig cells take up lipids for testosterone production [289], perhaps indicating a
shift in steroidogenesis. Calmodulin, a calcium-binding protein activated in the presence of
calcium, was previously known to be involved in mammalian sperm motility [290-292].
The above GO analysis suggests that specific signaling pathways, such as NGF
signaling, EGFR signaling, RAN cycling, and Androgen receptor signaling, may be altered
due to DBP exposures. To complement the above, Ingenuity Pathway Analysis (IPA) was
applied to the differential exonic REs to resolve the enrichment of signaling pathways, as well
as suggesting the direction of pathway modulation (Figure 4.8).

100

Figure 4.8. IPA pathways of REs altered across MARS study arms. (A) Pathway
enrichment for H1BH2 study comparisons. (B) Pathway enrichment for B1HB2 study
comparisons. Enriched pathways are ordered according to the relative significance, with most
significantly enriched pathways displayed on the left. Pathways highlighted in orange hues
and blue hues indicate predicted pathway activation or repression, respectively, with darker
colors indicating greater confidence in the activation/repression prediction. Briefly, pathway
activation/repression prediction is based on the correlation of inputted gene expression
changes with the pathway’s known activity patterns.
IPA signaling pathway enrichment revealed several interesting associations. Notably,
in the H1BH2 arm, the transition from crossover (B visit) to crossback (H2 visit), which
represents the return to high-DBP mesalamine, displayed activation of oxidative stress and
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DNA damage response pathways. This is consistent with previous reports of DBP-induced
spermatozoal damage and oxidative stress [67, 68]. However, the B1HB2 arm’s enriched
pathways do not strongly implicate oxidative stress and DNA damage response. The transition
from baseline (B1 visit) to crossover (H visit) was associated with several spermatogenesisrelated pathways, including activation of EIF2 signaling and the PPAR-alpha/RXR-alpha
signaling. These pathways were not strongly associated with either the H1BH2 arm or in the H
visit vs B2 visit comparison of the B1HB2 arm, suggesting that a concerted shift in the PPARalpha and EIF2 pathways only occurs upon the initial high-DBP exposure. The detrimental
effects of peroxisome proliferators, i.e., DBP, on germ cells likely acts through Sertoli cells
[58-60, 293]. The transition from crossover (H visit) to crossback (B2 visit) yielded a strong
activation of GP6 signaling [294, 295]. Additionally, the retinoic acid receptor (RAR) pathway,
which is a known mediator of germ cell differentiation [296], was also enriched, and although
no concerted activity was observed, levels of several of the altered pathway members
(CARM1, SWI/SNF, NCOR1, PKC) were consistent with an activation of the Retinoic acid
nuclear receptor (RAR) and Retinoid receptor (RXR) (via binding of retinoic acid). Notably,
several of the RAR’s altered pathway members (CARM1, SWI/SNF, NCOR1) associated with
changes in chromatin structure [43, 297-300] have the potential to mediate epigenetic effects
of intergenerational inheritance.
Upstream regulators of DBP-altered genes
In addition to pathway enrichment, IPA provided the relative enrichment and
associated activation/repression states for the upstream regulators of differential genes. The
enriched upstream regulators are shown in Table 4.7. The upstream regulators are not
present in the seminal plasma proteome, from Barrachina et al. [301]. In the spermatozoal
proteome, only Myc and MAPK9 are present [43]. All upstream regulators indicated in Table
4.7 were lowly expressed across the MARS samples, with a median expression value less
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than 1 RPKM. Only two genes, EGLN2 and FOXM1, had a median expression value
exceeding 1 RPKM, with values of 2.22 and 2.25, respectively (Table 4.8).
Table 4.7. Upstream regulators from IPA. Positive Z-scores are indicated in shades of red,
while Negative Z-scores are indicated in shades of blue. Deeper shades of the given color
represent more extreme Z-scores. All presented Z-scores represent a statistically significant
(p<0.05) enrichment of the regulator’s associated genes. A negative Z-score indicates that
the actions of the upstream regulator are predicted to be repressed.
Upstream regulators

B1HB2_B1_to_H

B1HB2_H_to_B2

H1BH2_H1_to_B

H1BH2_B_to_H2

MYC

-3.65

N/A

N/A

N/A

CST5

1.71

0.00

1.00

-0.50

ERBB2

N/A

N/A

-1.00

-1.55

EGLN

2.14

N/A

N/A

N/A

REST

N/A

N/A

-1.98

N/A

HR

N/A

N/A

N/A

-1.41

MAPK9

N/A

N/A

-1.07

N/A

TP53

N/A

N/A

-1.00

N/A

CCND1

N/A

N/A

N/A

-1.00

mir-10
miR-122-5p (miRNAs
w/seed GGAGUGU)

N/A

N/A

N/A

-0.97

N/A

N/A

N/A

0.45

CDK4/6

N/A

-0.45

N/A

N/A

FOXM1

N/A

N/A

-0.33

N/A

Table 4.8. Summarized expression values of IPA’s upstream regulators. The column
“Gene Symbol” indicates the gene name, while the columns “Median expression” and “Mean
expression” indicates the median and mean expression value, respectively, across the MARS
samples.
Gene Symbol

Median expression

Mean expression

MYC

0

0.32283

CST5

0

0.018956

ERBB2

0

0.001302

EGLN1

0

0.111128

EGLN2

0

1.423787

EGLN3

0

0

REST

0

0

HR

0

0.00872

MAPK9

0

0.041987

TP53

0

0.083205

CCND1

0

0.55502

CDK6

0

0.003696

CDK4

0

0.1018

FOXM1

0

0.544666
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In the current regulatory analysis, MYC, a well known transcription factor that acts as
a proto-oncogene, has a negative Z-score (-3.65), suggesting that the actions of Myc are
repressed by the transition to high DBP in the B1HB2 arm. This effect does not carry over to
any of the remaining three comparisons. Higher Myc expression is associated with increased
cell growth [302]. In mouse, spermatogonial stem cell renewal is regulated by Myc/Mycnmediated glycolysis [303].
Interestingly, Cystatin D (CST5 gene) was found to be enriched in all four
comparisons. In the B1HB2 arm, CST5 was moderately activated in the transition to high DBP,
and having no predicted activation or repression during the return to low DBP. In the H1BH2
arm, CST5 was lowly activated during the transition to low DBP, and lowly repressed during
the return to high DBP. The role of Cystatin D in spermatogenesis is unknown, and is not
highly expressed in testis. However, CST5, as a secreted cysteine proteinase inhibitor, may
play a protective role against proteinases [304].
Erb-B2 Receptor Tyrosine Kinase 2 (ERBB2), commonly known as HER2, is a
member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. It
was predicted to be mildly repressed in the H1BH2 arm comparisons, suggesting a continual
repression across the changing DBP levels.
EGLN is a family of prolyl hydroxylase enzymes, with canonical HIFα targets, which
act as an ancient oxygen-monitoring machinery [305]. In the B1HB2 arm, the transition to high
DBP was concurrent with a predicted moderate activation of EGLN. REST (RE1 Silencing
Transcription Factor), a transcriptional repressor, and HR (Lysine Demethylase And Nuclear
Receptor Corepressor) were both predicted to be repressed in the H1BH2 arm, with REST
enriched in the transition to low DBP and HR enriched in the return to high DBP. HR is a
histone demethylase, which acts to demethylate mono- and dimethylated Lys-9 of histone H3.
Although the B1HB2 arm’s enriched pathways do not strongly implicate oxidative stress and
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DNA damage response, HIF is integral to sensing and responding to hypoxia. Uncontrolled
hypoxia can result in oxidative stress.
Interestingly, two microRNAs, mir-10 and mir-122-5p, were enriched upstream
regulators during the return to high DBP in the H1BH2 arm. While neither microRNA was itself
altered by DBP exposure, shown in the following section “Small RNAs altered by DBP
exposure”, mir-10 was predicted to be repressed, while mir-122-5p was predicted to be mildly
activated, as shown in Table 4.7 and Figure 4.9. The mir-10a-5p, mir-10b-5p, and mir-1225p were all well expressed in human sperm, with median expression values of 105.5, 191.7,
170.6 RPM, respectively. The 3p sections of mir-10 and mir-122 were poorly expressed, being
zero RPM in nearly all samples. Reference values from SpermBase (http://spermbase.org),
which used a different sequencing platform (Ion Proton system), also indicate that mir-10a5p, mir-10b-5p, and mir-122-5p are well expressed in human sperm [306]. mir-10a-5p is
expressed at 57 RPK and 91.3 RPK in whole sperm from human and mouse, respectively.
mir-10b-5p is expressed at 31.5 and 65.8 RPK in whole sperm from human and mouse,
respectively. mir-122-5p is expressed at 88.2 RPK in human whole sperm, but is poorly
expressed in mouse sperm (0.7 RPK).

Figure 4.9. Downstream effectors of mir-10 and mir-122. Differential downstream
regulators of (A) mir-10 and (B) mir-122 are shown.
DBP exposure promotes expression of simple repeats
Several classes of repetitive element associated RNAs, including simple repeats,
endogenous retroviruses, and centromeric RNAs, have been identified within the population
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of human spermatozoal RNAs [156, 245]. The effect of high-DBP exposure in spermatozoa
for each study arm and study visit was assessed as a function of relative enrichment/depletion
of REs that overlapped a genomic repeat. As shown in Estill et al., centrometric repeats and
MER1A were enriched in mature human spermatozoa [245]. As expected, the centromeric
repeat, (AATGGAATGG)n, was enriched across all MARS study arms (see Figure 4.10A),
with no distinct differences across the study arms. This centromeric enrichment was primarily
due to novel orphan REs. Interestingly, the abundance of differential REs overlapping the
(AATGGAATGG)n repeat decreased from the B1 visit to the H visit. As shown in Figure 4.10B,
this suggests that in the B1HB2 arm, the transition to the high-DBP exposure reduces the levels
of (AATGGAATGG)n-associated REs. Centromeric RNA has been shown to facilitate the
localization of nucleoproteins and the chromosomal passenger complex (CPC) [307, 308].
Interestingly when nuclear structures are resolved, sperm centromeres are located towards
the nuclear periphery [309]. This is consistent with the view that centromeric repeat RNA may
represent residual transcripts that, in some manner, guide sperm differentiation and/or guide
mitotic progression of the early human embryo.
Simple repeats, such as GA-rich repeats and variations of TC-rich repeats (e.g.
(TTTC)n) were highly enriched across many of the MARS sperm samples as shown in Figure
4.10C. Interestingly, simple repeats were highly enriched in all study visits and arms, with the
exception of the B1 visit of the B1HB2 study arm. Within the MARS study set, the B1 visit is the
sole timepoint for which sperm samples have not been exposed to high-DBP mesalamine. All
novel RE classes (near-exon, intronic and orphan), but not the exonic REs, exhibit this DBPspecific pattern of repeat enrichment. Differential repeat analysis verified this DBP-specific
pattern for several of the simple repeats (Appendix I), with the primary exceptions of GA-rich
and A-rich repeat classes.
These results suggest that high-DBP exposure elicits an immediate and acute
response, represented by a dramatic increase in the expression of simple repeats in the male
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gamete. This showed that, in addition to being enriched in spermatozoa, RE-associated
genomic repeats are selectively modified by DBP exposure. As these repeats are
compartmentalized in sperm [156], perhaps they also have a role in sperm chromatin
organization. In this manner, their modification by DBP, that is known to increase DNA nicking
[310], may specifically alter chromatin states [311].

Figure 4.10. Enrichment of repetitive element expression. (A) Repeat enrichment (positive
log10 fold change) or depletion (negative log10 fold change) of centromere-associated
repeats. X-axis provides the repeat name, while the Y-axis indicates the relative enrichment
(positive log10 fold change) or depletion (negative log10 fold change). (B) The number of
differential REs that overlap centromeric repeats. X-axis provides the repeat name, while the
Y-axis indicates the number of differential REs for each significant expression change. (C)
Repeat enrichment (positive log10 fold change) or depletion (negative log10 fold change) of
Simple repeats. High-DBP exposure within the past spermatogenic cycle enriches simple
repeats in spermatozoa.
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Small RNA composition of spermatozoa
Several types of small RNAs, such as miRNAs and piRNAs, have known roles in
regulating mRNA and transposable element-derived RNAs and levels of repetitive elements.
piRNAs have been proposed to play a regulatory role in spermatogenesis and the mammalian
embryo, perhaps as part of the confrontation-consolidation of the embryo. miRNAs are wellknown to regulate their target genes through mRNA degradation and translational repression.
Therefore, miRNAs delivered to the embryo may play a regulatory role in regulating the early
use of maternal RNAs before zygotic genome activation. Among the other small RNA species
available in the mammalian genome (e.g. snoRNAs), tRNA fragments delivered by sperm
have been suggested to regulate the endogenous retroelement MERVL in the murine embryo
[71].
Common small RNA species of interest, such as miRNAs, piRNAs, tRNAs, tRNA
fragments, and siRNA can be detected with small RNA libraries (miRNAs ~22 bp) [250],
piRNA ~ 24-31 bp [251], and tRNA fragments ~28- to 34-nt [71]). Accordingly, small sizeselected RNA (sncRNA)-Seq libraries, were prepared and sequenced to assess the impact of
DBP exposure. Figure 4.11 shows the expected lengths of several small RNA species, in
context of an exemplar MARS small RNA sample. Several of the small RNA libraries show
peaks around the expected miRNA, piRNA, and tRNA fragment (tRF) sizes. As an initial
analysis to determine if small RNA species have different distributions between the two study
arms, the read sizes were binned into approximately 5 bp segments, for a total of 6 bins.
Figure 4.12 shows that the two study arms and their individual visits (Baseline, Crossover,
Crossback) were not noticeably different.
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Figure 4.11. Expected read lengths of small RNA species. The read length distribution of
an example sample is used as background. The Y-axis provides the read counts for a given
read length, while the X-axis indicates the read length. Expected miRNA, piRNA, and tRNA
fragment lengths are shown in green, yellow, and blue, respectively.

Figure 4.12. Small RNA read length comparisons. (A) Read count distributions. Y-axis
indicates the read count for each sample, and the. (B) Read count proportions. The Y-axis
indicates the proportion of a given sample belonging to the read length bin of interest. X-axis
indicates the study arm and study visit. Points are colored according to the patient that the
sample was sourced from. Panel headers indicate the read lengths included in the given
panel.
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Several previous studies have assessed the small RNA component of mammalian
sperm. In order to compare the small RNAs in the human sperm from the MARS study, the
highly expressed small RNAs were assessed, as shown in Table 4.9 and Figure 4.13. The
top 50 small RNAs were primarily tRNAs (15/50, 30%), piRNAs (13/50, 26%), rRNA (8/50,
16%) and miRNAs (7/50, 14%). When considering all small RNAs that were highly expressed
(using an arbitrary threshold of median RPM exceeding 50 RPM), 153 small RNAs were
identified as highly expressed. As with the more limited “Top 50” set shown in Table 4.9, the
highly expressed set was dominated by piRNAs (42/153, 27%), miRNAs (37/153, 24%),
tRNAs (25/153, 16%), small nuclear RNAs (16/153, 10%), and rRNA (8/153, 5%), as shown
in Figure 4.13.

Figure 4.13. Distribution of small RNA families in highly expressed small RNAs. Highly
expressed small RNAs were defined as having a median RPM exceeding 50 across all MARS
sperm samples.
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Table 4.9. Top 50 small RNAs in MARS small RNA libraries. “small RNA ID” indicates the
small RNA species, while the adjacent “Median RPM” column indicates the median expression
value in RPM, across the MARS small RNA libraries.
small RNA ID
LSU-rRNA_Hsa

Median RPM
419782.8

SSU-rRNA_Hsa
chrM
hsa_piR_016735
TRNA_GLY
5S
LSU-rRNA_Cel
SSU-rRNA_Dme
hsa_piR_000823
LSU-rRNA_Dme
hsa_piR_000765
Y4
hsa_piR_020326
tRNA-Asp-GAY
TRNA_GLU
HY1
tRNA-Leu-CTY
7SL
SSU-rRNA_Cel
RRNA45
hsa_piR_004153
LOR1I
TRNA_VAL
tRNA-Lys-AAG
hsa_piR_017716

109860.6
77858.1
20128.9
16437.5
11970.6
11908.2
9280.0
8419.9
8214.1
6957.7
6693.5
5798.1
5675.3
5505.7
3908.0
3381.0
3332.4
2705.0
2521.4
2288.6
1550.4
1411.4
1279.6
1090.8

small RNA ID
ENSG00000283293|
ENST00000636484
tRNA-Met
tRNA-Met-i
tRNA-Ser-AGY
hsa_piR_019914
hsa-let-7b-5p
hsa_piR_008114
hsa_piR_008113
tRNA-Leu-CTA_
hsa-miR-375
tRNA-SeC(e)-TGA
tRNA-Val-GTA
tRNA-Leu-CTA
hsa_piR_019825
hsa_piR_006046
hsa-miR-21-5p
U4B
hsa-let-7a-5p
tRNA-Pro-CCA
hsa-miR-26a-5p
hsa-miR-30a-5p
hsa_piR_015249
tRNA-Leu-TTG
hsa-miR-191-5p
hsa_piR_009294

Median RPM
1073.7
1012.6
1012.6
933.3
855.5
755.5
710.2
677.8
677.0
669.8
567.8
514.6
507.5
440.1
431.5
428.2
427.9
416.5
393.9
352.8
324.1
302.7
295.5
288.2
288.0

MARS small RNA populations were largely concordant with the small RNA proportions
in human sperm indicated by Donkin et al., who found that when rRNAs were excluded,
piRNAs, tRNAs, and miRNAs comprised a large proportion of the remaining small RNAs [46].
While Donkin et al. identified 37 piRNAs with a false discovery rate (FDR) below 0.1, those
37 piRNAs do not overlap with the piRNAs identified above as being highly abundant. This
likely reflects the different experimental paradigms (i.e phthalate exposure and bariatric
surgery for weight management).
Work in mice has previously shown an abundance of tRNA fragments in mature sperm
[312], with an excess of fragments generated from tRNA-GLY and tRNA-GLU (Glycine and
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Glutamic Acid). In human sperm, I find tRNA-GLY and tRNA-GLU to be the 1st and 3rd most
highly abundant tRNAs, respectively, as shown in Table 4.9. As noted in Chen et al., sperm
transfer RNA–derived small RNAs (tsRNAs) and miRNAs exhibit expression changes after
High-Fat Diet (HFD) in a paternal mouse model, and parallel inherited metabolic disorders in
offspring. The noted highly expressed tsRNAs in sperm (which accounted for ~70% of sperm
tsRNAs) were derived from tRNA-GLU, tRNA-GLY, and tRNA-VAL (Glutamic Acid, Glycine,
and Valine) [72], which correspond to the 3rd, 1st, and 5th most abundant tRNAs in the current
study. Additional murine sperm analysis [71] indicates that tRNA fragments are accumulated
by maturing sperm during epidydmal transit. Paternal protein restriction affects caudal sperm’s
tRNA fragment levels and miRNA levels. Notably, tRNA-GLY, which is highly expressed in
sperm, is more abundant in protein restricted mice. tRNA-GLY fragments delivered by sperm
have been proposed to regulate the target genes of the MERVL endogenous retroelement in
the murine embryo.
Previous work on spermatozoal small RNAs (18–30 nucleotides) by the Krawetz
laboratory, using ejaculates of three fertile individuals [313], suggested that between 20 and
60% of the sequenced reads were donor specific, indicated extensive sample heterogeneity
in sperm’s small RNAs. The MARS small RNAs were analyzed for expression specificity, and
revealed that of the 12,779 small RNAs, 48% were expressed at a level exceeding 5 RPM in
only a single sample, as shown in Figure 4.14. Overall, this suggests that a majority of the
small RNAs measured in the MARS study will exhibit extensive sample specificity, regardless
of the expression threshold used.
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Figure 4.14. Heterogeneity of small RNAs. For 12779 small RNAs, the Y-axis indicates the
count (in log10) of the small RNAs, and the X-axis indicates the count of small RNA libraries
with an expression value exceeding 5 RPM.
piRNA cluster expression
Small RNAs have a known role in genomic imprinting and establishment of the embryo
in plant species [314]. Given this suspected importance of piRNAs in gene regulation and
confrontation/consolidation within the embryo, the expressed piRNAs were examined to
determine if any particular piRNA clusters were transcribed. piRNA alignments were obtained
from https://www.pirnadb.org/ for hg38. piRNA cluster information was obtained from the
piRNA

cluster

database

(http://www.smallrnagroup.uni-mainz.de/piRNAclusterDB.html),

using the pooled generic testis dataset from Homo sapiens [183, 315]. Most piRNAs have
alignments in relatively few parts of the genome, with a few piRNAs occurring many times
(>100 times) in the human genome. A total of 14 piRNA clusters had two or more piRNAs
present (median RPM > 1 RPM) in the sperm small RNAs, as shown in Appendix J.
Interestingly, two clusters (on different chromosomes) had 6 expressed piRNAs, suggesting
that the two clusters may be active in late human spermatogenesis.
Small RNAs altered by DBP exposure
A LMEM was applied to the individual study arms to assess the impact of DBP
exposure on small spermatozoal RNAs under high-DBP and background-DBP conditions
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across the entire arm. This approach, did not differentiate between study visits (e.g. baseline,
crossover, and crossback), but instead treated samples as replicates of the associated highDBP or background-DBP conditions. This use of this approach was necessary due to small
sample sizes of the individual study visits. Both the use of an empirical P-value and BenjaminiHochberg correction produced similar numbers of significant small RNAs. For concordance
with adjustment strategy employed in the long RNAs, an empirical P-value was used for the
small RNAs. As shown in Figure 4.15 and detailed in Appendix K, in comparison to non-DBP
medication, the B1HB2 arm showed upregulation of 3 small RNAs in response to high-DBP
mesalamine and downregulation of 12 small RNAs. In the H1BH2 arm, exposure to high-DBP
mesalamine upregulated 9 small RNAs and downregulated 77 small RNAs. The difference in
detection of differential small RNAs between study arms was likely due to the smaller sample
size of the B1HB2 arm. CHARLIE3, a hAT-Charlie DNA transposon, and hsa_piR_019675
were differentially regulated in both study arms. Of note, CHARLIE3 was upregulated in the
B1HB2 arm, yet down regulated in the H1BH2 arm upon high-DBP exposure. In contrast,
hsa_piR_019675 was down regulated in both study arms upon high-DBP exposure. Although
the biological significance of hsa_piR_01967 is not yet known, its genomic loci overlap several
SSU-rRNA loci, suggesting that this piRNA may serve a regulatory role for rRNA [316].
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Figure 4.15. Volcano plots of differential small RNAs. The left and right panels show the
volcano plots for the H1BH2 arm and the B1HB2 arm, respectively. The X-axis indicates the
log10 expression change (slope) in RPM, while the Y-axis indicates the negative log10
empirical P-value.
Regulatory roles of small RNAs
Small RNAs, e.g., miRNAs and piRNAs, are known to be regulators of transposable
elements and mRNA expression [317-321]. Relatively few small RNAs were modified by DBP
exposure (Figure 4.15 and Appendix K), and do not appear to underly gene expression
changes observed in the long RNAs. However, given the presence of both complex and
simple genomic repeats that are compartmentalized within the sperm [156], their association
with sncRNAs was considered. The association of sncRNAs with genomic repeats were
assessed by correlation in each individual study arm. The use of a series of expressed small
RNAs that are physically linked to repeat sequences within the small RNA libraries enabled
their exact positioning. Independent of the study arm, greater than 90% of the small RNA
Spearman correlations were positive. In comparison, within the H1BH2 arm, 6.8% (37,098 of
548,628) and the B1HB2 arm 8.4% (18,880 of 224,115) of small RNA correlations were
negative, potentially reflecting inhibition.
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The majority of the negative small RNA pairs were concordant between both study
arms, suggesting that their effect remains constant across exposures (Figure 4.16). For
example, RNA pairs shared between the B1HB2 arm and H1BH2 arm include piRNA:rRNA,
miRNA:rRNA, rRNA:snRNA, rRNA:SINE1/7SL, rRNA:tRNA, ERV1;rRNA, while the B1HB2
arm also included ERV3:rRNA, L1:rRNA, rRNA:snoRNA, Endogenous Retrovirus:rRNA, and
ERV2:rRNA. Interestingly, the small rRNA fragments were negatively correlated with many of
the other small RNAs (piRNA, miRNA, snRNA, tRNA, snoRNA) and genomic repeats
(SINE1/7SL, ERV1, ERV2, ERV3, L1, Endogenous Retrovirus). piRNAs exhibited a series of
strongly negative correlations with Endogenous Retrovirus, L1, ERV1, and Simple repeats,
likely reflective of a suppressive role, while miRNAs were negatively correlated with
Endogenous Retrovirus. This is consistent with the view that piRNAs and miRNAs, either
directly or indirectly, act to suppress RNAs generated from Endogenous Retroviruses.
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Figure 4.16. Top 40 positive and negative small RNA pairs. (A) The RNA pairs with the
highest count, among the RNA pairs with a Spearman rho less than -0.2, are shown in order
of most counts to least counts, from left to right. The proportion of each RNA pair belonging
to given correlation range (e.g. a bin of 0.8;0.9 contains correlations with a rho greater than
or equal to 0.8 and less than 0.9.) are stacked along the Y-axis and colored according to the
correlation range. The RNA pairs in the top 40 negative pairs for both study arms (B1HB2 arm
and H1BH2 arm) are indicated in red text along the X-axis. For example, piRNA;rRNA contains
the greatest number of negative correlations in both study arms and is thus shown on the
leftmost side of each of the figures in panel A. The dominance of negative correlations is
displayed as a series of stacked bars in red shading. (B) The RNA pairs with the highest count,
among the RNA pairs with a Spearman rho greater than 0.5, are shown in order of most counts
to least counts, from left to right. The proportion of each RNA pair belonging to given
correlation range (e.g. a bin of 0.8;0.9 contains correlations with a rho greater than or equal
to 0.8 and less than 0.9.) are stacked along the Y-axis and colored according to the correlation
range. The RNA pairs in the top 40 positive pairs for both study arms (B1HB2 arm and H1BH2
arm) are indicated in red text along the X-axis.
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The interaction of long RNA repetitive elements with small RNAs
To assess the veracity of the above, genomic repeat associations were extended to
the long RNA libraries, thus excluding the possibility that the interactions were merely
observed in fragmented RNAs. As shown in Table 4.10, the majority of repetitive elements in
human sperm were simple repeats, followed by ERV1, tRNA, and ERVL. This is in accord
with both the repetitive elements observed in small RNA libraries (Figure 4.13C) and previous
repeat enrichment analyses through spermatogenesis to zygotic genome activation [156,
245].
Table 4.10. Overall repeat expression in long RNA libraries. “Repeat Family” column
indicates the repeat class. “Total” column indicates the total number of REs that overlap
genomic repeats from the given repeat class. “Median >1 RPM” and “Median >5 RPM”
indicate the number of REs overlapping the given genomic repeat that have a median
expression value greater than 1 RPM or 5 RPM, respectively.

REPEAT FAMILY

Total

SIMPLE_REPEAT
ERV1
TRNA
ERVL
UNKNOWN
ERVL-MALR
ERVK
DNA?
HAT-CHARLIE
SATELLITE
RRNA
HAT?
SCRNA
L1
LTR
GYPSY
HAT-TIP100?
MERLIN
DNA
L2

3292
285
46
118
39
78
38
18
73
10
3
6
5
129
5
17
3
1
11
9

B1HB2 ARM
H1BH2 ARM
Median>1 Median>5 Median>1 Median>5
RPM
RPM
RPM
RPM
578
315
582
322
27
19
26
14
15
9
16
11
6
4
6
4
5
2
4
1
5
3
4
2
4
2
4
2
3
2
3
2
3
1
3
0
2
2
2
2
2
2
2
2
2
2
2
2
2
1
2
1
1
1
1
1
1
1
1
0
1
0
1
0
1
0
1
0
1
0
1
0
1
0
0
0
1
0
0
0
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The combined small RNA:long RNA correlations primarily yielded positive correlations
(71.2% and 73.1% in the B1HB2 arm and H1BH2 arm, respectively), concordant with the small
RNA-only correlations (small RNAs:small RNAs). As previously observed for the small RNAonly analysis, the RNA pairs with the greatest number of negative correlations or positive
correlations were largely shared between the two study arms. However, unlike the small RNAonly analysis (Figure 4.16), nearly all of the top 40 negative pairs exhibited a high background
of positive correlations, among comparatively fewer negative correlations.
piRNAs can act as direct regulators of transposable elements [317] and miRNAs also
have indirect roles in modulating transposons and direct roles in modulating mRNA [318-321].
Both miRNA and piRNA were primarily correlated to long RNA repetitive elements in a positive
manner (Figure 4.17). However, a small portion of the miRNA pairing to Simple repeats,
ERV1, ERVL, and tRNA were highly negative. Similarly, a small portion of the piRNA pairings
to Simple repeats, ERV1, ERVL, ERVL-MaLR, and tRNA were highly negative. Interestingly,
despite a similar read coverage of the rRNA locus by long and short RNA libraries, rRNA
fragments in the long >200 bp RNA libraries were largely positively correlated with piRNA,
miRNA, and scaRNAs (Figure 4.18).

119

Figure 4.17. miRNA, piRNA and tRNA correlations to genomic repeats in long RNA
libraries. (A) Pairs for which a miRNA was correlated with a repeat in the long RNA samples.
(B) Pairs for which an piRNA was correlated with a repeat in the long RNA samples. (C) Pairs
for which an tRNA in the small RNA libraries was correlated with a repeat in the long RNA
samples. The top 20 most numerous pairs and their given Spearman correlations are shown,
with the pairs identically graphed in the same order for both study arms. The proportion of
each RNA pair belonging to given correlation range (e.g. a bin of 0.8;0.9 contains correlations
with a rho greater than or equal to 0.8 and less than 0.9.) are stacked along the Y-axis and
colored according to the correlation range.
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Figure 4.18. rRNA correlations to repeats and small RNAs. (A) Pairs for which an rRNA
repeat (derived from the long RNA) was correlated with an expressed small RNA are shown.
(B) Pairs for which an rRNA repeat (derived from the small RNAs) was correlated with a repeat
from the long RNAs are shown. The top 20 most numerous pairs and their given Spearman
correlations are shown, with the pairs identically graphed in the same order for both study
arms. The proportion of each RNA pair belonging to given correlation range (e.g. a bin of
0.8;0.9 contains correlations with a rho greater than or equal to 0.8 and less than 0.9.) are
stacked along the Y-axis and colored according to the correlation range.
Concordant with piRNA and miRNA pairings, the majority of tRNA (from small RNA
libraries) - long RNA genomic repeat pairs were positive, with a small number of each pair
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exhibiting negative correlations (Figure 4.17). Additionally, piRNA, miRNA, tRNA, and
scaRNA, while largely positively correlated with three main ERV family members (ERV1,
ERV2, and ERV3) [322], also exhibit a series of strong negative correlations (Figure 4.19).
Interestingly, all ERVs have strong negative correlations with short rRNA fragments and short
RNA simple repeats. Together, this data supports that view that tRNAs, miRNAs, and piRNAs
are negative regulators of the observed repeat partners, and they likely act in a target-specific
manner, rather than targeting an entire class.
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Figure 4.19. ERV correlations to small RNAs. (A-C) Pairs for which an ERV repeat (derived
from the long RNA) was correlated with an expressed small RNA are shown. The top 20 most
numerous pairs and their given Spearman correlations are shown, with the pairs identically
graphed in the same order for both study arms. The proportion of each RNA pair belonging to
given correlation range (e.g. a bin of 0.8;0.9 contains correlations with a rho greater than or
equal to 0.8 and less than 0.9.) are stacked along the Y-axis and colored according to the
correlation range.

123
Dynamic changes in sperm RNAs occur during spermiogenesis
Detection of consistent associations between small RNAs and long RNA with sperm
repetitive elements suggests a dynamic relationship. As shown in Figure 4.20, small rRNA
fragments and large rRNA fragments exhibit opposite correlations with piRNA, miRNA, tRNAs
and scaRNA (Figure 4.20, center). In addition, these small RNAs were primarily positively
correlated (Figure 4.20, solid line) with simple repeats and ERVs. However, select ERV1
repeats (HERV17-int and HERVIP10FH-int) and ERV3 repeats (MER68C, LTR47A2,
LTR86B2, and LTR86A2) were negatively correlated (Figure 4.20, dotted line) with small
RNAs. This suggested an opposite relationship between the select ERVs and piRNA, miRNA,
tRNAs and scaRNAs. Similarly, simple repeats, while positively correlated with most small
RNAs, had a series of strong negative correlations to small RNAs (Figure 4.20, dotted line
with blue star). Specific miRNAs, highlighted by hsa-miR-4516 and hsa-miR-30a-3p and
scaRNAs, such as scaRNA15, scaRNA 13, and scaRNA8, comprised a large proportion of
the negative correlations to simple repeats (Figure 4.20, dotted line with blue star). Among
the tRNAs, which are assumed to be tRNA fragments, tRNA-GLY, tRNA-VAL, tRNA-ILE, and
tRNA-MET accounted for the greatest number of negative correlations.

Figure 4.20. Relationships of sperm RNA repeats
and small RNAs. Negative and positive correlations
are represented as dashed lines and solid lines,
respectively. Negative correlations that only occur in
a specific manner are marked with a star. tRF=tRNA
fragment; scaRNA=Small Cajal body-specific RNA;
ERV=Endogenous RetroVirus
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The presented interactions in Figure 4.20 are not known to be causal (either indirectly
or directly) but are intended to illuminate the possible dynamic processes during
spermiogenesis. Creation of a functional spermatozoa capable of fertilization requires a
complex re-arrangement of organelles during the post-meiotic phase of spermatogenesis,
accompanied by removal of the cytoplasmic droplet. Additionally, the spermatid nucleus
undergoes extensive chromatin compaction of the haploid genome, replacing the majority of
histones with protamine toroids. Due to these changes and extensive degradation of RNAs,
including ribosomal RNAs, the ejaculated spermatid is transcriptionally and translationally
inert. The rRNA locus exhibited a similar read coverage of the by long and short RNA libraries.
However, given the opposite associations of long and short rRNA fragments to small RNA
species, it is tempting to speculate that the two rRNA populations represent decreasing and
increasing rRNA fragmentation, respectively. The paradigm in mammalian spermatozoa is
that sperm do not contain intact rRNA, having undergone extensive fragmentation during the
post-meiotic phase of spermatogenesis. The current analysis suggests that there is a
spectrum of rRNA fragmentation, ranging from long (>200 bp) fragments to short (<50 bp)
fragments. These long and short rRNA fragments were not strongly correlated (either
negatively or positively), and so are not connected in Figure 4.20. The biological phenotype
associated with the network is unknown. However, the dynamics are suggestive of a choice
between destructive and non-destructive pathways during spermatogenesis, and possibly the
quality of the ejaculated spermatozoa. This dynamic spermatozoal network may also play a
role in the considerable transcriptomic intra- and inter-individual heterogeneity of human
sperm.
v. Discussion
In both rural and urban environments, humans are exposed to cocktails of endocrine
disruptors [323]. While environmental regulations designate maximum allowable levels of only
a subset of the numerous xenobiotics, this level is primarily determined through animal
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models, which may not accurately reflect the human condition. The human male is known to
mediate some intergenerational effects in offspring [17], yet the intergenerational effect of
adult paternal exposures to common xenobiotics and endocrine disruptors, particularly in
humans, is poorly characterized. The MARS study showed that exposure of human males to
high levels of a single endocrine disruptor, di-butyl phthalate (DBP), was capable of reducing
sperm motility in DBP-naïve subjects [69].
Applying RNA-seq to the MARS samples (Figure 4.1) showed that DBP-induced
alterations in spermatozoal RNAs were largely unique to a single study arm (either the acute
B1HB2 or chronic H1BH2 study arm). Each biological response to increasing or decreasing
DBP levels yielded a different altered RNA profile (Table 4.4). Interestingly, novel RE’s
comprise a significant portion of altered REs, indicating that DBP exposure(s) affects far more
than the previously known transcripts. The RNA profiles observed in the ejaculated
spermatozoa reflect the final outcome of spermatogenesis, which includes both RNAs
generated in preparation for differentiation and those acquired during epididymal maturation
for transmission to the future embryo. Within the immunoprivileged state of the testis
(reviewed in [324]), the spermatogenic effect of high-DBP mesalamine is likely communicated
through Sertoli cells that support the germline during differentiation, or through the epididymis
during transit, when the sperm first become exposed to other fluids.
Mammalian models have previously indicated that phthalate exposure may be acting
on reproductive tissues through processes that include PPAR-dependent mechanisms [5860], inducing oxidative damage [67, 68]. In the current study, several spermatogenesis-related
pathways, including activation of EIF2 signaling and the PPAR-alpha/RXR-alpha signaling,
were strongly associated with the transition from baseline (B1 visit) to crossover (H visit)
(Figure 4.8B). This suggests that a concerted shift in the Peroxisome Proliferator-Activated
Receptor alpha (PPAR-alpha) and Eukaryotic Initiation Factor 2 (EIF2) pathways occurs at
the initial high-DBP exposure in DBP naïve males. Conversely, within the H1BH2 arm, after a
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temporary respite of a single spermatogenic cycle on non-DBP medication, the return to highDBP mesalamine activated oxidative stress and DNA damage response pathways, perhaps
signaling the beginning of the repair process (Figure 4.8A). The ontological association of
androgen receptor coregulation in the H1BH2 arm of the MARS study also suggests that
responses to in vivo adult exposures elicits androgen disruption, which has previously been
implicated in phthalate-induced testicular dysgenesis syndrome. Notably, subjects in the
H1BH2 arm have been chronically exposed to high-DBP mesalamine, some for several years,
prior to the MARS study and are assumed to have reached a phthalate-induced expression
plateau in response to the high-DBP levels. The temporary (1 spermatogenic cycle)
withdrawal from high-DBP mesalamine then precedes the additional and significant stress
imparted onto the germline upon re-introduction of high-DBP mesalamine.
Among the genomic repetitive elements shown to be enriched in spermatozoa, TCrich tetramers form a larger contribution to the sperm RNA when an individual has experienced
a high-DBP exposure in the previous spermatogenic cycle (Figure 4.10). The time required
to fully recover is not known and may well be far longer than the single crossback cycle
observed in the B1HB2 arm of the current study. Nevertheless, the study indicates that any
recent high-DBP exposure increases the abundance of simple repeats in human
spermatozoa. The biological function of these recurring simple repeats in spermatogenesis,
fertilization and early embryo development has yet to be defined [245]. However, they are
compartmentalized in sperm [156], perhaps reflective of a role in sperm chromatin
organization. Phthalate’s noted ability to increase DNA nicking [310] and thus spermatozoal
DNA fragmentation [67, 68] in a specific manner [311] may alter the specialized compact
chromatin environment in spermatozoa. The physiological effect(s) of the cocktail of
background exposure to endocrine disruptors in humans, particularly in somatic tissue, is
unknown. However, given the potential intergenerational effects of the paternal germline
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(mediated by sperm RNA content and sperm epigenome), ubiquitous human exposure to
phthalates and other known endocrine disruptors remains a concern.
The MARS study also provided the opportunity to assess the spermatozoal impact of
mild Inflammatory Bowel Disease (IBD). IBD, defined as Ulcerative colitis and Crohn’s
disease, is a common condition, with a prevalence of approximately 1 per 500 people [325].
The current study compared males with non-flaring, mild IBD treated daily with mesalamine
to a control cohort of fertile males from idiopathic infertile couples. As expected, mild IBD, or
chronic mesalamine use, had minimal impact on spermatozoal contents (Figure 4.6).
The transcriptomic dynamics across human spermatogenesis is complex [175, 245,
326]. Mechanisms driving transitions across sperm differentiation have been largely inferred
from mammalian model systems [327, 328]. The final stages of sperm differentiation,
spermiogenesis, is noted for extensive modification of chromatin structure, organelle
distribution, and changes in RNA composition [35, 36, 245]. However, the role of RNAs in
promoting these modifications has only recently begun to be addressed [156, 329]. Previous
studies on chromatin structure have suggested a role for genomic repeats in establishing and
maintaining chromatin. The MARS dataset demonstrated an spermatozoal enrichment of
transcribed repetitive elements, including simple repeats, ERV1, tRNA, and ERVL, which may
play a role in establishing the human spermatid. The relationship between transcribed repeats
(such as simple repeats and endogenous retroviruses), ribosomal RNAs, and small noncoding RNAs in ejaculated sperm was also uncovered. The identification of small cajal bodyspecific RNAs (scaRNAs), involved in small nuclear ribonucleoprotein (snRNP) biogenesis,
highlights the importance of RNA processing and localization in spermatogenesis.
The high-level network presented in Figure 4.20 provides a snapshot of the networks
involved in successful spermiogenesis, selective spermatid apoptosis [154, 330, 331], or
maturation during epididymal transit [71, 332-334]. The morphological and transcriptomic
intra- and inter-individual heterogeneity of human sperm [335-337] is likely, at least in part,
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due to choices along this network. This was exemplified by the RNA dynamics in
spermiogenesis of DBP-naïve subjects, adjusting their response in accord with position along
the network, i.e., spermatozoa recently exposed to high-DBP are enriched in simple repeats.
At present, the MARS study shows that exposure of human males to high levels of a
single endocrine disruptor, di-butyl phthalate (DBP), can alter spermatozoal RNAs and
expression of genomic repeats in sperm. Furthermore, an individual’s history of high-DBP
exposure influences their reproductive response to changes in DBP levels. The time period
required to fully recover from a high-DBP exposure, while currently undetermined, was
suggested in this study to be longer than a single spermatogenic cycle (approximately 90
days). Future in vitro and in vivo experiments relevant to adult phthalate exposures are
required to identify the mechanisms and pinpoint the biological processes at work in the
reproductive and endocrine systems of phthalate-exposed adults. Observational studies of
offspring from DBP-exposed fathers will provide a path to determine the extent of the impact
that paternal DBP exposure presents as health risk to their subsequent children.
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CHAPTER 5
CONCLUSIONS AND FUTURE DIRECTIONS
Developmental

Origins

of

Health

and

Disease

(DOHaD)

proposes

that

preconceptional, prenatal and childhood exposures affect health outcomes later in life. The
use of animal models has shone light on the importance of maternal health and gestational
influence on offspring health. Notably, environmental exposures, such as exogenous
endocrine disruptors, can be influential during key periods of susceptibility in fetal
development [338-341]. However, the male influence in DOHaD has only begun to be
appreciated. In this final chapter, I review the discoveries made regarding the preconceptional environment of human embryos, and contents of the male germline.
i. Assisted Reproductive Technologies
The circumstances surrounding a successful human birth are complex. The initial
events involve the fertilization of a matured oocyte by a presumably high-quality spermatozoa,
followed by embryonic cell division and finally implantation [342]. Advanced Assisted
Reproductive Technologies, such as IVF, ICSI, cryopreservation, controversial nuclear
transfer and Mitochondrial transfer techniques, manipulate the pre-implantation embryo [343345]. While such infertility treatments offer hope to individuals struggling to conceive, the
treatments may also have unintended consequences for the offspring due to an altered preconceptional and pre-implantation environment. With the exception of intentional embryonic
gene editing [346], the effect(s) of ART on offspring are expected to be primarily epigenetic in
nature. A variety of epigenetic mechanisms, such as DNA methylation, histone modifications,
and chromatin structure, are potentially altered by ART [82, 89, 91, 97].
DNA methylation, the addition of a methyl group to DNA, is typically examined in
context of 5-methylcytosine (5-mC). In Chapter 2, I examined the influence of several ART
processes, including embryo cryopreservation, on the 5-mC profiles of the child soon after
birth. As shown in Figure 2.1, the DNA methylation profiles of human newborns conceived
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naturally, or through the use of intrauterine insemination (IUI), or in vitro fertilization (IVF)
using Fresh or Cryopreserved (Frozen) embryo transfer, were compared. Except for the
naturally conceived infants, all newborns used in the study were born to parents experiencing
some degree of infertility, which required IUI or IVF/ICSI to resolve. Naturally conceived
infants were shown to have a dramatically different methylation profile compared to those born
through IUI or ICSI. Therefore, this research suggests that the underlying infertility of the
parents influences the child’s methylation. However, outside of ensuring that the samples
were from full-term newborns, this work did not consider maternal characteristics, such as
race, age, and socio-economic status, due to a lack of maternal and demographic information.
In particular, the natural conception group was drawn from an urban, primarily AfricanAmerican population, while the assisted conception group was drawn from patients
undergoing fertility treatment in a suburban clinic. Such maternal characteristics can bias
results and should be considered when modeling datasets from in future newborn cohorts.
However, if the current interpretation is accurate, this would lead to the striking conclusion
that successful treatment of infertile individuals, even by relatively non-invasive measures,
produces a cohort of children with an epigenome different from those born to fertile individuals.
Human infertility is a common condition, affecting approximately 12% of couples of
childbearing age in the United States [30], which has a variety of causes. Therefore,
examination of the newborn’s epigenome in context of the infertility diagnosis (e.g. male factor,
specific female factor) will be essential for characterizing this future population of children.
A second interesting observation was the striking similarity of IUI and IVF-Frozen
embryo transfer infants (Figure 2.2). This suggested that epigenetic aberrations in the IVF
conceptions may be abrogated using embryo cryopreservation. Notably, these results are in
accord with the observed reduction in birth defects using ART protocols that employ
cryopreserved embryos [89]. Taken together, these studies implicate a resetting mechanism
in cryopreserved embryos. However, women undergoing implantation of cryopreserved
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embryos are likely to be naturally cycling, whereas patients undergoing fresh embryo transfer
(excluding the use of gestational surrogates) recently experienced unusual hormonal and
physical stresses in preparation for oocyte extraction. Due to a number of social and economic
factors, embryo and oocyte cryopreservation are increasingly being utilized by infertility clinics
[347]. The above research indicates that this trend towards cryopreservation may be
beneficial to the offspring and help ameliorate any epigenetic aberrations introduced by the
use of IVF/ICSI.
Periconceptual nutrition, in the context of unassisted conception, is known to alter
epigenomes of offspring at specific loci termed metastable epialleles (MEs). With the current
cohorts, I tested the hypothesis that ME loci were sensitive to early nutritional exposure in the
context of IVF culture conditions. IVF culture conditions and parental infertility showed
consistently altered methylation at certain MEs. This was the first study to reveal an impact of
ART or fertility status on MEs and suggests a lasting epigenetic effect of IVF nutrition on the
developing embryo. However, it is important to note that the current study was limited to loci
targeted by the 450K array, and further limited by the ChAMP approach, which did not assess
methylation changes of loci with fewer than two probes. The implementation of the larger EPIC
array MethylationEPIC BeadChip array, which covers over 850,000 CpG sites and provides
greater coverage of distal regulatory elements, or bisulphite sequencing, which can provide
whole genome coverage, would be more informative in future cohorts. Additionally, while the
current cohort had limited patient data, a large matched cohort with detailed records of
maternal and gestational variables, employing more expansive DNA methylation detection
methods, would serve well to verify the observed sites and identify additional epimutations
that may be caused by ART.
ii. Sperm RNA
The RNA profiles of human sperm, as well as how RNA profiles change after endocrine
disruptor exposure, was explored in Chapters 3 and 4. The male germline is a highly
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specialized cell type, with a unique cell structure [35] and transcriptome [154]. Mature
spermatozoa are transcriptionally and translationally inactive, with a high degree of RNA
fragmentation to ensure silence and expunge the majority of the cytoplasm [35]. For the
majority of the known transcriptome, the considerable heterogeneity and transcriptome
fragmentation in spermatozoa renders common gene expression approaches inaccurate.
Additionally, recent studies have observed a series of RNAs arising from intronic and
intergenic loci, which are not enumerated in the annotated human transcriptome [154, 163].
To fully address these intronic and intergenic RNAs, the RNA Element (RE) discovery
algorithm (REDa) was developed [245]. REDa is a tool for the discovery of transcribed,
unannotated sequence elements from RNA-seq libraries, and was applied to a spectrum of
tissues and cells representing germline, embryonic, and somatic tissues, shown in Figure 3.3.
In all examined tissues, previously unannotated RNAs were identified, with transcription of
such RNAs throughout the autosomes and sex chromosomes. Interestingly, the post-meiotic
stages of spermatogenesis (Round spermatids and ejaculated sperm) contain large numbers
of novel (intergenic and intronic) REs (Figure 3.7). While the function of these novel RNAs in
spermatogenesis is not known, murine spermatozoa have shown preferential localization of
RNAs [156]. Identification of the cellular location of the human sperm RNAs, both from known
transcripts and novel REs, across the post-meiotic stage of spermatogenesis, would be a first
step towards understanding the potential function of sperm RNAs.
It has been proposed and shown in vitro that human sperm deliver a collection of RNAs
upon fertilization [154, 160, 211, 212]. The series of human RNA-seq profiles from sperm,
oocyte, and embryo allowed for the identification of REs that were transmitted to the human
oocyte solely by sperm. As expected, the majority of zygotic RNAs were shown to be derived
from the oocyte. However, up to 289 sperm REs were identified as a majority contributed by
paternal transmittance, with an FDR of ~3.4%, and 75 REs essentially provided by the sperm,
at an FDR of ~2.7% (Figure 3.10 A,B). While the role of these paternally transmitted RNAs
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in the embryo was not examined in the current work, such RNAs may play a regulatory role
in the embryo. Of particular interest are any full length RNAs, as these are potentially
translated in the embryo [154]. Micro-injection of known paternally delivered RNAs, in the
context of murine or human embryos, would serve to determine if such RNAs can tune embryo
development.
Novel REs (intronic, near-exon, and orphan REs) often correspond to the same
regions as genomic repeats. Given this association, the population of REs was used to
determine the enrichment of genomic repeats in various cell types. This approach has the
advantage of knowing the exact location and proxy expression (via RE expression) of the
genomic repeat. Certain retrotransposons are of known interest in the early human embryo,
such as ERVL [188, 348], SINE-VNTR-Alu (SVA) elements, and LTR12 (LTRs of HERV9)
[349]. The current study also demonstrated transcriptional enrichment of ERVL (MLT2A1 and
MER73) and SVA (SVA-D) during human embryogenesis. Repeat transcription during
spermatogenesis was also observed, with an enrichment of simple centromeric repeats,
MER1A (DNA transposon), HERVE, HSAT1 (Satellite) [350], and LTR71B (member of the
ERV1 family) [322] during spermatogenesis. The classes of enriched repeats appears to be
vastly different between spermatogenesis and embryogenesis, with an additional switch
during embryonic genome activation, when REs associated with MLT2A1 and SVA-D are
transcribed. It is important to note that the observed repeat enrichment in round spermatids
and spermatozoa may be indicative of a targeted retention of certain RNAs during the RNA
degradation and cytoplasmic expulsion of spermatozoa, rather than active transcription of the
given repeat. This distinction cannot be determined with the current data structure, but
requires measurement of the spermatozoal RNAs in context of a consistent exogenous control
RNA. An alternative approach would be to perform target counts with an array platform that
does not require sample amplification, such as nanoString [351]. It is currently unknown if
repeat transcription contributes solely to spermatogenesis, or if such RNAs also play a role in
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the early embryo. Microinjection of these RNAs into the mammalian embryo, followed by
examination of the embryonic epigenome and growth characteristics, would improve
understanding of these RNAs.
Humans are ubiquitously exposed to endocrine disruptors (EDs), such as phthalates.
However, the influence and underlying mechanisms of the cocktail of commonplace ED
exposures on reproduction in humans, particularly in adult males, is poorly understood. While
such exposures can easily be examined in animal models, there are practical issues to
observing the causative mechanisms of reproductive effects in humans. However, as
ejaculated sperm is an accessible cell type, examination of sperm RNAs may assist in
addressing the reproductive effects of EDs in human males. In addition to being potential
mediators of transgenerational inheritance, sperm RNAs may act as markers of environmental
perturbations or disease [163, 254]. Using the MARS study [69], changes in sperm RNAs
across longitudinal DBP exposure can be assessed to identify DBP-induced reproductive
changes. Additionally, the availability of MARS samples, which originate from individuals
suffering from mild IBD, provided the opportunity to identify IBD-induced changes in
spermatozoa. IBD-induced spermatozoal alterations were thus identified by comparing control
sperm samples to the B1HB2 arm samples, which represent men initiating the MARS study on
a DBP-naïve condition. This work showed few sperm RNA changes due to mild IBD. Future
cohorts should also include individuals with moderate to severe IBD, while controlling for
medication use. Overall, these results are reassuring for IBD-afflicted males.
By applying a LMEM to the MARS long RNA samples, the patterns of REs across
shifting DBP levels (High or Background) were generated. Surprisingly, few REs were altered
strictly with DBP levels (top two patterns of Table 4.4A). Instead the majority of differential
REs were altered in solely the Acute phase (Baseline to Crossover) or the Recovery phase
(Crossover to Crossback). This occurred regardless of the study arm, suggestive of an
phenotypic shift lasting long after the initial stimulus. The gene associations of differential REs

135
provided the opportunity to identify ontological terms and signaling pathways altered by DBP.
The DBP-naïve cohort (B1HB2 arm) was associated with translation, PPAR/ RXR-alpha
signaling, and a strong activation of GP6 signaling. PPARs are known to act as xenobiotic
sensors, and can interact with phthalates, resulting in PPAR activation [58-60]. The other
enriched pathways, notably GP6 signaling, have not previously been directly implicated with
DBP in literature. GP6 is a classical receptor for collagen, involved in platelet aggregation and
thrombus formation, but also is known to be enriched in human testis [352]. As a gradual
reduction in collagen binding by sperm during uterine transit has previously been suggested
to enable sperm capacitation [294, 295], GP6 signaling may play a role in sperm capacitation.
In contrast, the H1BH2 arm, implicates several pathways classically associated with
experimental phthalate exposures and phthalate-induced testicular dysgenesis syndrome,
such as oxidative stress, DNA damage response pathways, and androgen receptor
regulation. This suggested that re-introduction of DBP-containing medication after a single
spermatogenic cycle at background DBP level may harm the germline. The use of normalized
RNA expression to predict DBP-induced activation or repression of signaling pathways
provides a starting point for targeted proteomic analyses. However, verification of protein
expression and the presence of known protein modifications involved in signaling pathway
modulation is needed.
In addition to the gene ontologies and signaling pathways associated with the
differential REs, examination of repeat-associated REs suggested that high-DBP exposure
influenced repeat transcription. TC-rich simple repeats are upregulated by recent (1
spermatogenic cycle) high DBP exposure, and centromere-associated repeats appear to be
downregulated by high DBP in DBP-naïve individuals. The current approach has the
advantages of precisely placing expression of genomic repeats, by using RE expression as a
proxy for repeat expression. However, this assumes that the overlapping RE is an accurate
measure of the individual genomic loci. Therefore, the association of repeat transcription with
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DBP exposure(s) should be replicated using the read coverage of the individual repeat loci.
Simple repeats have previously been implicated in spermatozoal nuclear matrix-associated
regions [230], while centromeric RNAs may play a role in establishing stage specific
chromosomal structure and position throughout spermatogenesis [229, 230]. Altogether, this
data suggests that DBP likely alters germline chromatin structure during spermatogenesis.
While testing this hypothesis is outside the scope of this thesis, re-examination of the MARS
cohort or future cohorts for chromatin accessibility and histone marks (e.g. ChIP-seq) would
provide a further understanding of DBP-induced chromatin modifications.
Small RNAs have been implicated as likely mediators of paternal transmission. Using
a subset of the MARS samples, small RNA-seq libraries were generated to identify the
changes induced by human in vivo DBP exposure. Compared to the numerous DBP-regulated
REs in the long RNAs, relatively few small RNAs were identified as being altered by DBP
(Figure 4.15), in either study arm. However, a single piRNA, hsa_piR_01967, was
downregulated in both study arms upon high-DBP exposure. Despite the limited power of the
present small RNA analysis, this work suggests that DBP does impact small RNAs. The
physiological importance of the altered small RNAs in testis and the spermatogenic cycle is
not yet known. However, taken together, the long RNA and short RNA fractions of the MARS
samples suggest that DBP may alter various cellular mechanisms and signaling pathways
during post-meiotic spermatogenesis.
The male and female germline are known to have abundant expression of small
regulatory RNAs, such as piRNAs. Concordantly, abundant piRNAs were observed in the
MARS dataset. However, the regulatory relationships of RNAs during spermatogenesis is not
well known. Previous studies imply a role of small RNAs in repeat suppression, with piRNAs
acting as direct regulators of transposable elements [317] and miRNAs having an indirect role
[318-321]. However, the relationship of the small RNAs to the larger coding RNAs and RNAs
generated from genomic repeats during spermatogenesis is poorly defined. Using the MARS
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datasets, the availability of small RNAs and proxy genomic repeat expression permitted the
construction of the relationship between the two RNA categories. As shown in Figure 4.20,
consistent associations between small RNAs and long RNA with sperm repetitive elements
suggests a dynamic relationship. In particular, small rRNA fragments and large rRNA
fragments exhibit opposite correlations with piRNA, miRNA, tRNAs and scaRNA. Select ERV1
and ERV3 elements were also negatively correlated (Figure 4.20, dotted line) with small
RNAs, suggesting a contrary relationship. Similarly, simple repeats, while positively correlated
with most small RNAs, had a series of strong negative correlations to select small RNAs.
Notably, the network suggests opposite relationships of long and short rRNA fragments to
small regulatory RNAs. Spermatozoa are known to have extensively degraded ribosomal
RNA, and both long and short rRNA fragments have similar coverage of the consensus rRNA
loci. It is tempting to thus hypothesize that the small regulatory RNAs may be acting to cause
rRNA fragmentation. This hypothesis will require extensive work to prove (1) binding of the
small RNAs to the target rRNA locus and (2) causative fragmentation of rRNA. Regardless,
the network dynamic is suggestive of a choice between destructive and non-destructive
pathways during spermatogenesis, and possibly the quality of the ejaculated spermatozoa.
iii. Conclusion
The conception and uterine establishment of a human embryo is influenced by a
variety of factors, including the quality of the male and female germline. In Chapter 2, I outlined
the importance of the peri-conceptional environment in the context of assisted reproductive
technologies, namely, IVF/ICSI and cryopreservation. The sub-fertility of the parents and the
use of embryo cryopreservation alters methylation in the newborn’s blood cells. Additionally,
while metastable epialleles (MEs) have been previously associated with methyl donor
supplementation (in mouse) and seasonal diet changes (in human), this is the first work to
associate ART/infertility with MEs in humans.
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The involvement of the male germline in DoHAD has mostly been shown in mouse
and rat models. The tools to identify sperm RNAs, which likely are mediators of generational
transmission were developed and human spermatozoa were examined in the context of a
common endocrine disruptor. Using ejaculates from men longitudinally exposed to DBP, both
long and small RNAs were found to be altered by phthalate. Many of the differential long
RNAs, examined in context of RNA elements, were novel, non-exonic RNAs. These
exploratory works provide a set of RNAs and repeat classes to examine in future studies of
human spermatogenesis, embryogenesis, and endrocrine disruptor exposure.
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Appendix A : DNA quality scores for Newborn bloodspots. A260/A230 and A260/A280
quality scores for IUI, FH, and FZ samples are listed.
Sample
name
10006_B
10010_A
10046_B
10055_C
10058_A
10101_B
10117_B
10133_B
10136_C
10141_C
10156_B
10208_C
10225_A
10231_B
10255_A
10291_A
10292_C
10344_B
10346_B
10347_C
10350_B
10359_C
10374_A
10389_C
10402_B
10432_B
10434_B
10443_C
10447_C
10453_C
10460_C
10511_C
10512_A
10555_C
10558_B
10587_C
10601_B

A260/A230 A260/A280
0.08
0.13
0.09
0.1
0.1
0.15
0.1
0.08
0.1
0.09
0.09
0.07
0.14
0.11
0.1
0.14
0.09
0.1
0.08
0.17
0.11
0.12
0.09
0.11
0.13
0.12
0.11
0.13
0.08
0.11
0.07
0.12
0.11
0.1
0.12
0.09
0.13

2.5
2.58
2.61
2.65
3.18
2.07
2.64
2.84
2.49
2.83
1.92
2.53
2.52
1.85
2.84
2.55
2.6
2.33
2.32
2.32
2
2.27
2.92
2.43
1.91
2.03
2.09
2.27
2.9
2.79
2.94
2.52
2.79
2.94
2.49
2.76
2.32

Sample
name
10798_B
10821_C
10829_C
10831_C
10843_B
10846_B
10863_A
10869_B
10882_B
10890_C
10894_C
10932_B
10947_C
11002_B
11016_B
11029_B
11034_B
11048_C
11066_A
11067_A
11127_C
11165_C
11177_C
11283_B
11340_C
11359_B
11368_C
11378_B
11381_C
11387_B
11414_A
11420_B
11452_C
11458_B
11465_C
11508_A
11523_A

A260/A230 A260/A280
0.08
0.09
0.1
0.11
0.11
0.12
0.15
0.14
0.09
0.1
0.08
0.07
0.09
0.07
0.09
0.08
0.07
0.09
0.13
0.11
0.11
0.16
0.06
0.11
0.09
0.11
0.18
0.1
0.08
0.08
0.08
0.09
0.09
0.12
0.12
0.14
0.13

2.74
2.03
2.52
2.21
2.21
2.28
2.97
1.77
2.58
2.32
2.42
2.75
2.79
2.77
2.44
2.68
2.77
2.99
2.41
2.1
2.67
2.35
2.62
2.62
2.68
2.1
1.77
4.99
2.5
3.66
1.99
2.82
1.82
2.19
1.97
2.21
2.37
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10612_C
10649_C
10653_A
10667_C
10695_C
10697_B
10706_B
10716_A
10729_C
10743_C

0.07
0.12
0.1
0.09
0.1
0.09
0.11
0.13
0.1
0.1

3.61
2.61
2.43
2.93
2.36
3.39
2.05
2.35
2.42
2.44

11541_B
11580_C
11598_B
11600_C
11624_B
11629_B
11651_B
11691_A
11981_A
11998_A

0.06
0.1
0.1
0.14
0.12
0.15
0.12
0.1
0.11
0.07

3.44
2.59
2.82
2.19
2.37
3.4
2.22
2.72
2.25
4.51
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Appendix B: Enhancers overlapping differentially methylated regions. Chromosomal
locations of enhancers are provided.
FH vs IUI

chr10:8099889881000011
chr10:83734818373809
chr12:117483062117483484
chr12:1441356114413925
chr1:4238560942385954
chr16:8601214686012389
chr17:7509619075096538
chr17:7912880779129119
chr17:8082905480829460
chr18:7411451174114735
chr21:4457369644574026
chr2:200468498200468920
chr2:240362327240362618
chr2:242954051242954322
chr22:4316580543166293
chr5:1103805-1104368
chr5:1107341-1108073
chr5:669501-669935
chr7:2124507-2124641
chr8:142237099142237665
chr8:4942695249427328
chr8:4942754649427722

FZ
vs
IUI

FZ vs FH

IUI vs NAT

FH vs NAT

FZ vs NAT

chr17:7588356375884329
chr10:134361912134362323
chr10:2922876329229094
chr10:2951238-2951396

chr11:29199582920393
chr1:201619383201619798
chr1:247511365247511433
chr12:9584038795840581
chr16:5770111157701632
chr16:8797890687979489
chr16:8989381689894170
chr17:7680146276801678
chr17:7906887879069252
chr19:23323632332647
chr2:200468498200468920
chr2:8597253-8597584
chr7:101361034101362207
chr7:2150639-2150902

chr10:1405138614052060
chr10:2179895821799135
chr11:29199582920393
chr1:201619383201619798
chr1:247511365247511433
chr15:7501866575019349
chr17:7906887879069252
chr18:1184990311850727
chr19:23323632332647
chr19:4244010142440390
chr19:5735114457351414
chr21:4410468844105340
chr21:4457369644574026
chr2:1608919-1609202

chr7:4848839-4849223

chr2:1609558-1609866

chr10:1405138614052060
chr10:2179895821799135
chr10:7297378872974249
chr1:1260052512600853
chr11:29199582920393
chr1:201619383201619798
chr12:5335918153359363
chr12:77810117781133
chr15:7501866575019349
chr1:5928036459280505
chr16:8578556885785942
chr17:3817079338171091
chr17:5674405456744558
chr17:7906887879069252
chr18:1184990311850727
chr18:7291617772916455
chr19:23323632332647
chr20:2256752422567732
chr21:4457369644574026
chr2:1609558-1609866

chr10:4987962849879846
chr10:8099889881000011
chr10:8373481-8373809
chr11:3210988232110285
chr11:7813180578132171
chr12:5361246853612778
chr13:110521819110522258
chr13:2855492928555135
chr14:107252931107253417
chr1:4325035343250859
chr14:9523949695239653
chr15:3137275931373034
chr16:1585533-1585949
chr16:8601623386016516
chr16:8679522486795595
chr16:8870024988701257
chr16:8918495589185230
chr17:1420697014207459
chr17:1962783019628049
chr17:32253-32376
chr17:7687566776876103
chr17:7879327378793673
chr18:1184990311850727
chr18:7755234477552827
chr18:7772301377723575
chr19:3369394-3369884
chr19:5871562058715769
chr2:121624920121625080
chr21:3863040538630786

chr2:200468498200468920
chr2:241585712241586190
chr2:3583560-3583858
chr2:8597253-8597584
chr4:3374732-3375130
chr5:669501-669935
chr7:2548054-2548433
chr7:4764796-4765177
chr8:144948428144948782

chr2:240362327240362618
chr2:241585712241586190
chr22:4316580543166293
chr2:8597253-8597584
chr2:8703667487037618
chr4:3374732-3375130
chr5:1103805-1104368
chr5:669501-669935
chr7:4848839-4849223
chr7:7315718073157738
chr8:1156057511560973
chr8:144948428144948782
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chr2:240868441240868868
chr2:394418-394640
chr4:3374732-3375130
chr4:640356-640557
chr5:1103805-1104368
chr5:1107341-1108073
chr5:157001390157002014
chr5:178692524178692976
chr5:669501-669935
chr5:7185271271853181
chr6:170589556170589600
chr6:2888542228885544
chr6:3072000430720713
chr7:2599229625992472
chr7:4757996647580265
chr7:9899079598991133
chr8:142237099142237665
chr8:1847894-1848163
chr8:4942695249427328
chr8:4942754649427722
chr8:4983597449836286
chr9:140023271140023604
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Appendix C. Regulators with consistent methylation changes between genders of
multiple conception groups. Regulators with consistent methylation changes between
genders of two or more conception groups are shown. Methylation changes for each regulator
in the supporting conception groups are indicated as beta-value changes. Genes associated
with the given regulator are named and described in the columns titled “Associated Gene” and
“Protein function”.

Regulator

Hypermethylated

chr15:75018
66575019349

Methylation
changes

0.06;0.07;0.0
7;0.05

Count of
supporting
conception
groups

4

Associated Gene

CYP1A1

Homo sapiens
microtubule-actin
crosslinking factor
1 (MACF1)
Novel lincRNA
(RP11-167N24.3)
and RNU6-735P

Protein function

A member of the cytochrome P450
superfamily, monooxygenases which
catalyze many reactions involved in drug
metabolism and synthesis of cholesterol,
steroids and other lipids [353].
A protein that forms bridges between
cytoskeletal elements, MACF1 impacts
microtubule dynamics and associated
cellular processes [354].

0.05;0.05;0.0
4

3

0.05;0.06;0.0
4

3

Hyperchr1:755907
methylated 85-75591155

0.15;0.12;0.1
1

3

IHX8

A LIM homeobox transcription factor that
plays a role in tooth morphogenesis,
oogenesis and in neuronal differentiation
[355].

Hyperchr5:718527
methylated 12-71853181

0.03;0.04;0.0
7

3

LOC102503427

ncRNA, validated in RefSeq [356].

Hyperchr1:395479
methylated 03-39548129
Hypermethylated

Hypermethylated

chr12:95840
38795840581

chr16:84869
76384870234

0.05;0.03

Hyperchr7:106258
methylated 8-1063089

0.03;0.03

Hyperchr8:494269
methylated 52-49427328

0.09;0.08

Hyperchr8:494275
methylated 46-49427722

0.09;0.08

chr10:77165
09877165501
chr17:37896
Hyper808methylated
37897181
chr17:56744
Hyper054methylated
56744558
Hypermethylated

Hypermethylated

chr19:13113
44713113871

Hypermethylated

chr7:128094
514128094949

0.05;0.07

0.03;0.05

0.05;0.09

0.03;0.05

0.04;0.07

2

2

2

2

2

2

2

2

2

Cysteine-rich
secretory protein
LCCL domain
containing 2
(CRISPLD2)
Chromosome 7
open reading frame
50 (C7orf50)
Novel lincRNA
(RP11-567J20.3)
and
uncharacterized
LOC101929268
Novel lincRNA
(RP11-567J20.3)
and
uncharacterized
LOC101929268
ZNF503 antisense
RNA 2 (ZNF503AS2)
Growth factor
receptor-bound
protein 7 (GRB7)

RNU6-735P is a pseudogene of unknown
function.

A secretory protein which promotes matrix
assembly and may play a role in nonsyndromic cleft palate [357, 358].
A predicted intracellular protein with
unknown function [359].

Non-coding RNAs with unknown function.

Non-coding RNAs with unknown function.

A noncoding antisense RNA [360]
A growth factor receptor-binding protein
with roles in integrin signaling and cell
migration [361].
A protein highly expressed in testis and
required for the formation of intercellular
bridges during spermatogenesis [362].

Testis expressed
14 (TEX14)
Nuclear factor I/X
(CCAAT-binding
transcription factor)
(NFIX)

A transcription factor that binds viral and
cellular promoters [363]

Hypoxia inducible
lipid droplet-

Protein involved in intracellular lipid
accumulation [364]
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associated
(HILPDA)
Hypermethylated

chr10:29228
76329229094

Hyperchr19:38436
methylated
9-384669

0.09;0.07

0.04; 0.06

2

2

Hypermethylated

chr2:240362
327240362618

Hypomethylated

chr21:44573
69644574026

-0.07; -0.10;
-0.07

3

Hypomethylated

chr7:157405
982157406183

-0.06; -0.10;
-0.07

3

chr12:13302
Hypo1534methylated
133022956

Hypomethylated

chr12:13290
3795132904258

0.08;0.05

-0.12; -0.07

-0.03; -0.05

2

2

2

Theg spermatid
protein (THEG)
Histone
deacetylase 4
(HDAC4)
Novel lincRNA
(AP001631.10) and
Homo sapiens
crystallin, alpha A
(CRYAA)
PTPRN2
Novel lincRNA
(RP11-503G7.1)
and Novel lincRNA
(RP11-503G7.2)
and mucin 8
(MUC8)
Novel antisense
gene (RP13895J2.7) and
Homo sapiens
UDP-N-acetylalpha-Dgalactosamine:poly
peptide Nacetylgalactosamin
yltransferase 9
(GalNAc-T9)
(GALNT9)

A protein expressed in the haploid germ
cell nucleus with potential roles in protein
assembly [365].
A histone deacetylase involved in
transcriptional regulation through MEF2C
and MEF2D binding [366]
CRYAA is a (HSP20) family molecular
chaperone with autokinase activity, which
may be involved in intracellular
architecture. This protein is preferentially
expressed in the lens. [367]
Protein tyrosine phosphatase (PTP), of
the receptor-type PTPs. PTPRN is a
major autoantigen associated with insulindependent diabetes mellitus [368].
MUC8 is expressed in epithelial cells of
the human airway, although the function
of this gene is still being elucidated [369].

GALNT9 and related enzymes initiate Olinked oligosaccharide biosynthesis
through transfer of N-acetyl-Dgalactosamine residues [370].
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Appendix D. Enhancers with consistent bloodspot methylation changes. Enhancers
highlighted in blue are consistently altered between all three assisted conditions and natural
conception. Statistically significant methylation changes observed in conception comparisons
between NAT and IUI, FH, or FZ, are given in units of beta-values, with changes in male and
female comparisons shown in blue and red, respectively. Genes associated with the given
regulator are named and described in the columns titled “Associated Gene(s)” and “Protein
function”.
Observed
methylation
change

Hypomethylated

Hypomethylated

Hypomethylated

Hypomethylated

Hypomethylated

Hypomethylated

Enhancer

chr10:14051
38614052060

chr10:21798
95821799135

chr11:29199
58-2920393

chr17:79068
87879069252

chr18:11849
90311850727

chr19:23323
63-2332647

Methylation
Change

-0.06;-0.08/0.10;-0.07;0.07

-0.04;-0.04/0.09;-0.06;0.09

-0.06;-0.05;0.09/-0.06;0.05;-0.06

-0.07;-0.06;0.10/-0.10;0.08;-0.06

-0.08;-0.06;0.06/-0.05;0.04

-0.11;-0.09;0.10/-0.07;0.07;-0.05

Associated
Gene(s)

FERM domain
containing 4A
(FRMD4A)

Cancer
Susceptibility
Candidate 10
(CASC10) and
SKI/DACH domain
containing 1
(SKIDA1)
Cyclin-dependent
kinase inhibitor 1C
(p57, Kip2)
(CDKN1C), Solute
carrier family 22,
member 18
(SLC22A18), and
Solute carrier family
22 (organic cation
transporter),
member 18
antisense
(SLC22A18AS)

BAI1-associated
protein 2 (BAIAP2)

Guanine nucleotide
binding protein (G
protein), alpha
activating activity
polypeptide,
olfactory type
(GNAL), Charged
multivesicular body
protein 1B
(CHMP1B)

Signal peptide
peptidase like 2B
(SPPL2B), LSM7
homolog, U6 small
nuclear RNA
associated (S.
cerevisiae) (LSM7)

Protein function

May play roles in
cytoskeleton structure
and cell polarity through
protein binding [371].

SKIDA1 exhibits
nucleotide binding and
may play a role in cancer
risk [372].

CDKN1C inhibits several
G1 cyclin/Cdk complexes
and may be a tumor
suppressor. SLC22A18
acts as an organic cation
transporter and plays a
role in drug transport
[373, 374].

An adaptor protein which
aids in the conduction of
signals from membrane
bound G-proteins to
cytoplasmic effector
proteins. BAIAP2 may
play a role in
axonigenesis and insulin
signaling in the nervous
system [375].
GNAL, a stimulatory G
protein alpha subunit,
modulates signal
transduction within the
olfactory neuroepithelium
and basal ganglia.
CHMP1B , a component
of the ESCRT-III
complex, is likely
involved in multivesicular
bodies (MVBs) formation
[376, 377].
SPPL2B encodes an
intramembrane-cleaving
aspartic protease (ICLiP) involved in ITM2B
and TNF processing.
LSM7 is an Sm-like
protein which likely
participates in splicing
through interaction with
U6 snRNA [378, 379].

Notes
Evolutionarily conserved region is
located in the intron of FRMD4A
and promoter region of an
alternative FRMD4A isoform.
Region contains many transcription
factor binding sites. Site exhibits
high degree of chromatin
accessibility, as determined by
DNase Hypersensitivity.
Site is located approximately 13 kb
and 3 kb from start site of
C10orf114 and stop site of
SKIDA1, respectively. Site exhibits
high degree of chromatin
accessibility, as determined by
DNase Hypersensitivity.

Site is located in the intron of
SLC22A18AS, is directly upstream
of the promoter for SLC22A18,
and is approximately 13 kb
upstream of the transcriptional start
site for CDKN1C. Site exhibits high
degree of chromatin accessibility,
as determined by DNase
Hypersensitivity.

Enhancer is located in the intron of
BAIAP2, adjacent to many
transcription factor binding sites.
Site exhibits high degree of
chromatin accessibility, as
determined by DNase
Hypersensitivity.

Site is located in the intron of
GNAL and is in the promoter
region of CHMP1B. Site exhibits
high degree of chromatin
accessibility, as determined by
DNase Hypersensitivity.

Site is located in the intron of
SPPL2B and is approximately 4 kb
upstream of the LSM7
transcriptional start site. Site
exhibits high degree of chromatin
accessibility, as determined by
DNase Hypersensitivity.

146

Hypomethylated

chr2:160955
8-1609866

Hypomethylated

chr2:241585
712241586190

Hypomethylated

chr2:859725
3-8597584

Hypomethylated

chr21:44573
69644574026

Hypomethylated

chr4:337473
2-3375130

Hypomethylated

chr8:144948
428144948782

Hypomethylated

chr1:201619
383201619798

-0.09;-0.10/0.07;-0.08;0.07

-0.10;-0.07/0.10;-0.06;0.11

G protein-coupled
receptor 35
(GPR35) and
Aquaporin 12B
(AQP12B)

-0.06;-0.08/0.10;-0.11;0.10

-0.07;-0.08/0.06;-0.05;0.08

-0.04;-0.04;0.07/-0.08;0.11
-0.05;-0.05;0.06/-0.06;0.05;-0.07

chr5:669501
-669935

-0.05;-0.05/0.05;-0.04;0.06

Site is located in the intron of
AC144450.1, and is approximately
25 kb, 15 kb, and 26 kb away from
AC141930.2, AC144450.2, and
PXDN, respectively. Site exhibits
high degree of chromatin
accessibility, as determined by
DNase Hypersensitivity.

Site is located approximately 15 kb
and 30 kb from GPR35 and
AQP12B, respectively. Site exhibits
moderate chromatin accessibility,
as determined by DNase
Hypersensitivity.
Site is located at least 85 kb away
from any annotated gene. Site
exhibits moderate chromatin
accessibility, as determined by
DNase Hypersensitivity.

Novel lincRNA
(AP001631.10) and
Crystallin, alpha A
(CRYAA)

Regulator of Gprotein signaling 12
(RGS12)

Epiplakin 1
(EPPK1)

Neuron navigator 1
(NAV1)

CYP1A1

chr15:75018
66575019349
Hypomethylated

Secreted hemecontaining peroxidase is
involved in extracellular
matrix formation.
Involved in ocular
development and may
have a systemic role in
peroxidase metabolism.
[380, 381]
A receptor for kynurenic
acid, GPR35 is involved
in intracellular signaling.
AQP12B, as a member
of the aquaporin family,
forms a pore to facilitate
transport of water and
solutes across cell
membranes [382, 383].

-0.07;-0.09;0.08/-0.08;0.06;-0.08

-0.05;-0.05/0.04;-0.05

Hypomethylated

LincRNAs
(AC144450.2,
AC141930.2),
putative antisense
gene AC144450.1,
Peroxidasin
homolog (PXDN)

Tubulin
polymerization
promoting protein
(TPPP)

CRYAA is a (HSP20)
family molecular
chaperone with
autokinase activity, which
may be involved in
intracellular architecture.
This protein is
preferentially expressed
in the lens. [367]
Involved in signal
transduction, RGS12
acts inhibits signal
transduction and thus
acts as a transcriptional
repressor [384].
A member of the plakin
family, EPPK1 may
regulate and maintain
keratin intermediate
filament networks [385].
A member of the neuron
navigator family which
may play a role in axon
guidance [386]
A member of the
cytochrome P450
superfamily,
monooxygenases which
catalyze many reactions
involved in drug
metabolism and
synthesis of cholesterol,
steroids and other lipids
[353].
Protein involved in
polymerization of tubulin
and maintainence of the
microtubule network
[387].

Site is located ~ 5kb and 15 kb
away from AP001631.10 and
CRYAA, respectively. Site exhibits
high degree of chromatin
accessibility, as determined by
DNase Hypersensitivity.

Site is located in intron of RGS12.
Site exhibits a high degree of
chromatin accessibility, as
determined by DNase
Hypersensitivity.
Site is located in the unspliced 5'
UTR of EPPK1. Site exhibits a high
degree of chromatin accessibility,
as determined by DNase
Hypersensitivity.
Site is located in the first intron of
NAV1. Site exhibits a high degree
of chromatin accessibility, as
determined by DNase
Hypersensitivity.

Site is located in the promoter of
CYP1A1. Site exhibits a high
degree of chromatin accessibility,
as determined by DNase
Hypersensitivity.

Site is located in the first intron of
TPPP. Site exhibits a moderate
degree of chromatin accessibility,
as determined by DNase
Hypersensitivity.
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Appendix E: RE discovery computational methods (REDa)
Processing bam files
The RE discovery algorithm is designed to be run entirely in R, with the user providing aligned
reads in BAM file format. To conserve memory, the BAM files are first converted to bigWig
format. The user is expected to use the helper function “generatebw” to generate both the
required bigWigs as well as the text file containing the number of aligned reads per sample.
However, the required bigWigs can also be generated by converting BAM files to bedgraph
format, using the bedtools tool genomeCoverageBed, with the parameters “-split –bg”, and
subsequently bigwig format, using the bedGraphToBigWig program (available from the UCSC
Genome Browser utilities).
Collapsing redundant exons
Gene isoforms and transcripts often share overlapping exons and UTRs. In the RE discovery
tool, overlapping annotated regions (here described as exons, regardless of the coding
potential) on the same strand are collapsed into a single loci, designated as “exonic”. This
singular representation of multi-exonic transcripts is not conducive to isoform discovery, but
works well for fragmented RNAs, as is seen in spermatozoa or formalin-fixed paraffin
embedded (FFPE) tissues. The “prepareExons” function collapses exons using the “bedR”
package.
Discovering expressed regions
The initial step in discovering expressed regions of the genome is performed in the “findRE”
function. The user needs to provide their genome of interest in BSgenome format, and a gene
annotation file in GTF format. Although the current study performed RE discovery on the hg38
build of the human genome, the algorithm is adaptable for different species and genome
builds. There is no restriction on the format of chromosome names used in the genome.
However, later annotation steps are coded to be used with ensembl gene annotations
available through the R package ‘biomaRt’, and thus it is recommended that the GTF file uses
ensembl gene IDs (please see https://www.gencodegenes.org/releases/current.html for
examples). The genome is first processed by binning into 10 bp regions. Coverage across
each 10 bp bin is calculated and bins overlapping an annotated region in the GTF file (here
described as exons, regardless of the coding potential) are removed from consideration. The
remaining genomic bins are compared to the designated library size-normalized threshold mu
(µ), with those bins equal to or exceeding the coverage required in µ retained as a novel RNA
element (RE). This threshold µ, for a theoretical RNA-seq library with 3 million reads, would
require a mean coverage of 7.5 reads for a given 10 bp bin in order to label the bin as
expressed. REs within 100 bp of one another are merged into a single new RE. It is important
to note that the default parameters used by the “findRE” function retain expressed regions if
they are present in at least one sample. REs defined across each sample are subsequently
merged with the “combineRE” function, in which the REs from each iteration are concatenated
into a single GRanges object. The concatenated object is then reduced, merging overlapping
and adjacent (within 50 bp) REs.
Annotating REs
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Once the newly discovered REs are generated, they need to be annotated according to their
genomic position, which is achieved in the “annotateRE” function. Intronic regions are defined
according to the user-supplied GTF file, followed by identifying novel REs that overlap an
intron. The distance between any non-intronic novel REs and exons is then calculated and
used to define non-intronic novel REs as near-exon (less than 10kb from an exon) or orphan
(greater than or equal to 10 kb from an exon).
In the human genome, poorly annotated genes have occasionally been observed to have
transcription beyond their designated borders. In an optional step, performed with the
“extendExon” function, near-exon REs within a default 20 bp of an exon are examined. The
read coverage across near-exon REs, in 10 bp increments, are compared to the average read
coverage of the adjacent exon. If the read coverage in the near-exon RE is increased or
decreased by less than 50% of the average read coverage of the adjacent exon, the novel RE
is merged with the adjacent exon. This process is repeated until no more 10 bp bins of the
near-exon RE remain, or the near-exon RE coverage changes by more than 50% of the
average read coverage of the adjacent exon.
In order to provide the user with the common gene symbol of each ensembl gene ID, the
function “annotateFinal” is provided. The “biomaRt” package is used to transform the ensembl
gene ID into the common gene symbol. The output is a complete bed file of exonic and novel
REs, along with the common gene symbol(s) and ensembl gene id(s) of the REs. This bed
file can subsequently be used in expression analysis.
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Appendix F: RNA-seq samples applied to REDa (RE discovery). This table provides the
unique sample name (Sample.name) for each RNA-seq library, as well as the corresponding
tissue type and RNA-preparation type (Tissue, Tissue.simple, RNA.type and Pool). The
publication or GEO dataset from which the sample was drawn is provided in "Publication"
column.
Sample.name

Group

Tissue

Tissue.simple

Test.Ambion

Krawetz

Testis

Testis

RNA.ty
pe
Aplus

Test.Clone

Krawetz

Testis

Testis

Aplus

testes1

Krawetz

Testis

Testis

testes2

Krawetz

Testis

Testis

SRR893048

Xue

oocyte

Oocyte

Total
RNA
Total
RNA
Aplus

SRR893049

Xue

pronucleus

Aplus

SRR893050

Xue

pronucleus

SRR893051

Xue

pronucleus

SRR893052

Xue

zygote

SRR893053

Xue

zygote

SRR893054

Xue

2-cell_blastomere

Embryo_pronu
cleus
Embryo_pronu
cleus
Embryo_pronu
cleus
Embryo_zygot
e
Embryo_zygot
e
Embryo_2cell

SRR893055

Xue

2-cell_blastomere

Embryo_2cell

Aplus

SRR893056

Xue

2-cell_blastomere

Embryo_2cell

Aplus

SRR893057

Xue

4-cell_blastomere

Embryo_4cell

Aplus

SRR893058

Xue

4-cell_blastomere

Embryo_4cell

Aplus

SRR893059

Xue

4-cell_blastomere

Embryo_4cell

Aplus

SRR893060

Xue

4-cell_blastomere

Embryo_4cell

Aplus

SRR893061

Xue

8-cell_blastomere

Embryo_8cell

Aplus

SRR893062

Xue

8-cell_blastomere

Embryo_8cell

Aplus

SRR893063

Xue

8-cell_blastomere

Embryo_8cell

Aplus

SRR893064

Xue

8-cell_blastomere

Embryo_8cell

Aplus

SRR893065

Xue

8-cell_blastomere

Embryo_8cell

Aplus

SRR893066

Xue

8-cell_blastomere

Embryo_8cell

Aplus

SRR893067

Xue

8-cell_blastomere

Embryo_8cell

Aplus

SRR893068

Xue

8-cell_blastomere

Embryo_8cell

Aplus

SRR893069

Xue

8-cell_blastomere

Embryo_8cell

Aplus

SRR893070

Xue

8-cell_blastomere

Embryo_8cell

Aplus

SRR893071

Xue

8-cell_blastomere

Embryo_8cell

Aplus

SRR893072

Xue

morula

Aplus

SRR893073

Xue

morula

SRR893074

Xue

morula

SRR893046

Xue

oocyte

Embryo_morul
a
Embryo_morul
a
Embryo_morul
a
Oocyte

SRR893047

Xue

oocyte

Oocyte

Aplus

Aplus
Aplus
Aplus
Aplus
Aplus

Aplus
Aplus
Aplus

Dat
e
20
09
20
09
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13
20
13

Pool

Publication

pool

doi: 10.1007/s00441-015-22371
doi: 10.1007/s00441-015-22371
doi: 10.1007/s00441-015-22371
doi: 10.1007/s00441-015-22371
doi:10.1038/nature12364

pool
pool
pool
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell
single
cell

doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364
doi:10.1038/nature12364

150
SRR2130093

Dang

zygote

SRR2130125

Dang

TE

SRR2130124

Dang

TE

SRR2130123

Dang

TE

SRR2130122

Dang

ICM

Embryo_zygot
e
Embryo_troph
oblast
Embryo_troph
oblast
Embryo_troph
oblast
Embryo_ICM

SRR2130121

Dang

ICM

Embryo_ICM

SRR2130120

Dang

ICM

Embryo_ICM

SRR2130119

Dang

late_blastocyst

SRR2130118

Dang

late_blastoycst

SRR2130117

Dang

late_blastoycst

SRR2130116

Dang

middle_blastocyst

SRR2130115

Dang

middle_blastocyst

SRR2130114

Dang

middle_blastocyst

SRR2130113

Dang

early_blastocsyt

SRR2130112

Dang

early_blastocsyt

SRR2130111

Dang

early_blastocsyt

SRR2130110

Dang

morula

SRR2130109

Dang

morula

SRR2130108

Dang

morula

SRR2130107

Dang

morula

SRR2130106

Dang

8_cell

Embryo_blast
ocyst
Embryo_blast
ocyst
Embryo_blast
ocyst
Embryo_blast
ocyst
Embryo_blast
ocyst
Embryo_blast
ocyst
Embryo_blast
ocyst
Embryo_blast
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Embryo_blast
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a
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a
Embryo_morul
a
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a
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SRR2130105

Dang

8_cell

Embryo_8cell

SRR2130104

Dang

8_cell

Embryo_8cell

SRR2130103

Dang

8_cell
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SRR2130102

Dang

8_cell

Embryo_8cell

SRR2130101

Dang

4_cell

Embryo_4cell

SRR2130100

Dang

4_cell

Embryo_4cell

SRR2130099
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SRR2130098

Dang
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Embryo_4cell

SRR2130097

Dang
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SRR2130096
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2_cell
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SRR2130094
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e
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e
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MII_oocyte
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RNA
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RNA
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RNA
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RNA
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RNA
Total
RNA
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RNA
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RNA
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RNA
Total
RNA
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RNA
Total
RNA
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RNA
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RNA
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RNA
Total
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RNA
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RNA
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RNA
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RNA
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RNA
Total
RNA
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RNA
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RNA
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RNA
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RNA
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RNA
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RNA
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RNA
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RNA
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RNA
Total
RNA
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RNA

20
16
20
16
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16
20
16
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16
20
16
20
16
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16
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16
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cell
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cell
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cell
single
cell
single
cell
single
cell
single
cell
single
cell
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cell
single
cell
single
cell
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cell
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cell
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single
cell
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cell
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SRR2130086

Dang

MII_oocyte

Oocyte

SRR2130085

Dang

MII_oocyte

Oocyte

SRR3062174

Dang

human_stem_cells

ESC

SRR3062173

Dang

human_stem_cells

ESC

SRR3062172

Dang

human_stem_cells

ESC

SRR3062171

Dang

human_stem_cells

ESC

SRR3501436

Dang

human_stem_cells

ESC

SRR3501437

Dang

human_stem_cells

ESC

SRR3501438

Dang

human_stem_cells

ESC

sperm_A

Sperm

Sperm

Sperm

Sperm

Aplus

Sperm

Sperm

Aplus

Sperm

Sperm

liver.female.6yo

Liver

Total
RNA
Aplus

liver.male.32yo

Liver

Aplus

liver.fetal

Liver

Aplus

Testis

Testis

Aplus

Testis

Testis

Aplus

Testis

Testis

Aplus

Testis

Testis

Aplus

liver.fetal

Liver

Aplus

SRR1791304
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s
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s
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s
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s
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s
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s
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s
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s
Jodar
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RNA
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RNA
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RNA
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RNA
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RNA
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RNA
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RNA
Total
RNA
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RNA
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Sperm

Sperm

SRR1791305

Jodar

Sperm

Sperm

SRR1791306

Jodar

Sperm

Sperm

SRR1791307

Jodar

Sperm

Sperm

SRR1791308

Jodar

Sperm

Sperm

SRR1791309

Jodar

Sperm

Sperm

SRR1791310

Jodar
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Sperm

SRR3146452
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A.dark.spermatogonia

Adark_sperm

SRR3146494
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Jan
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leptotene.zygotene.sper
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late.pachytene.spermato
cytes
round.spermatids
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rm
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Total
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Total
RNA
Total
RNA
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RNA
Total
RNA
Total
RNA
Total
RNA
Total
RNA
Total
RNA
Total
RNA
Total
RNA
Total
RNA
Total
RNA
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sperm_C
sperm_stranded_
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SRR3192419
SRR3192418
SRR3192440
SRR4422587
SRR4422588
SRR4421667
SRR4421668
SRR3192439
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16
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Appendix G: Location of novel REs exceeding 1 kb in length. A total of 138 novel REs
exceed one kilobase in length. The chromosomal location (in hg38 coordinates) of the RE is
provided in the first three columns, “Chromosome”, “Start position”, and “End position”. The
length of the RE, in base pairs, is provided in column “RE length”. For intronic and near-exon
REs, the associated gene names are provided in column “Gene symbol”. The designation of
an RE as near-exon, intronic, or novel is given in column “RE class”.
Chromosome

Start position

End position

RE length

chr9

133019427

133021126

1700

chr5
chr1
chr1
chr1
chr1
chr1
chr2
chr2
chr2
chr3
chr4
chr4
chr5
chr6
chr7
chr7
chr7
chr9
chr10
chr14
chr14
chr17
chr19
chr22
chr22
chr22
chr1
chr1
chr1
chr2
chr3
chr6
chr7
chr8
chr9
chr9
chr11
chr12
chr15
chr16
chr19
chr19
chr20
chr1
chr1

4867045
1595371
25907041
37859741
40860961
180190981
19351349
44167539
132270379
50258368
15002500
118630440
177456545
2966400
905617
65838216
65840796
136107687
26645650
70230224
106286318
7881186
4227969
23892523
30967066
41994621
38129381
149924351
154952201
112062629
168845049
36863796
30157438
99944163
34667387
35103667
70121258
2855495
22767380
22115491
4618609
50497439
48501613
2604371
178514771

4868064
1596770
25908250
37862430
40862366
180192010
19352410
44168859
132271658
50259819
15004335
118634189
177458707
2972205
906626
65839335
65842065
136109081
26646779
70232587
106287657
7882765
4229118
23893922
30968552
41998652
38130522
149925820
154953600
112063728
168846468
36865095
30162876
99946062
34668426
35105374
70122757
2856944
22770269
22116500
4619678
50500158
48516852
2605540
178515820

1020
1400
1210
2690
1406
1030
1062
1321
1280
1452
1836
3750
2163
5806
1010
1120
1270
1395
1130
2364
1340
1580
1150
1400
1487
4032
1142
1470
1400
1100
1420
1300
5439
1900
1040
1708
1500
1450
2890
1010
1070
2720
15240
1170
1050

Gene symbol

RE class

EEF1A1P5

NOVEL_10KB_EXON

AC026415.1
FNDC10
STMN1
INPP5B
CITED4
QSOX1
OSR1
AC019129.2
CDC27P1
GNAI2
CPEB2
AC110079.1
DBN1
SERPINB6
ADAP1
AC093582.1
AC093582.1
AL138781.1
AL390961.1
AL160191.3
HOMER2P2
NAA38
EBI3
AP000350.4
MORC2
SEPT3
AL139158.3
SF3B4
PBXIP1
TMEM87B
NA
PPIL1
MTURN,AC007036.3
NA
AL162231.2
FAM214B
ANO1
ITFG2
AC138649.1
VWA3A
AC011498.5
EMC10
RNU7-144P
MMEL1
TEX35

NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_ORPHAN
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_ORPHAN
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_INTRONIC
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chr1
chr1
chr1
chr6
chr7
chr7
chr7
chr7

222471921
222473491
222476031
23854156
149587
942327
51390017
51391797

222473380
222475320
222477304
23855645
152547
943466
51391366
51393186

1460
1830
1274
1490
2961
1140
1350
1390

CICP13
AL513314.2
AL513314.2
AL139093.1
AC093627.4
ADAP1
AC012441.1
AC012441.1

NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_10KB_EXON

chr7
chr7
chr10
chr16
chr16
chr17
chr20
chr1
chr1
chr2
chr2
chr2
chr3
chr3
chr3
chr3
chr4
chr4
chr4
chr4
chr4
chr5
chr5
chr5
chr5
chr5
chr6
chr7
chr7
chr7
chr7
chr7
chr7
chr7
chr8
chr8
chr8
chr9
chr9
chr10
chr10
chr10
chr10
chr11
chr12
chr13
chr13
chr15

63930996
112618816
132887000
1672491
2528236
3385930
50958623
24086831
154206511
45309399
165665809
216857249
169821889
195941779
196001229
197640019
10083250
119405650
119407310
183850820
189846080
1620305
7299375
70487825
70509795
70774825
166899956
32591137
37847147
57216146
57219716
132561286
143579446
143748736
27011147
42451183
54049383
68971447
88129307
671190
46129883
46357239
131385470
119397667
97988365
40481146
111317126
23439460

63932015
112620645
132888069
1673510
2531510
3386955
50963931
24087900
154207648
45311588
165667138
216858478
169822941
195945588
196005068
197642188
10084379
119407129
119409332
183852569
189847239
1624854
7301459
70491084
70511814
70778714
166902745
32592176
37848366
57218355
57221165
132564405
143580725
143750055
27012422
42452682
54050712
68972466
88132710
672949
46131429
46358769
131386809
119398776
97989664
40483205
111318245
23441682

1020
1830
1070
1020
3275
1026
5309
1070
1138
2190
1330
1230
1053
3810
3840
2170
1130
1480
2023
1750
1160
4550
2085
3260
2020
3890
2790
1040
1220
2210
1450
3120
1280
1320
1276
1500
1330
1020
3404
1760
1547
1531
1340
1110
1300
2060
1120
2223

SLC25A1P3
AC002463.1
CFAP46
CRAMP1
AMDHD2
AC087498.1
MOCS3
MYOM3
C1orf43
LINC01121
CSRNP3
AC007563.2
LRRIQ4
AC124944.3
AC024937.2
AC024560.3
WDR1
GTF2IP12
GTF2IP12
STOX2
FRG1-DT
AC026412.1
AC091951.1
AC146944.3
AC146944.1
AC139272.1
RPS6KA2
DPY19L1P1
EPDR1
AC099654.1
AC099654.1
PLXNA4
AC073264.2
RNU6-267P
AC067904.1
SLC20A2
LYPLA1
PIP5K1B
SPATA31C2
DIP2C
AGAP7P
AGAP14P
NA
USP2-AS1
MIR4303
LINC00598
TEX29
GOLGA6L2

NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_ORPHAN
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_10KB_EXON
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chr16
chr17
chr17
chr18
chr19
chr19
chr19
chr19
chr19
chr19

90166011
68148996
81580005
73325334
23322559
23465429
23878309
24179389
29015399
46918489

90167060
68150055
81581034
73326733
23323958
23469978
23882468
24181548
29016728
46922356

1050
1060
1030
1400
1400
4550
4160
2160
1330
3868

FAM157C
LRRC37A16P
NPLOC4
LINC02582
ZNF91
AC074140.1
AC139769.2
NA
LINC01532
ARHGAP35

NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_ORPHAN
NOVEL_10KB_EXON
NOVEL_10KB_EXON

chr19
chr20
chr20
chr20
chr20
chr20
chr20
chr20
chr20
chr21
chrX
chrX
chrX
chrX
chrX
chr2
chr15
chr3
chr21
chr21
chrY
chrY
chrY
chrY
chrY
chrY

50039299
1817803
5483953
47833573
47894373
47897423
48122623
48473243
48499743
28993116
527285
622205
625535
942355
1910245
241808169
64951720
195644509
8228686
8455846
527180
622200
625540
942350
1910130
2213400

50040528
1819042
5485022
47834972
47897142
47898942
48126802
48475192
48501212
28994175
528594
623384
627004
943544
1911684
241809368
64952949
195646888
8230745
8457845
528589
623389
627009
943549
1911589
2214439

1230
1240
1070
1400
2770
1520
4180
1950
1470
1060
1310
1180
1470
1190
1440
1200
1230
2380
2060
2000
1410
1190
1470
1200
1460
1040

ZNF473
AL121760.1
AL121757.1
RNU7-173P
RNU7-92P
RNU7-92P
NA
AL049541.1
RNU7-144P
LTN1
FABP5P13
SHOX
SHOX
NA
NA
AC131097.3
ANKDD1A
AC233280.2
FP671120.1
NA
FABP5P13
SHOX
SHOX
NA
NA
DHRSX

NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_ORPHAN
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_ORPHAN
NOVEL_ORPHAN
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_ORPHAN
NOVEL_10KB_EXON
NOVEL_10KB_EXON
NOVEL_INTRONIC
NOVEL_ORPHAN
NOVEL_ORPHAN
NOVEL_10KB_EXON
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Appendix H: Specifications for quantitative quality control of MARS samples.
Step 1: If the sample has less than 20% of the aligned reads belonging to the human genome
and less than 2 million autosomal reads (duplicates included), then the sample is assigned as
“Category 1: Low Genomic”. Otherwise, the sample continues to step 2.
Step 2: If the sample has greater than 75% of the aligned reads belonging to the human
genome and one of the two following conditions: Read duplication rate less than 10% or less
than 5% of aligned reads belonging to ribosomal RNA, then the sample is assigned as
“Category 2: High intergenic reads”. Otherwise, the sample continues to step 3.
Step 3: If the sample has a % of aligned reads belonging to the human genome between 20%
and 40%, and greater than 4% of the aligned reads belonging to the bacteria or viruses, then
the sample is assigned as “Category 3: High bacterial and viral reads”. Otherwise, the sample
continues to step 4.
Step 4: If the sample has a % of aligned reads belonging to the human genome between 20%
and 40%, and greater than 50% of the aligned reads belonging to the ERCC spike-in, then
the sample is assigned as “Category 4: High spike-in reads”. Otherwise, the sample continues
to step 5.
Step 5: If the sample has a % of aligned reads belonging to the human genome between 20%
and 40%, and greater than 40% of the reads remaining unmapped, then the sample is
assigned as “Category 5: High unmapped reads”. Otherwise, the sample has passed quality
control and is determined to be of satisfactory quality.
The R function for the above process is shown below:
makelab <- function(x){ ##where x is a row number, corresponding to a particular sample
a <- ar{ar$sample==x,}
if(a$genomic_prop<0.2 & a$autosome<2000000){
b <- "Cond1_lowgenomic"}
else if(a$genomic_prop>0.75 & (a$duplicates_prop < 0.1 | a$rRNA_prop < 0.05)){
b <- "Cond2_grassy"}
else if(a$genomic_prop>=0.2 & a$genomic_prop<=0.4 & a$bactviral_prop>0.04){
b <- "Cond3_highbactviral"}
else if(a$genomic_prop>=0.2 & a$genomic_prop<=0.4 & a$ercc_prop>0.5){
b <- "Cond4_highercc"}
else if(a$genomic_prop>=0.2 & a$genomic_prop<=0.4 & a$unmapped_prop>0.4){
b <- "Cond5_highunmapped"}
else {
b <- "OK"
}
return(b)
}
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Appendix I: Differential expression of sperm-enriched genomic repeats. The number of
differential REs that overlap a given repeat are indicated for (A) Simple repeats, (B) Complex
repeats, and (C) Centromeric repeats. X-axis provides the repeat name, while the Y-axis
indicates the number of differential REs for each significant expression change.

157
Appendix J. piRNA clusters with multiple piRNAs expressed in human sperm. The
cluster location and name are indicated in the columns “Chromosome”, “Start”, “End”, “Cluster
width”, and “Cluster_name”. “Cluster expression in Testis” provides the expression details
from the pooled generic testis dataset, from which the clusters were generated. The column
“Count of expressed piRNAs” indicates the number of piRNAs present in human sperm
(median RPM > 1 RPM) belonging to the given cluster.

Chromosome

Start

End

Cluster
Width

Cluster name

Cluster expression in Testis

Count of
expressed
piRNAs

chr19
chr3
chr1
chr10
chr15
chr15
chr4
chr9
chr10

16011114
12848046
179582014
28786000
51246002
96761025
119403036
81910020
79680067

16044967
12879013
179593814
28797031
51308028
96790009
119414007
81933023
79719007

33854
30968
11801
11032
62027
28985
10972
23004
38941

cluster_168
cluster_234
cluster_21
cluster_27
cluster_99
cluster_111
cluster_248
cluster_330
cluster_40

normal_testis_generic|10711.0258613575|mono:plus|168
normal_testis_generic|1513.99429755676|mono:minus|234
normal_testis_generic|1903.72089572736|mono:minus|21
normal_testis_generic|7153.61881881805|mono:minus|27
normal_testis_generic|14407.8869660576|mono:minus|99
normal_testis_generic|3644.61909348552|mono:minus|111
normal_testis_generic|218.559754300489|mono:minus|248
normal_testis_generic|1269.70452451239|mono:minus|330
normal_testis_generic|535.912720047788|mono:minus|40

6
6
3
3
3
3
3
3
2

chr11
chr11
chr6

45666000
75003029
33863011

45730027
75014999
33925970

64028
11971
62960

cluster_51
cluster_56
cluster_271

2
2
2

chr9

113101011

113122392

21382

cluster_340

chrX

9400016

9419006

18991

cluster_351

normal_testis_generic|23143.2207101714|mono:minus|51
normal_testis_generic|1048.76550357495|mono:plus|56
normal_testis_generic|34453.9318019432|bi:minus-plus (split
between 33892867 and 33892867)|271
normal_testis_generic|11059.4403415613|bi:minus-plus (split
between 113112111 and 113112118)|340
normal_testis_generic|1353.62783508312|mono:minus|351

2
2

158
Appendix K. Small RNAs altered by DBP. Cells highlighted in lime green exhibit the same
expression trend in both study arms, while those highlighted in light orange exhibit opposite
expression trends.
B1HB2 arm

H1BH2 arm

High-DBP >
Non-DBP

High-DBP < NonDBP

High-DBP > NonDBP

L1M2_5
AluYg6
CHARLIE3

hsa_piR_016677
hsa_piR_016742
hsa-miR-192-5p
hsa_piR_019675
hsa-miR-200a-3p
tRNA-Gln-CAA

7SL
GOLEM
hsa-miR-339-5p
hsa_piR_005076
hsa_piR_010010
hsa_piR_011482

hsa-miR-186-5p

hsa_piR_017724

hsa-miR-27b-3p

MER28

CHARLIE10

TRNA_GLU

MER54A
hsa-miR-499a-5p
hsa_piR_016735

High-DBP < Non-DBP
ALRb
AluSq
AluSq10
AluYf1
AluYk12
CHARLIE3
ENSG00000199313|ENST000
00362443
ENSG00000222094|ENST000
00410162
ENSG00000252461|ENST000
00516652
ENSG00000252677|ENST000
00516868
HERV16
HERV-Fc1
HERVK3I
hsa-let-7d-3p
hsa-miR-142-5p
hsa-miR-151b
hsa-miR-28-3p
hsa-miR-320a
hsa-miR-3656
hsa-miR-423-5p
hsa-miR-486-5p
hsa-miR-508-5p
hsa-miR-574-5p
hsa-miR-891a-5p
hsa_piR_000753
hsa_piR_001809
hsa_piR_003116
hsa_piR_003180
hsa_piR_003220
hsa_piR_003257
hsa_piR_004427
hsa_piR_004880
hsa_piR_005278
hsa_piR_005371
hsa_piR_005675
hsa_piR_005767
hsa_piR_006426
hsa_piR_006434
hsa_piR_008114

hsa_piR_008397
hsa_piR_009228
hsa_piR_013247
hsa_piR_016582
hsa_piR_016584
hsa_piR_016804
hsa_piR_017550
hsa_piR_017591
hsa_piR_017781
hsa_piR_017990
hsa_piR_017996
hsa_piR_018717
hsa_piR_018790
hsa_piR_019675
hsa_piR_020497
hsa_piR_021041
hsa_piR_021722
hsa_piR_022107
hsa_piR_023221
hsa_piR_023224
hsa_piR_023415
L1M3C_5
L1MB7
L1MC3
L1P4d_5end
LTR10C
LTR16A
LTR1F1
LTR30
LTR66
MER54
MER66_I
MER72
MLT1D
MST_I
SVA_A
THE1D
tRNA-Ala-GCA
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ABSTRACT
DEFINING THE EFFECT OF ENVIRONMENTAL PERTURBATION ON THE MALE
GERMLINE
by
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Degree: Doctor of Philosophy
Periconceptional environment, according to the Developmental Origins of Health and
Disease (DOHaD) theory, influences offspring phenotype, primarily via epigenetic
mechanisms. Although the paternal component in humans is poorly understood, both
maternal and paternal peri-conceptional environment are now believed to contribute to this
phenomenon. Manipulation of the early embryo for treating human infertility, is suspected of
contributing to offspring abnormalities through epigenetic mechanisms. To directly address
the effects of common assisted reproductive technology procedures on the offspring
epigenome, the DNA methylation profiles of newborns conceived naturally, or through the use
of intrauterine insemination (IUI), or in vitro fertilization (IVF) using Fresh or Cryopreserved
(Frozen) embryo transfer, were compared. In addition to a reduction of epigenetic aberrations
in the IVF conceptions using cryopreservation, metastable epialleles also exhibited altered
methylation with fertility status. ART, embryo nutrition, and fertility status are thus suggested
to have a lasting epigenetic effect of on the developing embryo. While the paternal contribution
to the human embryo is uncertain, sperm deliver a collection of proteins and RNA to the
zygote. To identify the entire cadre of intergenic spermatozoal RNAs, RNA Element (RE)
discovery algorithm (REDa) was developed and applied to a spectrum of germline, embryonic,
and somatic tissues. This highlighted extensive transcription throughout the human genome
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and yielded previously unidentified human RNAs. Human spermatogenesis was found to
exhibit extensive intergenic transcription and pervasive repetitive sequence expression. By
analyzing the collection of novel and annotated spermatozoal RNAs in sperm samples from
the Mesalamine and Reproductive Health Study (MARS), the effect of endocrine disruptor
exposure on human sperm RNA profiles was determined. Sperm RNA profiles among men
and their relationship to di-butyl phthalate (DBP) was longitudinally assessed across binary
(high or background) DBP crossover exposures. Numerous changes in the composition of
sperm RNA elements were detected during the acute and recovery phases, which suggest
that exposure to, or removal from high DBP, produces effects that require longer than one
spermatogenic cycle to resolve, if at all. Overall, chronic phthalate exposure influences the
male germline, and acts on the dynamic RNA expression during human spermiogenesis.
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